plan prepare perform annual report table content turnover corporate overview plan prepare perform corporate information cr statutory report management discussion analysis director report report corporate governance profit business responsibility report financial statement consolidated standalone cr notice entered league indian company detail please visit wwwajantapharmacom planning planning preparing performing ajanta pharma represent continuous sequence initiative global mindset deliver differentiated product global market fine tune scientific strategy line changing focus specific requirement global customer market year continued move towards building meaningful longterm value threepronged strategy plan prepare perform result encouraging player enhanced presence usa driven product launch superior execution preparing reinforced therapy specific strategy drive growth india business deliver strengthened effort regain growth momentum effective solution emerging market matter build healthy product pipeline focused market global healthcare enhanced rd spend robust product landscape development successful u fda inspection manufacturing facility performing commissioned new manufacturing facility future build sustainable growth requirement business creates value stakeholder annual report serving healthcare need worldwide ajanta pharma specialty pharmaceutical company engaged development manufacturing marketing quality finished dosage business includes branded generic india rest asia africa generic usa mission serve global healthcare need empathy innovation technology scale robust service operational leadership delivery excellence global footprint leadership global marketing network singleminded focus quality segment field force geography excellence stateoftheart rd facility customercentric approach ingenious use science innovative st market solution technology provide advanced large manufacturing facility solution approved leading regulatory proactive efficient execution agency ensure timely launch optimum utilisation resource distribution deliver superior return resilient leadership proven track record delivering committed inspired team sustained growth adding value stakeholder manufacturing operational highlight facility filed additional andas u fda taking total count formulation api manufacturing facility india commissioned st phase manufacturing facility guwahati formulation facility mauritius u fda completes inspection dahej paithan manufacturing facility enhanced rd spend revenue revenue last year business segment india emerging market usa specialty segment customised product portfolio focus oral solid ophthalmology dermatology market mix para ii iii iv cardiology pain management many firsttomarket product final andas approved leadership product amongst leading player many segment product commercialised market product shelf tentative anda approval presence country across medical representative asia africa andas review launched many first institutional sale amongst andas filed fy market global supplier antimalarial drug global fund strength employee team rd scientist year ended year ended st march different nationality st march annual report financial performance total income cr revenue cr year cagr fy fy fy fy fy ebitda ebitda cr net profit year cagr fy fy fy fy fy net profit cr free cash flow cr year cagr fy fy fy fy fy plan prepare perform corporate overview financial highlight cash profit cr dividend payout year cagr fy fy fy fy fy fy fy fy fy fy ebitda margin ronw fy fy fy fy fy fy fy fy fy fy net margin roce fy fy fy fy fy fy fy fy fy fy annual report management speak strategy present right market differentiated difficulttoproduce product designed create impact optimise opportunity across geography dear stakeholder continue plan revival infrastructure timely expansion growth emerging market rd facility commencement steady growth year implementing sustainable business guwahati plant year characterised strategy expansion outcome foresight ability plan prepare perform emerging market team futureoriented action taken two line market opportunity fy part preparation year ago dynamic ajanta pharma reviving growth market achievement fy similarly strengthened outcome philosophy usa success current year grew rd team accelerating demonstrated meticulous planning instance outcome product filing different market proactive preparedness across plan laid fy detailed preparation operation resulting meaningful player market recent u fda inspection satisfactory performance introduced seven new product manufacturing plant helped u sail including two successful day one inspection without strategy present right launch usa fy major concern comment market differentiated difficultto launch planned fy produce product designed precise preparation allowed u file industry largely knowledge create impact optimise eight andas u fda driven therefore importance opportunity across geography ready filing innovation important ensures consistent growth u ensuing year demonstrates preparedness cannot year strong product pipeline overemphasised consequently monetised approval steadily augmenting india market plan validation rd effort rd investment help doctor leader subtherapeutic treat difficult disease segment supported order fulfil global patient grapple many innovative firsttomarket aspiration also worked investment growing product launch better customer meticulous plan augment absolute term also experience enhance manufacturing rd percentage turnover signifying rajesh agrawal yogesh agrawal joint managing director managing director timely expansion rd facility commencement guwahati plant year outcome foresight futureoriented action taken two year ago immense importance place headwind challenge also reinforce footprint innovation rd investment remain relevant emerging chosen market strengthen fy rose cr market manner value balance sheet enhance revenue cr accretive capability talent pool revenue fy continue create value financial performance reflective stakeholder core investment ambition ability grow performance belief despite challenge fy achieved many milestone sustainable growth possible achieved consolidated net profit backed threepronged strategy achieve notwithstanding dynamic cr growth compared plan prepare perform business environment cr last year consolidated believe approach shall evolving regulatory scenario total income also touched cr continue work compared cr rise confident delivering even better planning preparedness across previous year performance future every aspect business best yet come borne fruit performance core objective augment outcome fy delivered differentiated product portfolio regard outstanding result usa offer impactful solution backed yogesh agrawal rajesh agrawal continued grow india intensive extensive research effectively managed currency specialty therapeutic segment annual report opportunity landscape rising income increased government healthcare expenditure higher life expectancy growing chronic illness augmenting demand pharmaceutical product service globally ajanta pharma uniquely positioned pharmaceutical opportunity landscape vision led u follow unconventional path believe offer sustainable revenue competitive advantage enable u grow consistently coming year strategic priority fy reinforcing reviving building operational india emerging usa excellence market market market continue innovation deploy additional quick launch strengthen process resource approved product strengthen leadership enhance rd plant subtherapeutic launch new product enhance customer productivity segment supply chain experience increase market share scaling operation enhance sale force file andas new plant productivity create strong pipeline put place multiple growth catalyst believe greatest competitive advantage passion deliver outcome presence country planning marketspecific global strategy plan prepare perform corporate overview plan prepare perform ajanta pharma follow continue launch product countryspecific therapeutic strengthen marketing team requirement specific model invigorate market coming year approach focus select country measure stability wider product portfolio economic scenario expect resulted sustainable regain growth momentum profitable business branded generic business medium term strengthening presence india year developed entered philippine six year propensity launching number ago recognised inherent first market focus growth potential market new drug delivery system ndds insight allowed u cater specific around actively marketed therapeutic area anti brand brand india first infectives dermatology orthopaedics focus specialty therapy ophthalmic cardiovascular ajanta pharma niche product led u post gastro intestinal among strategy always strong cagr branded top pharma company generic business fy demonstrated one fastest present growth graph philippine right market plan remain focused market delivered cagr highgrowth specialty five year driven plan entry therapeutic segment india new product launch increased new geographical enhance leadership cardiology traction existing product dermatology ophthalmology pain market based management aggressive launch creating sound usa strategy clear understanding improving research productivity growth aspiration inspired led superior growth fy presence large complex opportunity launched product marketplace provide profitable ability india propel opportunity focused growth coming year strong creating presence usa place specialty pipeline product offing world largest pharmaceutical differentiated line strategy plan prepare marketplace selecting niche perform complex product oral solid complex product space filed abbreviated market invigorating asia africa new drug application andas established strong received meticulous planning presence rest asia africa final approval two tentative resulted greater branded generic business approval awaiting approval major segment antimalaria anti andas plan file scale enhanced bacterial cardiovascular orthopaedic andas fy u fda product portfolio gynaecology paediatric fy accomplished among others medical day one launch confirms higher penetration representative field strategy plan prepare perform across global market formidable presence market preparing emerging opportunity challenge plan prepare perform corporate overview plan prepare perform strengthening rd core quality framework assurance rd remains critical differentiator procedure team focus strategic positioning multiple strategy reduce cost important element brand obtaining regulatory conformity image supremely important reinforcing market leadership regularly upgrade rd initiative driven market process line evolving demand implementation regulatory scenario advanced technology play key role context quality control quality assurance standard significant expertise benchmarked best ajanta pharma develop manufacture complex industry strive enhance formulation various dosage form consistently future readiness including tablet capsule powder dependent ophthalmic sterile eye drop continuously review ointment injectables upgrade standard research performance match development rd agenda best industry support growth strategy rd capability developing new product follow standard operating worldclass process enrich procedure ensure best enhance portfolio manufacturing process manufacturing facility strive constant process improvement attain year manufacturing cost competency proactively focus developing complex steadily enhanced product high entry barrier investment initiative expected area service enhance product registration filing changing need broaden product basket key market presence patient healthcare professional manufacturing facility along expansion existing society facility building new facility equipped address pursue growth objective coming year global healthcare need quality key survival growth global pharmaceutical empathy innovation landscape manufacturing technology facility conform rigorous consolidated total income profit tax year trend cr consolidated total income cagr pat cagr fy fy fy fy fy fy fy fy fy total operating income fy profit tax performing set industry benchmark plan prepare perform corporate overview plan prepare perform ajanta pharma built strong countryspecific product foundation entrepreneurial specific model business energy professional integrity augmenting well enhance market commitment board director share international market leadership team consistently product registration provide guidance create hand equal number nurture sustainable value approval thus investment stakeholder operate facility rd new product business highest ethical fuelling future growth plan standard remain committed achieving sustainable part professional ethos profitable growth focus improving operational efficiency hr practice customer effectiveness consolidated total income cr investment give u chance strengthen industry standing cagr thought leadership ajanta pharma flexible risk focused business model enables u fy fy fy fy fy deliver effective solution customer generate healthy return monitor operating margin prudently manage operating cost shareholder ensure business cost build sustainable effective leverage scale flexible delivery model effective business vision procurement value added commitment service deliver client stakeholder exercising rigorous fiscal discipline enabled u grow strengthening transparency developing risk matrix adhere revenue highest standard corporate cr fy governance time ensuring accuracy financial cr fy reporting effective internal cagr control annual report supporting community sustainability strategy embedded approach community service work realm healthcare education general community wellbeing summary total direct beneficiary health activity fy patient benefitted free eye checkup camp organised different part country education education brings awareness awareness brings confidence healthcare ajanta pharma focus bringing meaningful transformation confidence brings change associated various school rural tribal area cataract surgery performed giving vision life lack resource provide educational infrastructure poor people opportunity less privileged one form renovating school rural tribal india provide building science laboratory needy patient best health library computer lab area cataract operation emphasis promoting family planning programme plastic surgery year education girl child besides provide vocational training also added prisoner maharashtra many girl student area family planning surgery performed jail healthcare initiative sewing embroidery singing additionally longterm benefit computer training among others poor patient provided assistance enhances girl child employability upgradation charitable hospital right formal education subsidised food facility patient relative near also process settingup independent technical institute government hospital benefitted vocational training rural provided skin treatment plastic surgery large section unemployed treatment plan prepare perform corporate overview corporate information corporate information board director auditor mannalal b agrawal kapoor parekh associate chairman cost auditor purushottam b agrawal sevekari khare associate vice chairman internal auditor madhusudan b agrawal mahajan aibara vice chairman chief financial officer yogesh agrawal arvind agrawal managing director company secretary rajesh agrawal gaurang shah joint managing director cin chandrakant khetan lmhplc director registered office dr anil kumar ajanta house charkop director kandivli west mumbai tel k h vishwanathan fax director website wwwajantapharmacom email infoajantapharmacom prabhakar r dalal director dr anjana grewal director annual report management discussion analysis economic overview outlook factor underpenetration rising healthcare spends international monetary fund imf expects global household greater prevalence chronic disease drive economy grow fy fy growth domestic market time generic drug versus growth fy outlook emerging developed market foray growing emerging market economy expected broadly improve though market drive performance internationally volatility capital flow remain challenge fy india likely among top three according economic survey india real pharmaceutical market incremental growth sixth gdp growth projected fy could reach largest market globally absolute size overall market fy project india one size expected grow billion fy primarily fastest growing country landscape uncertain due rising consumer spending rapid urbanisation global economy increasing healthcare insurance awareness industry poised grow driven increasing affordability shifting pharmaceutical sector overview disease pattern healthcare reform however recent global policy shift increased government control factor pharmaceutical industry one world fastest growing create uncertainty market growth industry remains one biggest contributor world economy unprecedented expansion global healthcare access past year seen fy india likely hundred million people low middle income among top three pharmaceutical group benefiting governmental programme rising income market incremental growth sixth largest market globally usa continue world largest pharmaceutical market emerging market make top market absolute size developed market spending growth driven original brand emerging market continue driven emerging market nonoriginal product make average huge potential growth spending emerging emerging market volume spending market increase per caput volume monetary allocation towards medicine suggests conscious desire emerging market longterm economic growth increasing government private insurance market emerging expectation healthcare provision changing diet country increase bandwidth healthcare volume lifestyle increasing demand healthcare product medicine use projected increase compound annual across life stage primarily treat chronic condition growth rate globally next five year including respiratory cardiovascular disease demand fy fy expected grow significantly faster market coming year mature economy pharmaceutical market africa expected reach time downward pressure pricing government focus billion fy tropical climate africa make prevention treatment high cost rd pose major continent largest reservoir infectious disease particularly challenge industry globally malaria tuberculosis tb acquired immune deficiency syndrome aid noncommunicable disease india cardiovascular diabetes projected rise india pharma industry placed third global ranking term illness africa fy key challenge volume th value industry grown cagr market volatile local currency internal disturbance fy expected grow transfer restriction keep player billion fy billion fy source ibef toe indian pharma company welldiversified business usa market model optimal business mix across primary medicine spending growth usa market slowing geography india emerging market usa steadily since fy bounced back sharply fy fy generic medicine continue larger industry commendable growth path share prescription medicine market usa poised stepup trajectory combination coming five year market grow billion plan prepare perform statutory report management discussion analysis billion fy invoice price basis segment performance growth billion billion fy net basis global demand generic drug continue grow consumer pursue avenue reduce cost usa generic drug comprise pharma market volume around billion worth patent expiry next five year generic business significant growth potential however issue compliance fast erosion price along clear strategy new administration remain key challenge market around billion worth pharma market dermatology cardiology ophthalmology pain mgt patent expiry next five ipm ajanta pharma year generic business export significant growth potential export grew fy driven strong growth usa market year company company overview received anda approval launched product ajanta pharma speciality pharmaceutical company usa market product day launch engaged development manufacture marketing strategy company diversifying different market quality finished dosage domestic international helped maintain growth momentum even market business includes branded generic emerging subdued growth africa negative growth asia market asia africa generic developed market emerging market got impacted due currency usa institution sale employ nearly people devaluation restriction across asia africa worldwide product sold country export detail cr operational highlight entered elite club fortune indian company turnover crossed cr profit crossed cr commissioned st phase guwahati manufacturing plant u fda completes inspection paithan dahej plant without major observation enhanced rd spend fuel growth performance highlight india india branded generic business continued perform well per ims mat march company grew total export africa asia usa indian pharmaceutical market ipm growth even fy fy within speciality segment company operates growth higher industry except dermatology research development company continues launch new product many research development rd represents cornerstone st market pipeline innovation ajanta pharma rd played vital role launch coming year company sustained growth last decade team well qualified experienced professional india institution business degrown specialised across value chain pharmaceutical previous year company decided defocus research responsible creating strong product business due low margin pipeline different market rd facility comply international standard well equipped excellent infrastructure supported bestinclass manpower annual report geographywise sale fy territory sale cr sale rd scientist new product launched fy india africa asia company rd initiative support activity usa various business new product process others development engagement technology establishing technology commercial scale analysis consolidated financial statement year follows ajanta pharma designed scientifically driven successful rd continues ensure delivery profit loss statement sustainable pipeline highvalue drug product revenue operation company rd strategy centred improving speed revenue operation increased cr yield generic product financial year fy cr fy increase driven company invested total operating income growth volume along niche new launch rd continues build support infrastructure product rd spend total oper income excluding capex material cost cr material cost declined fy fy reduction account growth quality business niche first time product launch employee expense peoplerelated expense increased cr fy cr fy increase due additional manpower recruited marketing rd support function expense expense include marketing distribution rd fy administrative expense stood cr fy fy fy fy fy cr fy revenue expense gone last year higher spend rd loss foreign currency fluctuation major reason increase financial review company healthy financial performance margin year contributed strong product portfolio ebidta net margin stood respectively differentiated approach focus execution fy compared respectively strategy improving product mix gaining presence fy result quality product mix higher market going forward company shall strive efficiency sustain performance continuation approval expansion manufacturing capacity vertical balance sheet add value ajanta pharma stakeholder shareholder fund shareholder fund increased cr fy snapshot cr fy increase primarily due increase net margin earnings per share stood cr fy fy year fy fy growth income operation noncurrent liability ebidta balance head declined cr pbt fy cr fy largely due repayment pat longterm borrowing plan prepare perform statutory report management discussion analysis current liability following table highlight key risk along mitigating balance head reduced cr fy plan place manage risk cr fy decrease due reduction shortterm borrowing sr risk statement mitigation plan noncurrent asset competition risk innovation per customer need noncurrent asset increased cr fy customisation product primarily due addition property plant equipment ground presence every market guwahati dahej facility regulatory risk robust quality assurance framework regular training update current asset global economic well dispersed geographic presence balance head increased cr fy volatility risk regular monitoring local presence cr fy increase largely due foreign disciplined hedging policy increase investment surplus fund exchange risk systematic monitoring human asset internal control system adequacy company take pride dynamic knowledgedriven talent pool employee base consistently contributed internal control framework governing operation towards growth sustainability year ensures effectiveness automated internal business efficiency control operation company belief open translucent culture reliability financial centralised global process welldefined robust leadership competency framework reporting framework instils strengthens common leadership approach compliance law integrated key support across organisation leadership capability regulation function integral talent management philosophy leadership monitor ensures quarterly tracking development initiative development programme process designed prepare company leader adjust prudent financial annual quality objective fastpaced change industry manage growth control accountability u qms quality management consistently encourages culture integrity management system employee recognition motivation achieved software built company automated control company welldesigned policy procedure process recognise reward contribution report formation team various employee benefit scheme internal auditor different location ajanta pharma work environment motivates submit report people achieve best encourages ecosystem update teamwork continuous learning worklife balance audit committee company promotes innovation rewarding idea board review make real difference key facet business provides direction company total employee strength stood st march cautionary statement certain statement management discussion risk management analysis describing company objective prediction ajanta pharma institutionalised strong risk may forwardlooking statement within meaning management structure enables regular meticulous applicable law regulation actual result may vary examination business activity identification significantly forward looking statement contained evaluation mitigation potential internal external document due various risk uncertainty risk company established robust process risk uncertainty include effect economic guideline along strong overview monitoring political condition india volatility interest rate system board senior management level new regulation government policy may impact laid procedure inform board member company business well ability implement risk assessment risk minimisation measure strategy company undertake update organisation ajanta pharma operates framework statement strong ethical value high level integrity activity strategy considerably mitigates risk annual report director report dear shareholder director take pleasure presenting thirtyeighth annual report audited financial statement year ended st march financial result cr except eps standalone consolidated year ended march growth growth total revenue ebitda profit tax dividend paid equity share including tax transfer general reserve nil nil earnings per share eps dividend share capital year company declared paid two year share issued interim dividend totaling per equity esos consequent thereto total paid equity share director recommend interim share capital company st march dividend considered final stood cr divided equity share particular employee stock performance review option grantedvestedexercised year company posted remarkable performance given annexure report year review continued grow different parameter domestic business contributed whereas credit rating export contributed total revenue company company bank facility rated credit analysis continues launch new product first market product research limited care company continues gain market share therapeutic segment rating working capital facility geography operates denotes strong degree safety regarding timely payment financial obligation long term company continues operate one segment borrowing company rating aa indicates ie pharmaceutical change high degree safety regarding timely servicing nature business company financial obligation material change commitment subsidiary associate affecting financial position company company continues six subsidiary occurred end financial year overseas including one step subsidiary date report change year financials subsidiary disclosed significant material order passed consolidated financial statement form part company regulator court annual report tribunal impact going concern status company operation future statement containing salient feature financial statement subsidiary pursuant section management discussion analysis company act act read rule management discussion analysis mda form company account rule annexed part annual report given elsewhere report prescribed form aoci report annexure b financial statement subsidiary plan prepare perform statutory report director report company available inspection aspect would enable effectively shareholder registered office company discharge responsibility function conferred company laid policy material program undertaken subsidiary none subsidiary material year include subsidiary per policy policy placed website company httpwwwajantapharma overview business operation comadmindatapolicycodesceacbe afaecpolicyonmaterialsubsidiariespdf ii tax regulatory update compliance indas company invested jv turkmenderman ajanta pharma limited tdapl two decade back iii nvestor relation employee development management control however later etc company surrendered management control favour local partner since control role responsibility function iv significant influence tdapl independent director corporate law operates severe restriction significantly impairs ability transfer fund hence company v visit dahej manufacturing facility impaired entire investment tdapl considered unrelated party associate vi business operation subsidiary account consolidated vii rd operation way forward director change director detail familiarization programme key managerial personnel year imparted placed company independent director given declaration website wwwajantapharmacom meet criterion independence admindatadirectorfamiliarizationprogram laid section act directorsfamilarisationprogrammepdf security exchange board india listing obligation disclosure requirement e evaluation board committee director regulation listing regulation based pursuant provision act disclosure provided director none listing regulation board carried disqualified appointed director performance evaluation board section act committee independent director independent director separate b retirement rotation meeting evaluated performance non mr madhusudan b agrawal mr rajesh independent director board whole agrawal retire rotation ensuing chairman board manner annual general meeting eligible offer evaluation carried detailed reappointment board recommends corporate governance report reappointment approval member f policy appointment remuneration c board meeting director year five board meeting held detail criterion laid appointment detail given corporate director policy remuneration director governance report given corporate governance report independent director familiarization audit committee programme detail pertaining composition audit company continued independent committee included corporate governance director familiarization program familiarizing report form part report company operation critical annual report new project c cost auditor company commenced commercial company appointed sevekari khare production new manufacturing facility associate practicing cost accountant audit guwahati phase dahej construction phase cost record company financial ii guwahati underway addition company year subject ratification proactively assesses requirement infrastructure remuneration member ensuing agm future growth continuously invests internal control system risk management auditor compliance framework statutory auditor company place well defined adequate auditor report year review internal financial control framework year contain qualification adverse control tested material weakness remark auditor also reported design operation observed risk fraud committed company management system followed company officer employee detailed mda statutory auditor kapoor parekh vigil mechanism associate chartered accountant mumbai hold company set vigil mechanism viz whistle office till conclusion ensuing annual general blower policy enable employee director meeting agm eligible report audit committee chairman genuine appointment term section act concern unethical behaviour irregularity noticed company could basis recommendation audit adversely affect company operation posted committee board appointed b r intranet company reviewed co llp new auditor subject approval audit committee time time concern member ensuing annual general meeting irregularity reported employee company received consent certificate director till date eligibility b r co llp accordance section applicable related party transaction policy provision act rule issued thereunder related party transaction rpts entered confirmed hold valid financial year arm length basis certificate issued peer review board ordinary course business particular institute chartered accountant india icai contract arrangement furnished required listing regulation r pt foreseen repetitive nature omnibus board recommends approval member approval audit committee obtained beginning appointment period five year financial year rpts affected year conclusion th agm till conclusion disclosed note financial statement rd agm subject ratification member agm board approved adopted policy related party transaction uploaded b secretarial auditor company website httpwwwajantapharmacom pursuant provision section admindatapolicycodesecbcfcf act company appointment eecfpolicyonrelatedpartytransactionspdf remuneration managerial personnel rule company appointed alwyn managerial remuneration particular dsouza co company secretary practice employee undertake secretarial audit company information pursuant rule company secretarial audit report annexed appointment remuneration managerial report annexure c personnel rule annexed report qualification reservation adverse remark annexure also given elsewhere report report plan prepare perform statutory report director report information pursuant rule company accounting standard followed along appointment remuneration managerial proper explanation relating material personnel rule pertaining top ten name departure particular employee also form part report however information sent along b director selected accounting report pursuant proviso section policy applied consistently made act shareholder interested obtaining judgment estimate reasonable copy may write company secretary prudent give true fair view compliance officer registered office address state affair company end company financial year ended st march profit company year loan guarantee investment detail loan guarantee investment covered c proper sufficient care taken provision section act given maintenance adequate accounting note financial statement record accordance provision act safeguarding asset company corporate social responsibility csr preventing detecting fraud company csr policy primarily rest three irregularity broad tenet healthcare education community development within ambit annual accountsfinancial statement schedule vii act year company prepared going concern basis continued several initiative csr program directly well agency permitted e proper internal financial control place act detail csr policy csr activity financial control adequate undertaken year annexed report operating effectively annexure e also given elsewhere report f director devised proper system ensure compliance provision deposit applicable law place adequate company accepted deposit operating effectively public falling within purview section act read company acceptance deposit conservation energy technology rule absorption foreign exchange earnings outgo unclaimed dividend unclaimed share information relating conservation energy pursuance regulation read schedule vi technology absorption foreign exchange earnings listing regulation company outgo pursuant section act read year transferred unclaimed share unclaimed company account rule annexed suspense account opened purpose report annexure g following due process corporate governance extract annual return report corporate governance annexed extract annual return form mgt form integral part annual report certificate annexed report annexure f auditor regarding compliance condition corporate governance stipulated listing director responsibility statement regulation also appended report best knowledge belief according corporate governance information explanation obtained director confirm business responsibility reporting business responsibility report company preparation annual account year ended st march form part year ended st march applicable annual report given elsewhere report annual report human resource process followed complainant keeping company firm belief human icc whilst dealing issue related sexual resource play pivotal role success harassment work place woman employee organization company continued organise permanent temporary contractual trainee various inbound outbound training programes covered policy company recreational team building activity enhance received complaint year employee skill motivation also foster team spirit company also conducted various workshop gratitude acknowledgement event grooming upgrading vocational director place record sincere gratitude skill talent pool order meet future talent staunch dedication highly motivated requirement industrial relation cordial performance employee across globe throughout year contributed greatly persistent performance company director also sincerely thank policy sexual harassment woman stakeholder medical professional business work place partner government statutory body bank company place policy prevention financial institution analyst shareholder prohibition redressal sexual harassment continued assistance cooperation support woman workplace accordance requirement sexual harassment woman behalf board director workplace prevention prohibition redressal act internal complaint committee icc set per statutory requirement mannalal b agrawal redress complaint regarding sexual harassment chairman policy set guideline redressal enquiry mumbai rd may plan prepare perform statutory report director report annexure director report employee stock option scheme description detail option total option granted b pricing formula exercise price per option c option vested option exercised e total number share arising result exercise option f option lapsed year none g variation term option exercise price reduced option h money realized exercise option total option force j employeewise detail option granted senior managerial personnel option granted employee company employee overseas subsidiary ii employee option granted amounting none total option granted year iii employee option equal exceeding issued none capital granted year k diluted earnings per share eps calculated accordance accounting standard eps l company calculated employee compensation cost using applicable intrinsic value stock option difference employee compensation cost computed employee compensation cost shall recognized used fair value option shall disclosed impact difference profit eps company weighted average exercise price weighted average fair value weighted average exercise price option option outstanding disclosed separately option whose exercise price either equal exceeds less market price stock weighted average fair value option option option n description method significant assumption used year estimate fair value option including following weighted average information variable weighted average information plan esos option option option grant date th may th july th july last date acceptance th june th august th august risk free rate expected life year year year year volatility dividend yield price underlying share market time option grant original grant date th august however grant date revised variation exercise price note fair value calculated using blackscholes option pricing formula stock price closing price nse date grant considered valuing option granted volatility historical volatility stock till date grant considered calculate fair value option risk free rate return risk free interest rate date grant considered calculation interest rate applicable maturity equal expected life option based zero coupon yield curve government security time maturity time maturity expected life option period company expects option live minimum life stock option minimum period option cannot exercised maximum life period option cannot exercised expected dividend yield expected dividend yield calculated average dividend yield four financial year preceding date grant annual report annexure b director report form aoc statement containing salient feature financial statement subsidiariesassociate companiesjoint venture pursuant first proviso subsection section read rule company account rule part subsidiary cr sl ajanta pharma ajanta pharma ajanta pharma ajanta pharma name subsidiary mauritius limited philippine inc usa inc nigeria ltd consolidated reporting period subsidiary concerned different mar mar mar mar holding company reporting period reporting currency subsidiary mur php usd nn reporting exchange rate last date relevant financial year case foreign subsidiary rupee equivalent unit foreign currency st march share capital reserve surplus total asset total liability excluding share capital reserve surplus investment turnover profit taxation provision taxation profit taxation proposed dividend shareholding note ajanta pharma mauritius ltd consolidated figure includes wholly owned subsidiary ajanta pharma mauritius intl ltd detail ajanta pharma uk ltd given equity contribution made yet started business operation per report even date attached kapoor parekh associate behalf board director chartered accountant nilesh parekh mannalal b agrawal partner chairman purushottam b agrawal yogesh agrawal arvind agrawal vice chairman managing director chief financial officer madhusudan b agrawal rajesh agrawal gaurang shah mumbai rd may vice chairman joint managing director company secretary plan prepare perform statutory report director report annexure c director report secretarial audit report financial year ended st march pursuant section company act rule company appointment remuneration managerial personnel rule security exchange board india member listing obligation disclosure requirement ajanta pharma limited regulation conducted secretarial audit compliance security exchange board india b applicable statutory provision adherence substantial acquisition share takeover good corporate practice ajanta pharma limited regulation hereinafter called company security exchange board india c secretarial audit conducted manner provided prohibition insider trading regulation u reasonable basis evaluating corporate conduct statutory compliance expressing opinion security exchange board india issue capital disclosure requirement based verification company statutory regulation register book paper minute book form return filed record maintained company e security exchange board india share information provided company officer based employee benefit regulation agent authorized representative conduct secretarial audit hereby report opinion security exchange board india f company audit period covering registrar issue share transfer agent financial year ended st march complied regulation regarding company act statutory provision listed hereunder also dealing client company followed proper boardprocesses required compliance mechanism place extent security exchange board india g manner subject reporting made hereinafter delisting equity share regulation applicable company examined book paper minute book form return filed record maintained security exchange board india h company financial year ended st march buyback security regulation according provision applicable company bought back proposed buyback security company act act rule made financial year review thereunder vi specific businessindustry related law applicable ii security contract regulation act scra company company complied rule made thereunder specific applicable law rule regulation guideline viz drug cosmetic act iii depository act regulation pharmacy act food drug administration byelaws framed thereunder licensing term condition applicable general law rule regulation guideline foreign exchange management act iv rule regulation made thereunder extent also examined compliance applicable foreign direct investment overseas direct investment clause following external commercial borrowing applicable secretarial standard regard meeting v following regulation guideline prescribed board director ss general meeting security exchange board india act ss issued institute company sebi act secretary india annual report ii listing regulation entered operation monitor ensure compliance company bse limited national stock applicable law rule regulation guideline exchange india limited informed company responded appropriately communication received various statutory regulatory period review company complied authority including initiating action corrective provision act rule regulation guideline measure wherever found necessary standard etc mentioned material noncompliance come knowledge report audit period following eventsactions taken place major bearing report board director company affair pursuance referred company duly constituted proper balance law rule regulation guideline standard executive director nonexecutive director independent director change composition board company meeting held th march board director took place period considered approved amalgamation gab review investment private limited gab company proposed amalgamation would carried vide adequate notice given director schedule scheme amalgamation arrangement gab board meeting agenda detailed note agenda company respective shareholder sent least seven day advance system section read section section exists seeking obtaining information act applicable provision act clarification agenda item meeting meaningful participation meeting minute board meeting identified alwyn dsouza co dissent member board hence company secretary reason believe decision board approved director present alwyn p dsouza report adequate system place mumbai fcs process company commensurate size date rd may c p plan prepare perform statutory report director report annexure director report detail pursuant rule company appointment remuneration managerial personnel rule name designation director kmp ratio remuneration increase decrease remuneration director median remuneration fy employee company fy mannalal agrawal ii purushottam agrawal iii madhusudan agrawal iv yogesh agrawal v rajesh agrawal vi chandrakant khetan vii dr anil kumar viii k h viswanathan ix prabhakar dalal x dr anjana grewal xi arvind agrawal chief financial officer na xii gaurang shah company secretary na includes sitting fee paid nonexecutive director sitting fee increased wef st april percentage increase median remuneration employee financial year number permanent employee roll company average percentile increase already made salary average increase remuneration employee employee managerial personnel last financial year increase financial year comparison percentile increase managerial remuneration percentile increase managerial remuneration justification thereof point median remuneration managerial personnel exceptional circumstance increase range need justification managerial remuneration affirmation remuneration per remuneration yes policy company annual report annexure e director report report csr pursuant section company act rule company corporate social responsibility rule brief outline company csr policy including overview project programme proposed undertaken reference weblink csr policy project programme csr policy appended weblink httpwwwajantapharmacomadmindatapolicycodescsrpoilcypdf composition csr committee mr mannalal b agrawal chairman mr chandrakant khetan member mr yogesh agrawal member dr anil kumar member average profit tax company last three financial year cr prescribed csr expenditure two per cent amount item company required spend cr towards csr detail csr spent financial year total amount spent financial year cr b amount unspent none c manner amount spent financial year detailed lac location state amount csr project activity sector budget direct agency dist spent medical assistance eye care family maharashtra agency planning hospital charge subsidized food patient relative maharashtra agency facility gradation charitable hospital maharashtra agency direct educational assistance b india agency renovation facility school b india agency technical institute b maharashtra agency community development rural area c maharashtra agency direct total refers detail sector promoting health care including preventive health care b promoting education including special education c reducing inequality faced socially economically backward group note overhead included amount spent agency seth shri bhagwandasji agrawal charitable trust corporate social responsibility committee company hereby confirms implementation monitoring csr policy compliance csr objective policy company ajanta pharma limited behalf csr committee ajanta pharma limited yogesh agrawal mannalal b agrawal managing director chairman csr committee mumbai rd may plan prepare perform statutory report director report csr policy amended board director th october background drinking water community hall park welfare corporate social responsibility ajanta pharma stem victim natural calamity amenity government ideology providing sustainable value hospital subsidized meal needy patient society company operates meeting relative initiative interest stakeholder recognize importance contributing towards development underprivileged maintaining balance ecosystem support section society committed execute initiate program continual improvement responsibly small contribution aspire environment health safety standard improve quality life weaker section society making available basic necessity selective basis contribute government easily accessible andor available voluntary organization academic institute working cause listed schedule vii csr policy company act rule framed program ajantas csr policy primarily rest broad category healthcare education community surplus arising csr project program development ecology program aimed activity shall form part business profit longterm sustainability inclusive development company special emphasis area around company operational location program designed implemented budget taking consideration specific need area minimum average net profit tax preceding three year allocated every financial year healthcare aim provide medical assistance csr activity expenditure incurred capacity rural underprivileged living remote village area building program training workshop seminar initiative like conference etc corporate communication strategy engagement stakeholder whether free medical camp health eye cataract internal external implement csr company surgery family welfare related area accounted csr expenditure unspent csr budget company financial year allowed b developing basic infrastructure around lapse carried forward next year government hospital people visiting remote area like shelter subsidized food monitoring review similar facility company board formed csr committee oversee policy execution prepare monitoring education effort concentrate providing mechanism ensure implementation project quality learning affordable cost rural area aiding programme activity proposed undertaken school vocational skill center related institution company per policy community development advocate support csr policy shall periodically reviewed sustainability rural area giving assistance safe appropriately revised csr committee annual report annexure f director report form mgt extract annual return financial year ended st march pursuant section company act rule company management administration rule registration detail cin lmhplc registration date name company ajanta pharma limited categorysubcategory company company share capital address registered office contact detail ajanta house govt industrial area charkop kandivali west mumbai tel fax website wwwajantapharmacom email investorgrievanceajantapharmacom whether listed company yes name address contact detail registrar transfer agent link intime india pvt ltd c park l b marg vikhroli west mumbai tel fax email rnthelpdesklinkintimecoin ii principal business activity company business activity contributing total turnover company shall stated sr name description main product nic code product total turnover service service company pharmaceutical product iii particular holding subsidiary associate company sr name address company cin gln holdingsubsidiary share applicable associate held section ajanta pharma usa inc na subsidiary st ave raritan nj ajanta pharma philippine inc na subsidiary unit axa life bldg sen gil puyat ave makati city phillipines ajanta pharma mauritius limited na subsidiary medium building goodlands mauritius ajanta pharma mauritius international limited na subsidiary step abax corporate administrator ltd th floor tower subsidiary cyber city ebene mauritius ajanta pharma nigeria limited na subsidiary block house b houson wright estate oregun lagos ajanta pharma uk ltd na subsidiary cabot house compass point business park st ives plan prepare perform statutory report director report iv share holding pattern equity share capital breakup percentage total equity categorywise shareholding shareholding beginning year shareholding end year change sn category shareholder total total demat physical total demat physical total share share year shareholding promoter promoter group indian individual hindu undivided family b central government state government c financial institution bank specify body corporate sub total foreign individual nonresident individual foreign individual b government c institution foreign portfolio investor e specify sub total total shareholding promoter promoter groupaaa b public shareholding institution mutual fund uti b venture capital fund c alternate investment fund foreign venture capital investor e foreign portfolio investor f financial institution bank g insurance company h provident fund pension fund specify sub total b central government state government president india sub total b noninstitutions individual individual shareholder holding nominal share capital upto lakh ii individual shareholder holding nominal share capital excess lakh b nbfcs registered rbi c employee trust overseas depositoriesholding drs balancing figure e specify trust foreign national hindu undivided family non resident indian non repat non resident indian repat clearing member market maker body corporate sub total b total public shareholding bbb b total ab c non promoter non public custodiandr holder employee benefit trust sebi share based employee benefit regulation total abc annual report b shareholding promoter sn shareholder name shareholding beginning year shareholding end year change total share share total share shareholding share share pledged share pledged company encumbered company encumbered year total total share share gab investment pvt ltd mr rajesh agrawal mr yogesh agrawal mr mannalal b agrawal mr purushottam b agrawal mr madhusudan b agrawal ganga export represented na na na na mr manisha agrawal mr aayush agrawal mr richa r agrawal ganga export represented na na na mr yogesh agrawal mr rajesh agrawal mr ravi p agrawal mr aayush agrawal mr madhusudan b agrawal huf mr mannalal b agrawal huf mr purushottam b agrawal huf mr ravi p agrawal mr aayush agrawal mr mamta agrawal mr manisha agrawal mr richa r agrawal mr smriti r agrawal mr vimal agrawal mr yogesh agrawal trustee yogesh agrawal trust mr rajesh agrawal trustee rajesh agrawal trust mr ravi p agrawal trustee ravi agrawal trust mr aayush agrawal trustee aayush agrawal trust note change promoter holding account interse transfer share amongst promoter year c change promoter shareholding please specify change sn particular shareholding beginning year cumulative shareholding year share total share share total share company company mannalal b agrawal less nov interse transfer add marinterse transfer less marinterse transfer less marinterse transfer purushottam b agrawal less sep interse transfer plan prepare perform statutory report director report sn particular shareholding beginning year cumulative shareholding year share total share share total share company company add marinterse transfer add marinterse transfer less marinterse transfer madhusudan b agrawal less sep interse transfer add mar interse transfer add mar interse transfer less mar interse transfer yogesh agrawal add sep interse transfer add nov interse transfer less marinterse transfer rajesh agrawal add sep interse transfer add nov interse transfer less marinterse transfer less marinterse transfer ganga export represented manisha agrawal aayush agrawal richa agrawal ganga export represented yogesh agrawal rajesh agrawal ravi agrawal aayush agrawal mannalal b agrawal huf less sep interse transfer purushottam b agrawal huf less sep interse transfer madhusudan b agrawal huf less sep interse transfer ravi p agrawal add sep interse transfer less marinterse transfer less marinterse transfer aayush agrawal add sep interse transfer less mar interse transfer less mar interse transfer mamta agrawal less sep interse transfer manisha agrawal less sep interse transfer richa r agrawal less sep interse transfer smriti r agrawal less sep interse transfer vimal agrawal less sep interse transfer add marinterse transfer add marinterse transfer annual report sn particular shareholding beginning year cumulative shareholding year share total share share total share company company add marinterse transfer less marinterse transfer yogesh agrawal trustee yogesh agrawal trust add marinterse transfer rajesh agrawal trustee rajesh agrawal trust add marinterse transfer ravi p agrawal trustee ravi agrawal trust add marinterse transfer aayush agrawal trustee aayush agrawal trust add marinterse transfer change partner partnership firm ganga export shareholding top ten shareholder director promoter holder gdrs adrs sn top shareholder shareholding beginning cumulative shareholding year year share total share share total share company company matthew india fund less market sale motilal oswal focused multicap fund add market purchase less market sale narendra kumar agarwal less market sale narendra kumar agarwal less market sale kotak mahindra international limited onkar singh kalra add market purchase prerna chaudhary add market purchase sushama chaudhary add market purchase orbimed partner master mauritius limited add market purchase orbimed partner ii mauritius limited add market purchase suresh kumar agarwal less market sale madhulika agrawal less market sale plan prepare perform statutory report director report e shareholding director key managerial personnel sn shareholding director key shareholding beginning cumulative shareholding managerial personnel year year share total share share total share company company mannalal b agrawal chairman less nov interse transfer add marinterse transfer less marinterse transfer less marinterse transfer purushottam b agrawal vicechairman less sep interse transfer add marinterse transfer add marinterse transfer less marinterse transfer madhusudan b agrawal vicechairman less sep interse transfer add mar interse transfer add mar interse transfer less mar interse transfer yogesh agrawal managing director add sep interse transfer add nov interse transfer less marinterse transfer rajesh agrawal joint managing director add sep interse transfer add nov interse transfer less marinterse transfer less marinterse transfer yogesh agrawal trustee yogesh agrawal trust add marinterse transfer rajesh agrawal trustee rajesh agrawal trust add marinterse transfer dr anil kumar independent director chandrakant khetan independent director kh viswanathan independent director prabhakar dalal independent director dr anjana grewal independent director arvind agrawal chief financial officer gaurang shah company secretary change number share held promoter director due interse transfer share amongst promoter year annual report v indebtedness indebtedness company including interest outstandingaccrued due payment cr secured loan unsecured deposit total excluding loan indebtedness deposit indebtedness beginning financial year principal amount ii interest due paid iii interest accrued due total iiiiii change indebtedness financial year addition reduction net change indebtedness end financial year principal amount ii interest due paid iii interest accrued due total iiiiii vi remuneration director key managerial personnel remuneration managing director wholetime director andor manager sn particular remuneration name mdwtd manager total amount purushottam madhusudan yogesh rajesh b agrawal b agrawal agrawal agrawal gross salary salary per provision contained section incometax act b value perquisite u income tax act c profit lieu salary section income tax act stock option na na na na na sweat equity na na na na na commission nil nil nil nil nil profit others specify others please specify nil nil nil nil nil total ceiling per act net profit company calculated per section company act plan prepare perform statutory report director report b remuneration director sn particular remuneration name director total mannalal chandrakant dr anil kh p r dalal dr anjana amount b agrawal khetan kumar viswanathan grewal independent director fee attending board committee meeting commission others please specify total nonexecutive director fee attending board committee meeting commission others please specify total total b ceiling per act net profit company calculated per section company act c remuneration key managerial personnel mdmanagerwtd sn particular remuneration key managerial personnel c cfo total amount gross salary salary per provision contained section incometax act b value perquisite u incometax act c profit lieu salary section incometax act na na na stock option na na na sweat equity na na na commission na na na profit others specify others please specify na na na total vii penalty punishment compounding offence type section brief detail penalty authority appeal made company description punishment compounding rd nclt give act fee imposed court detail company penalty punishment none compounding b director penalty punishment none compounding c officer default penalty punishment none compounding annual report annexure g director report conservation energy energy conservation measure taken year monitored power factor unity ii replacement cfl metal headlight lamp led light plant warehouse iii continuous monitoring hvac system ahu iv eliminated leakage utility system v installation solar heater one manufacturing facility vi installation motion sensor reduce electricity wastage vii fixed variable frequency heavy load machine viii ensured best possible automation reduce electricity wastage impact measure reduction power consumption ii reduction fuel consumption iii reduction carbon footprint iv reduction fuel power cost v increase operational efficiency total energy consumption energy consumption per unit production per detail form form year ended march power fuel consumption electricity purchased unit thousand kwh total amount lac rateunit kwh b generation unit thousand kwh unit per ltr diesel oil kwh cost unit kwh ii consumption per unit production company manufacture apis several drug formulation different pack size therefore impracticable apportion consumption cost utility product step taken company utilizing alternate source energy taken step adopt green energy alternate invested significantly installation solar heater system one manufacturing facility capital investment energy conservation equipment company invested significantly energy conservation equipment across unit b research development technology absorption continued fortify research foundation prudent investment place u frontline technology help u deliver complex product continued develop new product process enrich portfolio give impetus growth plan year added around scientist strengthen team significant expertise develop manufacture complex formulation various dosage form including tablet capsule powder ophthalmic sterile eye drop ointment injectables year continued plan prepare perform statutory report director report develop robust potent cost effective formulation introduced st time ophthalmic meet patient need bridge gap launch last year special emphasis deployment new process synthesis active pharmaceutical ingredient launched world fastest acting india first development novel drug delivery system existing ocular antiallergic drug approved newer active drug substance use cutting usfda regulator technology making superior quality product analytical method development validation etc received approval andas launched commercialized product u market filed specific area r carried news product usfda anda approval development peroduo gel treatment acne first day launch omeprazole sodium development minocycline foam without bicarbonate capsule u market surfactant acne treatment apis successfully developed charged development minocycline gel acne stability study fy api scaledup treatment plant commercialization domesticrow market development lotion fungal infection several apis development ready development double triple combination scale plant level product effective fast remedy future plan action development low high power tablet coming year company plan treatment pulmonary arterial hypertension new platform technology development derma development tablet treatment product better stability rheumatoid arthritis development parenteral topical dosage u developed market company form made successful development formulation area development ophthalmic product row market immediaterelease solid oral dosage form including nanonized technology develop preservative free ophthalmic product powder oral solution suspension continue innovate apis specialty segment extendedrelease delayedrelease pellet focus formulation development patent based capsule dosage form challenge product oros osmotic release oral system based developlaunch annually first time technology solid oral dosage form product product india file andas various therapeutic segment continue quality upgradation existing product ophthalmic product various therapeutic newer technology segment filing regulated market continue develop costeffective formulation benefit derived result rd expanding consumer base company launched new product seven domestic market one row accelerate r activity support product market seven u market pipeline various market across globe annual report effort brief made towards technology expenditure rd absorption adaptation innovation company strives develop technologically advanced particular cr potent affordable product meet patient capital expenditure need focus continuous quality upgradation recurring expenditure existing product adopting new technology total developing new improved drug delivery system total rd expenditure percentage enhancing patient comfort total turnover company set separate stateofart r c foreign exchange earnings outgo facility meet need different geography information activity relating export initiative segment top quality benchmark taken increase export etc covered r facility team develop formulation management discussion analysis annual apis meet stringent regulatory norm audit report enjoy consumer preference worldwide total foreign exchange used earned company lay emphasis absorbing adapting earnings foreign currency cr latest technology find innovative solution previous year cr form novel drug delivery system double triple combination give multiple relief alternative outgo foreign currency cr previous efficient formulation visàvis traditional one etc year cr plan prepare perform statutory report report corporate governance report corporate governance company philosophy corporate nonexecutive promoter director independent governance director including woman director director ajanta pharma belief sustained growth rich varied experience field business enhancing shareholder value sound corporate management medicine banking finance project governance must ensure fairness every management risk management international stakeholder customer investor vendor operation marketing hr corporate governance community operate transparency bring extensive knowledge expertise accountability two basic tenet corporate board board provides strategic guidance governance accordingly always seek company ensures effective monitoring ensure performance driven integrity management corporate governance practice value ethic proud responsible corporate citizen b board meeting attendance board meeting date finalized consultation company compliance mandatory director agenda paper detailed note requirement corporate governance laid background information circulated least day new listing regulation also prior meeting thereby enabling board complying nonmandatory requirement effectively reasonably perform duty company guiding principle laid take informed decision arrangement made code business conduct duly adopted adhered participation board member board meeting director senior management personnel video conferencing requested posted website company detailed presentation made management apprise board important development ii board director industry business segment operation marketing composition category director product hr subsidiary etc year change board composition five board meeting held th april year board continues comprise th july th october th january director executive promoter director th march composition director st march excluding directorship committee membership private limited company foreign company attendance board annual general meeting given committee membership audit committee stakeholder relationship committee name director category attendance committee membership board agm directorship member chairman mr mannalal b agrawal promoter nonexecutive yes mr purushottam b agrawal promoter executive yes mr madhusudan b agrawal promoter executive yes mr yogesh agrawal promoter executive yes mr rajesh agrawal promoter executive yes mr chandrakant khetan independent yes dr anil kumar independent yes mr k h viswanathan independent yes mr prabhakar dalal independent yes dr anjana grewal independent yes note mr mannalal b agrawal mr purushottam b agrawal mr madhusudan b agrawal brother mr yogesh agrawal mr rajesh agrawal son mr mannalal b agrawal b none nonexecutives director holding share company annual report c reappointment director retiring rotation f independent director meeting detail director seeking appointmentreappointment year review one meeting forthcoming annual general meeting required independent director held th january regulation security exchange independent director reviewed matter board india listing obligation disclosure per schedule iv company act act requirement regulation listing regulation annexed notice convening annual general independent director present meeting form part annual report meeting independent director familiarisation programme g code conduct detail familiarisation programme imparted board director laid code conduct independent director put website director senior management code company link accessed wwwajantapharma board member senior management comadmindatadirectorfamiliarizationprogram personnel director senior management directorsfamilarisationprogrammepdf affirmed compliance code conduct approved adopted board director e performance evaluation declaration effect signed managing board carried annual performance evaluation director annexed report code committee independent director conduct posted website year nomination remuneration committee company wwwajantapharmacom evaluated individual director performance separate meeting independent director evaluated performance h prevention insider trading executive director board whole chairman company devised adopted code conduct regulate monitor report trading performance evaluation done scale company security person access poor good rating unpublished price sensitive information performance laid criterion like company company secretary compliance officer purpose code year board composition diversity governance due compliance code leadership direction strategic input etc company insider requisite disclosure made stock exchange time time ii executive director skill knowledge performance compliance ethical standard risk iii audit committee mitigation sustainability etc term reference audit committee cover matter prescribed regulation listing regulation independent director objectivity bringing iii section act interalia includes independent judgement time devotion domain knowledge contribution etc oversight company financial reporting process disclosure financial hairman guidance overall direction board iv c information ensure financial statement member participation governance conducting correct sufficient credible meeting impartially etc ii reviewing management quarterly committee effectiveness implementation v annual financial statement submission policy procedure plan adherence board approval term reference strategic input board etc evaluation internal financial control risk iii board expressed satisfaction process management system well performance director committee board whole iv recommendation appointment remuneration term appointment statutory auditor plan prepare perform statutory report report corporate governance review monitor auditor independence v formulation criterion evaluation iii performance effectiveness audit process performance independent director board director approval subsequent modification vi transaction related party iv evaluate performance individual director vii scrutiny intercorporate loan investment v devise policy diversity board director viii discussion internal auditor significant vi identifying person qualified become finding follow director may appointed senior management recommend board discussion statutory auditor ix director appointment removal nature scope audit well postaudit discussion ascertain area concern committee comprises four independent director financial year two meeting x reviewing functioning whistle blower mechanism committee held th april th january composition committee committee comprises director member attendance meeting year three independent director member including chairman audit committee financially literate ability read understand financial statement financial year five meeting held th april th july th october th january th march name designation meeting attended composition committee st march member attendance meeting dr anil kumar chairman year mr chandrakant khetan member mr k h viswanathan member name designation meeting mr prabhakar dalal member attended mr chandrakant khetan chairman company secretary act secretary mr k h viswanathan member committee mr prabhakar dalal member mr mannalal b agrawal member v remuneration director nomination remuneration committee formulated company secretary act secretary policy remuneration director key managerial committee personnel kmp employee per policy remuneration nonexecutive director chief financial officer statutory auditor internal independent director includes fee attending auditor attend meeting meeting board well committee commission net profit travelling expense iv nomination remuneration committee remuneration executive director shall fair term reference committee comprise reasonable taking account level skill various matter provided regulation knowledge core competence individual function listing regulation section act duty responsibility company performance interalia include achievement compensation peer industry standard factor laid policy formulation criterion determining qualification positive attribute committee shall recommend board periodic independence director revision remuneration executive director board shall fix remuneration taking ii formulate recommend board policy consideration factor also ceiling limit relating remuneration director key prescribed act shall also managerial personnel employee approved shareholder required annual report pecuniary relationship transaction nonexecutive director visàvis company year independent director paid sitting fee commission year stock option granted director remuneration paid executive nonexecutive director year ended st march lac remuneration director remuneration sitting fee commission total mr purushottam b agrawal mr madhusudan b agrawal mr yogesh agrawal mr rajesh agrawal mr mannalal b agrawal mr chandrakant khetan dr anil kumar mr prabhakar dalal mr k h viswanathan dr anjana grewal vi stakeholder relationship committee contributing towards development committee performs various function conferred underprivileged section society based listing regulation section act recommendation csr committee company mainly cover ensuring resolution grievance laid csr policy displayed security holder company website company accessed http wwwajantapharmacomadmindatapolicycodes committee comprises three director csrpoilcypdf csr policy within ambit two independent financial year schedule vii act four meeting committee held th april th july th october committee oversees implementation th january composition committee execution csr policy provides guidance member attendance meeting year various csr activity undertaken company committee comprises four director name designation meeting financial year four meeting committee attended held th april th july dr anil kumar chairman th october th january composition dr anjana grewal member committee member attendance mr rajesh agrawal member meeting year name designation meeting mr gaurang shah designated compliance attended officer company act secretary mr mannalal b agrawal chairman committee mr yogesh agrawal member mr chandrakant khetan member company received complaint year dr anil kumar member redressedanswered satisfaction investor investor grievance remained unattendedpending company secretary act secretary committee vii corporate social responsibility committee csr viii compensation committee corporate social responsibility company committee constituted granting employee stem philosophy providing sustainable stock option eligible employee esop value society company operates scheme company financial year plan prepare perform statutory report report corporate governance two meeting held th may result announces forthwith result th july detail composition stock exchange share committee member attendance meeting company listed together press release brief analysis result published meeting within hour economic time english name designation daily newspaper maharashtra time marathi attended mr chandrakant khetan chairman newspaper result simultaneously mr yogesh agrawal member posted website company dr anjana grewal member wwwajantapharmacom also uploaded dr anil kumar member website national stock exchange india ltd bse limited official news company secretary act secretary release presentation made institutional committee investorsanalysts also posted website company ix executive committee board constituted executive committee dealing xii general shareholder information various urgent operational matter viz granting th annual general meeting held power attorney employee need basis opening wednesday th july aspee operating bank account availing various banking auditorium laxminarayan mandir complex facility routine administrative matter eight marve road next nutan school malad west meeting executive committee held mumbai maharashtra year detail composition committee member attendance meeting financial calendar financial year st april st march name designation meeting quarterly result declared normally attended th week following month end mr yogesh agrawal chairman financial quarter mr rajesh agrawal member mr purushottam b agrawal member date book closure mr madhusudan b agrawal member wednesday th june wednesday th july day inclusive x general body meeting annual general meeting last year held dividend payment date agm date time venue interim dividend paid th november special th march proposed final dividend resolution additional dividend recommended passed th th august prabodhankar listing stock exchange thackrey bse limited code ajantapharm natyagrah sodawala lane b national stock exchange india limited borivali west mumbai code ajantpharmeq th th july th th july annual listing fee paid time stock exchange year company passed resolution postal ballot isin number nsdl cdsl ineb xi mean communication board director approves take record cin number unaudited quarterly result audited annual lmhplc annual report stock market data bombay stock exchangebse national stock exchangense high low high low apr may jun jul aug sep oct nov dec jan feb mar performance apl share price comparison bse sensex stock performance per share sensex apr may jun jul aug sep oct nov dec jan feb mar apl bse bse sensex plan prepare perform statutory report report corporate governance registrar transfer agent sr category st march link intime india private limited unit ajanta pharma total limited c park l b marg vikhroli west share share mumbai mutual fund tel fax bank financial email rnthelpdesklinkintimecoin institution insurance company centralstate share transfer system govt institutionsnon share physical form sent registering transfer government institution private corporate body registrar share transfer agent link indian public intime india private limited registered returned nrisocbsfiisforeign within statutory period day date national receipt document order respect clearance share transfer committee company meet total often required year total number share transferred physical form follows dematerialisation share liquidity total equity capital held transfer request dematerialized form nsdl cdsl period processed effected share st march per guideline sebi trading day dispatched equity share company permitted dematerialised form nil nil nil share company liquid traded nil nil nil normal volume bse nse relevant data total average daily turnover financial year given distribution equity shareholding st march bombay national bse nse stock stock share shareholder share exchange exchange held bse nse share upto value term outstanding gdradrwarrants convertible instrument conversion date likely impact equity company issued type security commodity price risk foreign exchange risk total hedging activity company purchase active pharmaceutical pattern shareholding ingredient api material used manufacturing operation foreign domestic sr category st march supplier material sourced total domestic market therefore significant share share foreign exchange fluctuation risk company promoter holding risk management framework proactively promoter mitigate impact measure like cost based foreign promoter na na price increase cost reduction measure portfolio annual report rationalization renegotiate procurement contract ii share held demat form etc company also develops ongoing basis concerned depository participant alternate supply source key product subject economic justification currency risk mainly arise iii detail compliance officer overseas operation financing activity exchange mr gaurang shah rate fluctuation could significantly impact earning avp legal company secretary net equity invoicing foreign currency ajanta house govt ind area expenditure foreign currency translation charkop kandivali west financial statement overseas subsidiary mumbai indian rupee company defined exchange tel fax risk management framework manage risk email investorgrievanceajantapharmacom excluding translation risk company hedge foreign exchange risk exposure way forward xiii subsidiary company exchange contract per decision forex company indian subsidiary management committee time time requirement appointment independent director company board material indian employee stock option scheme esos subsidiary applicable audited annual financial year option exercised statement overseas subsidiary company employee subsidiary company also tabled audit committee board meeting granted bonus element option thus copy minute board meeting total option allotted listed subsidiary company individually given stock exchange year option director tabled subsequent granted employee including employee board meeting web link policy determining overseas subsidiary company st march material subsidiary httpwwwajantapharmacom option due vesting admindatapolicycodesceacbeaf aecpolicyonmaterialsubsidiariespdf plant location company manufacturing plant xivother disclosure follows transaction material nature related party may potential b b b midc industrial area paithan dist conflict interest company large aurangabad transaction related party disclosed ii midc industrial area chikalthana note financial statement aurangabad iii gut chitegaon paithan road dist b instance noncompliance aurangabad penaltiesstrictures imposed stock iv gut plot waluj aurangabad exchange sebi statutory authority v plot z dahej sez part ii dist bharuch matter related capital market vi mirza palashbari road mouza kamrup r dist last financial year guwahati board director company c r centre located charkop kandivali west adopted put place whistle blower policy mumbai personnel denied access investor correspondence address audit committee detail vigil mechanism share held physical form whistle blower policy provided director link intime india pvt ltd report unit ajanta pharma limited c park l b marg vikhroli west managing director cfo company mumbai certified board regard tel fax compliance made term regulation email rnthelpdesklinkintimecoin listing regulation part b schedule ii certificate form part annual report plan prepare perform statutory report report corporate governance e noncompliance requirement h financial statement company corporate governance report prepared accordance indian required disclosure made stock exchange accounting standard indas notified regulatory body required company indian accounting standard rule amended company indian f risk management committee would formed accounting standard amendment rule deemed necessary period including year ended st march company prepared financial g company complies following non mandatory statement accordance accounting requirement regulation specified part standard notified section e schedule ii listing regulation act read company account rule previous gaap financial statement company appointed separate person prepared accrual basis post chairman managing director historical cost basis except certain asset liability measured fair value ii nonexecutive chairman provided revalued amount wherever applicable office company expense also allowed reimbursement expense incurred behalf board director performance duty mannalal b agrawal iii internal auditor report audit committee mumbai rd may chairman declaration pursuant schedule v listing regulation accordance schedule v listing regulation stock exchange hereby declare director senior management company affirmed compliance code conduct applicable year ended st march ajanta pharma limited yogesh agrawal managing director mumbai rd may annual report certificate pursuant regulation listing regulation mr yogesh agrawal managing director mr arvind agrawal chief financial officer hereby certify financial year ended st march reviewed indas financial statement cash flow statement year best knowledge belief statement contain materially untrue statement omit material fact contain statement might misleading ii statement together present true fair view company affair compliance indas applicable law regulation b best knowledge belief transaction entered company year fraudulent illegal violative company code conduct c accept responsibility establishing maintaining internal control financial reporting evaluated effectiveness internal control system company pertaining financial reporting disclosed auditor audit committee deficiency design operation internal control aware step taken propose take rectify deficiency indicated auditor audit committee significant change internal control financial reporting year ii significant change accounting policy year iii instance significant fraud become aware ajanta pharma limited ajanta pharma limited yogesh agrawal arvind agrawal managing director chief financial officer mumbai rd may plan prepare perform statutory report report corporate governance auditor certificate corporate governance member ajanta pharma limited examined compliance condition corporate governance ajanta pharma limited company year ended st march prescribed regulation b para c e schedule v chapter iv sebi listing obligation disclosure requirement regulation listing regulation compliance condition corporate governance responsibility management examination limited review procedure implementation thereof adopted company ensuring compliance condition corporate governance neither audit expression opinion financial statement company opinion best information according explanation given u based representation made director management certify company complied condition corporate governance stipulated mentioned listing regulation state compliance neither assurance future viability company efficiency effectiveness management conducted affair company kapoor parekh associate chartered accountant icai frn w nilesh parekh partner mumbai rd may annual report business responsibility report section general information company corporate identity number cin company lmhplc name company ajanta pharma limited registered address ajanta house charkop kandivli west mumbai website wwwajantapharmacom email id infoajantapharmacom financial year reported st april st march sector company engaged industrial manufacture pharmaceutical product code activity codewise list three key productsservices company artefan metxl softdrops manufacturesprovides balance sheet total number location business activity number international location undertaken company company six foreign subsidiary including one step subsidiary located usa nigeria philippine mauritius uk b number national location registered corporate office located kandivli mumbai ii six manufacturing plant situated paithan chikalthana waluj chitegaon maharashtra b dahej gujarat c guwahati assam iii rd centre situated kandivli mumbai iv two central warehouse situated zikarpur chandigarh aurangabad maharashtra v c f agent various location throughout country market served company domestic global section b financial detail company paid capital inr cr total turnover inr cr standalone total profit tax inr cr standalone total spending corporate social responsibility csr company total spending csr year ended percentage profit tax st march cr profit tax list activity expenditure incurred healthcare b education c community development section c detail company subsidiary company company st march company subsidiary including one step subsidiary subsidiary companycompanies participate br subsidiary incorporated outside india comply initiative parent company yes indicate requirement respective country number subsidiary company independent business responsibility initiative entityentities eg supplier distributor etc entity directly participate br initiative company business participate br company initiative company yes indicate percentage entityentities less plan prepare perform statutory report business responsibility report section br information b detail br head detail directordirectors responsible br particular detail detail directordirector responsible din number applicable na implementation br policypolicies name mr arvind agrawal designation cfo din number telephone number name mr yogesh agrawal email id arvindagrawal designation managing director ajantapharmacom principlewise per nvgs br policypolicies detail compliance reply yn p p p p p p p p p policypolicies x policy formulated consultation relevant stakeholder policy conform national policy broadly based national voluntary guideline international standard yes specify social environmental economical responsibility business issued word ministry corporate affair government india policy approved board yes signed mdownerceo appropriate board director company specified committee boarddirectorofficial oversee implementation policy indicate link policy viewed online policy formally communicated relevant internal external stakeholder company inhouse structure implement policypolicies company grievance redressal mechanism related policypoliciesto address stakeholder grievance related policypolicies company carried independent audit st year independent auditevaluation done taken evaluation working policy next year internal external agency policy placed intranet company except csr policy available httpwwwajantapharmacomadmindatapolicycodes csrpoilcypdf b answer question serial number principle please explain tick option question p company understood principle company stage find position formulate implement need felt formulate policy specified principle specific policy public advocacy company engage directly company financial manpower resource available task planned done within next month planned done within next year reason please specify annual report governance related br indicate frequency board director annually committee board ceo assess br performance company within month month annually year b company publish br sustainability report company publish br sustainability report hyperlink viewing report frequently however detail relating corporate social responsibility published activity presented annual report section e principlewise performance principle policy relating ethic bribery corruptionyes company put place code conduct director cover company yes extend senior management personnel extends group including groupjoint venturessupplierscontractorsngos employee director subsidiary company also put others place whistleblower policy order enable employee others bring notice board management wrongdoing unethical practice observed company many stakeholder complaint received complaint received stakeholder past financial year percentage fy satisfactorily resolved management provide detail thereof word principle list product service whose design tiban teneligliptin antidiabetic low cost drug incorporated social environmental concern risk andor b betoact bepotastine nd generation antiocular anti opportunity allergic product st time india c azutan azilsartan management diabetic hypertension product provide following detail product consume major quantum energy respect resource use energy water raw material etc per water either production level consumer level unit product optional company taken several effective measure reduce reduction sourcingproduction distribution overall consumption energy water achieved since previous year throughout value chain b reduction usage consumer energy water achieved since previous year company procedure place sustainable company established stringent process approve vendor sourcing including transportation material procured quality assurance team yes percentage input sourced conduct periodic audit vendor especially sustainably also provide detail thereof supply key material ensure sustainability word company enters annual freight contract leading transporter ensuring sustainable seamless movement material good company taken step procure good yes company procures lab reagent solvent service local small producer including community packing material local small producer vicinity surrounding place work manufacturing location periodically audit facility yes step taken improve guide quality front also service level capacity capability local small vendor improve quality standard adapt customer requirement company mechanism recycle product waste water generated plant recycled recovered waste yes percentage recycling reused thereby reducing consumption fresh water treated product waste separately also waste water used gardening company premise provide detail thereof word solvent recycled reused plan prepare perform statutory report business responsibility report principle please indicate total number employee please indicate total number employee hired temporarycontractualcasual basis please indicate number permanent woman employee please indicate number permanent employee disability employee association recognized management yes manufacturing plant percentage permanent employee member recognized employee association please indicate number complaint relating child labour forced labour involuntary labour sexual harassment last financial year pending end financial year category complaint filed complaint pending financial year end financial year child labourforced labourinvoluntary labour nil nil sexual harassment nil nil discriminatory employment nil nil percentage mentioned employee given safety skill upgradation training last year permanent employee b permanent woman employee permanent employee includes permanent woman employee c casualtemporarycontractual employee employee disability principle company mapped internal yes external stakeholder yesno company identified yes disadvantaged vulnerable marginalized stakeholder special initiative taken engage disadvantaged vulnerable marginalized stakeholder company engage disadvantaged enable educate empower focused initiative health vulnerable marginalized stakeholder education woman empowerment rural infrastructure provide detail thereof word provide needy patient best health area cataract operation family planning program plastic surgery camp completely free cost including transport food medicine eye glass associated various school rural tribal area provide educational infrastructure form renovating school building science laboratory library computer lab scholarship deserving student etc provide vocational training girl student area sewing embroidery singing computer etc girl availed benefit facility different school rural india annual report principle policy company human right cover cover entire ajanta pharma limited group however company extend groupjoint venturessuppliers cover supplier contractor ngo others contractor ngosothers b many stakeholder complaint received none past financial year percent satisfactorily resolved management principle policy related principle cover policy cover company subsidiary alongwith company extends groupjoint venture contractor working within premise company supplierscontractors ngosothers company strategy initiative address conservation optimum utilisation natural resource continues global environmental issue climate change topmost priority company environment health safety policy company stress conservation energy global warming etc yn yes please give hyperlink webpage etc eliminatingreducing waste company mechanism place recycling waste water company identify assess potential yes taking necessary stepsmeasures control environmental risk yn mitigate company project related clean applicable development mechanism provide detail thereof word also yes whether environmental compliance report filed company undertaken initiative energy conservation measure taken year clean technology energy efficiency renewable energy monitored power factor unit etc yn yes please give hyperlink web page etc variable frequency drive fixed heavy load machine energy efficient led tube light fixed instead regular tube light plant watt cfl light warehouse replaced led watt monitored hvac system ahu required eliminated leakage utility system installed solar heater emissionswaste generated company yes parameter within limit within permissible limit given cpcbspcb financial year reported number show cause legal notice received none cpcbspcb pending ie resolved satisfaction end financial year principle company member trade chamber association bombay chamber commerce industry yes name major one business deal b india association industriesaiai indomauritius chamber commerce industry c imcci indian drug manufacturer association b advocatedlobbied association advancement improvement public good yesno yes specify broad area drop box governance administration economic reform inclusive development policy energy security water food security sustainable business principle others plan prepare perform statutory report business responsibility report principle company specified yes company specified programmesinitiatives field healthcare programmesinitiativesprojects education community development health pursuit policy related principle yes detail thereof constantly working eradicating cataract rural mass people regained vision living better life last decade organised diagnostics eye camp screening villager tribal rural area last decade initiative family planning program remote rural tribal india family planning operation last year conducted plastic surgery camp child rural tribal india physical deformity like cut nose lip mark squint eye white patch etc caused due burn accident injury birth defect treated needy poor patient last decade education identified girl child education focus area working various school vidarbha marathwada region maharashtra undertaken renovation infrastructure school including classroom washroom computer lab music lab science lab library etc till student benefited program school identified upliftment developing girl prepare future help independent built successfully implemented wellplanned comprehensive woman empowerment program many school rural part india program imparts knowledge exposure life skill girl age group year created part school curriculum girl deprived section gain skill english singing computer tailoring skill personality enhancement would help career financially independent social development built maintained waiting shed government hospital campus providing proper sitting drinking water facility light fan etc make waiting patient relative comfortable relative getting treatment till date built shelter renovated dharmshalas benefited million patient relative running subsidised canteen called annachatra poor patient relative rural india get hygienic food meal snack every day nominal cost needy poor patient taken benefit facility programmesprojects programme undertaken inhouse well charitable trust undertaken inhouse teamown ngo foundationexternal ngogovernment structuresany organization done impact assessment yes initiative company direct cr contribution community development project amount inr detail detail project undertaken company mentioned annexure e project undertaken director report taken step ensure ajanta pharma dedicated inhouse team visit inaccessible community development adopted remote area looking need based community development activity gap community please explain identified ajanta undertakes complete execution maintenance csr activity word company majorly work field woman education empowerment cataract operation health solution social development infrastructure facility etc annual report principle percentage customer complaintsconsumer case company received total complaint financial pending end financial year year satisfactorily resolved investigation two old consumer case pending consumer court end financial year company display product information product pharmaceutical product company display statutory label mandated per local law yes information required respect product labelling nonaremarks additional information product information case filed stakeholder company none regarding unfair trade practice irresponsible advertising andor anticompetitive behaviour last five year pending end financial year provide detail thereof word company carry consumer survey consumer consumer survey regularly carried company satisfaction trend doctor level behalf board director mannalal b agrawal mumbai rd may chairman financial statement consolidated standalone annual report independent auditor report auditor responsibility member responsibility express opinion consolidated ajanta pharma limited ind financial statement based audit conducting audit taken account provision report consolidated ind financial act accounting auditing standard matter statement required included audit report audited accompanying consolidated ind provision act rule made thereunder financial statement ajanta pharma limited holding company subsidiary collectively referred conducted audit accordance standard group comprising consolidated balance auditing specified section act sheet st march consolidated statement standard require comply ethical requirement profit loss including comprehensive income plan perform audit obtain reasonable assurance consolidated cash flow statement consolidated whether consolidated ind financial statement statement change equity year ended free material misstatement summary significant accounting policy explanatory information hereinafter referred audit involves performing procedure obtain audit consolidated ind financial statement evidence amount disclosure consolidated ind financial statement procedure management responsibility selected depend auditor judgment including consolidated ind financial statement assessment risk material misstatement holding company board director responsible consolidated ind financial statement whether due preparation presentation consolidated ind fraud error making risk assessment auditor financial statement term requirement considers internal financial control relevant holding company act act give true fair view company preparation consolidated ind financial consolidated state affair financial position consolidated statement give true fair view order design profit financial performance including comprehensive audit procedure appropriate circumstance income consolidated cash flow consolidated statement audit also includes evaluating appropriateness change equity group accordance accounting policy used reasonableness accounting principle generally accepted india including accounting estimate made holding company board accounting standard specified section director well evaluating overall presentation act read relevant rule issued thereunder respective consolidated ind financial statement board director company included group responsible maintenance adequate accounting believe audit evidence obtained u sufficient record accordance provision act appropriate provide basis audit opinion safeguarding asset group preventing consolidated ind financial statement detecting fraud irregularity selection application appropriate accounting policy making opinion judgment estimate reasonable prudent opinion best information according design implementation maintenance adequate explanation given u aforesaid consolidated ind internal financial control operating effectively financial statement give information required ensuring accuracy completeness accounting act manner required give true fair view record relevant preparation presentation conformity accounting principle generally accepted consolidated ind financial statement give true india consolidated state affair financial position fair view free material misstatement whether group st march consolidated profit due fraud error used purpose financial performance including comprehensive income preparation consolidated ind financial statement group consolidated cash flow consolidated director holding company aforesaid change equity group year ended date plan prepare perform financial statement consolidated matter holding company none director audit financial statement financial information holding company disqualified st march subsidiary whose financial statement financial information appointed director term reflect total asset cr st march total section act revenue cr net cash inflow amounting cr year ended date considered f respect adequacy internal financial consolidated ind financial statement control financial reporting group operating effectiveness control refer financial statement financial information separate report annexure audited auditor whose report furnished u management opinion far relates g respect matter included amount disclosure included respect auditor report accordance rule subsidiary based solely report auditor company audit auditor rule opinion best information opinion consolidated ind financial statement according explanation given u report legal regulatory requirement modified respect matter respect consolidated ind financial statement reliance work done report auditor disclose impact pending litigation st march financial position report legal regulatory refer note consolidated financial requirement statement required section act report extent applicable ii group entered longterm contract including derivative contract requiring sought obtained information provision applicable law accounting explanation best knowledge standard material foreseeable loss belief necessary purpose audit aforesaid consolidated financial statement delay transferring iii amount required transferred b opinion proper book account required investor education protection fund law relating preparation aforesaid holding company consolidated ind financial statement kept far appears examination company provided requisite iv book disclosure consolidated ind financial statement holding well dealing c consolidated balance sheet consolidated specified bank note period statement profit loss consolidated cash th november th december flow statement consolidated statement accordance book change equity dealt report account maintained company refer agreement relevant book account note consolidated ind financial maintained purpose preparation statement consolidated ind financial statement kapoor parekh associate opinion aforesaid consolidated ind chartered accountant financial statement comply indian icai frn w accounting standard prescribed section act read relevant rule issued thereunder nilesh parekh e basis written representation received partner director holding company st mno march taken record board director mumbai rd may annual report annexure independent auditor report annexure referred para f heading audit involves performing procedure obtain audit report legal regulatory requirement evidence adequacy internal financial report even date member ajanta pharma control system financial reporting operating limited consolidated ind financial statement effectiveness audit internal financial control year ended st march financial reporting included obtaining understanding internal financial control financial reporting assessing report internal financial control risk material weakness exists testing financial reporting clause sub evaluating design operating effectiveness internal section section company act control based assessed risk procedure selected act depend auditor judgement including assessment conjunction audit consolidated ind risk material misstatement financial statement financial statement group year ended whether due fraud error st march audited internal financial control financial reporting holding company date believe audit evidence obtained sufficient appropriate provide basis audit management responsibility internal opinion holding company internal financial control financial control system financial reporting board director holding company responsible establishing maintaining internal financial control meaning internal financial control based internal control financial reporting criterion financial reporting established holding company considering essential company internal financial control financial reporting component internal control stated guidance process designed provide reasonable assurance note audit internal financial control financial regarding reliability financial reporting reporting issued institute chartered accountant preparation financial statement external purpose india icai responsibility include design accordance generally accepted accounting principle implementation maintenance adequate internal financial company internal financial control financial reporting control operating effectively ensuring orderly includes policy procedure pertain efficient conduct business including adherence maintenance record reasonable detail accurately company policy safeguarding asset fairly reflect transaction disposition prevention detection fraud error accuracy asset company provide reasonable assurance completeness accounting record timely transaction recorded necessary permit preparation preparation presentation reliable financial information financial statement accordance generally accepted required company act accounting principle receipt expenditure company made accordance auditor responsibility authorisation management director company responsibility express opinion holding provide reasonable assurance regarding prevention company internal financial control financial reporting timely detection unauthorised acquisition use disposition based audit conducted audit accordance company asset could material effect guidance note audit internal financial control financial statement financial reporting issued icai standard auditing issued icai deemed prescribed inherent limitation internal financial section company act control financial reporting extent applicable audit internal financial control inherent limitation internal financial control standard mentioned guidance note financial reporting including possibility collusion require comply ethical requirement plan improper management override control material perform audit obtain reasonable assurance misstatement due error fraud may occur whether adequate internal financial control financial detected also projection evaluation internal reporting established maintained control financial control financial reporting future period operated effectively material respect subject risk internal financial control plan prepare perform financial statement consolidated financial reporting may become inadequate matter change condition degree compliance aforesaid report section act policy procedure may deteriorate adequacy operating effectiveness internal financial control financial reporting restricted holding opinion company since subsidiary group foreign opinion holding company material subsidiary subject report internal respect adequate internal financial control system financial control financial reporting internal financial control financial reporting operating effectively st march kapoor parekh associate based internal control financial reporting chartered accountant criterion established holding company considering icai frn w essential component internal control stated guidance note audit internal financial control financial nilesh parekh reporting issued icai partner mno mumbai rd may annual report consolidated balance sheet st march cr particular note march march april asset noncurrent asset property plant equipment b capital workinprogress c intangible asset intangible asset development e financial asset investment ii others f deferred tax asset net g noncurrent asset current asset inventory b financial asset investment ii trade receivables iii cash cash equivalent iv bank balance iii v financial asset c current tax asset net current asset total asset equity liability equity equity share capital b equity liability noncurrent liability financial liability borrowing ii financial liability b provision c deferred tax liability net current liability financial liability borrowing ii trade payable iii financial liability b current liability c provision current tax liability net total equity liability see accompanying note forming part financial statement per report even date attached kapoor parekh associate behalf board director chartered accountant nilesh parekh mannalal b agrawal partner chairman purushottam b agrawal yogesh agrawal arvind agrawal vice chairman managing director chief financial officer madhusudan b agrawal rajesh agrawal gaurang shah mumbai rd may vice chairman joint managing director company secretary plan prepare perform financial statement consolidated statement consolidated profit loss year ended st march cr note march march income revenue operation income total income expense cost material consumed purchase stockintrade change inventory finished good workinprogress stockintrade employee benefit expense finance cost depreciation amortisation expense expense total expense profit tax tax expense current tax deferred tax profit year comprehensive income comprehensive income reclassified profit loss subsequent year exchange difference translation foreign operation income tax effect net comprehensive income reclassified profit loss subsequent year comprehensive income reclassified profit loss subsequent year remeasurement gain loss defined benefit plan income tax effect net comprehensive income reclassified profit loss subsequent year comprehensive income year net tax total comprehensive income year net tax exceptional item discontinuing operation earning per equity share face value basic diluted see accompanying note forming part financial statement per report even date attached kapoor parekh associate behalf board director chartered accountant nilesh parekh mannalal b agrawal partner chairman purushottam b agrawal yogesh agrawal arvind agrawal vice chairman managing director chief financial officer madhusudan b agrawal rajesh agrawal gaurang shah mumbai rd may vice chairman joint managing director company secretary annual report statement consolidated cash flow year ended st march cr march march cash flow operating activity profit tax adjustment reconcile profit tax net cash flow depreciation amortisation expense provision expired good loss sale discard property plant equipment interest expense gain financial instrument fvtpl income investment deposit employee stock option expense receivable written exchange fluctuation operating profit working capital change change working capital decrease increase trade receivables decrease increase current financial asset decrease increase noncurrent asset decrease increase current asset decrease increase inventory increase decrease non current financial liability increase decrease current liability increase decrease non current provision increase decrease current provision increase decrease trade payable cash generated operation direct tax paid net refund net cash generated operating activity b cash flow investing activity capital expenditure property plant equipment including capital advance proceeds sale property plant equipment bank balance considered cash cash equivalent net purchase investment proceeds investment income investment deposit net cash generated used investing activity plan prepare perform financial statement consolidated cr march march c cash flow financing activity proceeds long term borrowing repayment long term borrowing proceeds repayment short term borrowing proceeds issue equity share esop interest paid dividend paid dividend distribution tax paid net cash generated used financing activity net increase decrease cash cash equivalent cash cash equivalent beginning year cash cash equivalent end year refer note figure bracket indicates outflow see accompanying note forming part financial statement per report even date attached kapoor parekh associate behalf board director chartered accountant nilesh parekh mannalal b agrawal partner chairman purushottam b agrawal yogesh agrawal arvind agrawal vice chairman managing director chief financial officer madhusudan b agrawal rajesh agrawal gaurang shah mumbai rd may vice chairman joint managing director company secretary annual report consolidated statement change equity year ended st march equity share capital cr change equity change equity balance balance balance share capital share capital april march march year year authorised issued subscribed paid b equity cr particular item foreign share comprehensive capital security currency non general based retained income total redemption premium translation total controlling reserve payment earnings measurement gain equity reserve account reserve interest reserve loss defined benefit plan st april profit period comprehensive income total comprehensive income utilised bonus share transfer general reserve exercise stock option share based payment employee dividend paid dividend distribution tax reversal dividend paid reversal dividend distribution tax st march profit period comprehensive income total comprehensive income exercise stock option share based payment employee dividend paid dividend distribution tax st march see accompanying note forming part financial statement per report even date attached kapoor parekh associate behalf board director chartered accountant nilesh parekh mannalal b agrawal partner chairman purushottam b agrawal yogesh agrawal arvind agrawal vice chairman managing director chief financial officer madhusudan b agrawal rajesh agrawal gaurang shah mumbai rd may vice chairman joint managing director company secretary plan prepare perform financial statement consolidated note consolidated financial statement year ended st march corporate information basis consolidation ajanta pharma limited holding company consolidated financial statement comprise public limited company incorporated domiciled financial statement holding company india share listed bombay stock exchange wholly owned subsidiary disclosed note national stock exchange registered office financial statement holding company holding company located ajanta house charkop wholly owned subsidiary consolidated kandivali west mumbai consolidated financial line line basis adding together book statement cf comprises company value like item asset liability income subsidiary referred collectively group expense eliminating intragroup balance intra group transaction unrealised profit resulting group engaged development manufacturing presented extent possible marketing speciality pharmaceutical quality manner group independent finished dosage financial statement statement profit loss component comprehensive income consolidated financial statement group attributed equity holder holding year ended st march authorised company group issue company board director rd may financial statement holding company wholly owned subsidiary consolidated basis preparation using uniform accounting policy like transaction financial statement group event similar circumstance prepared accordance indian accounting necessary adjustment made financial standard indas notified company statement subsidiary bring accounting indian accounting standard rule amended policy line group accounting policy company indian accounting standard amendment rule financial statement subsidiary used consolidation drawn reporting financial statement group first ind date holding company ie year ended financial statement covered ind first st march time adoption indian accounting standard functional presentation currency period including year ended functional currency subsidiary company st march group prepared financial respective local currency financial statement statement accordance accounting presented indian rupee inr rupee standard notified section r functional currency company act read together company holding company account rule previous gaap rounding amount explanation transition indas amount disclosed financial statement affected group equity net profit provided note rounded nearest cr amount note less shown actual financial statement prepared current versus noncurrent classification accrual basis historical cost basis except asset liability balance sheet following asset liability presented based currentnoncurrent classification measured fair value revalued amount wherever applicable asset current expected realised intended sold derivative financial instrument consumed normal operating cycleor certain financial asset measured fair value held primarily purpose tradingor annual report note consolidated financial statement year ended st march expected realised within twelve month capital workinprogress respect asset reporting period ready intended use cash cash equivalent unless restricted carried cost comprising direct cost related exchanged used settle liability incidental expense attributable interest least twelve month reporting period identifiable revenue expense including asset classified noncurrent interest incurred respect various project expansion net income earned liability current project development stage prior intended expected settled normal operating cycle use considered pre operative expense disclosed capital workinprogress held primarily purpose trading due settled within twelve month capital expenditure tangible asset research reporting period development classified property plant unconditional right defer equipment depreciated settlement liability least twelve month basis property plant equipment reporting period property plant equipment eliminated liability treated noncurrent financial statement either disposal retired active use loss arising deferred tax asset liability classified non case retirement property plant current asset liability respectively equipment gain loss arising disposal property plant equipment significant accounting policy recognised statement profit loss property plant equipment year occurrence freehold land carried historical cost item property plant equipment depreciation holding company stated cost less accumulated depreciation depreciable amount asset cost impairment loss asset amount substituted cost less estimated residual value property plant cost includes cost acquisition installation equipment provided written value construction direct expense incurred method useful life asset bring asset working condition specified schedule ii company act finance cost incurred date asset property plant equipment ready intended use excludes cenvat added disposed year depreciation value added tax eligible credit setoff provided prorata basis premium leasehold land amortised period cost includes cost replacing part lease building constructed leasehold land plant equipment borrowing cost depreciated based useful life specified longterm construction project recognition schedule ii company act criterion met significant part plant lease period land beyond life equipment required replaced building case building constructed interval depreciated separately leasehold land amortised primary based specific useful life likewise lease period land major inspection performed cost recognised carrying amount asset residual value useful life method plant equipment replacement depreciation reviewed financial year recognition criterion satisfied repair end adjusted prospectively appropriate maintenance cost recognised statement profit loss incurred plan prepare perform financial statement consolidated note consolidated financial statement year ended st march asset carrying amount written life expected pattern consumption immediately recoverable amount future economic benefit embodied asset asset carrying amount greater considered modify amortisation period estimated recoverable amount method appropriate treated change accounting estimate depreciation subsidiary depreciation property plant equipment gain loss arising derecognition provided rate required permissible intangible asset measured difference gaap respective country net disposal proceeds management belief estimated useful carrying amount asset recognised life realistic reflect fair approximation statement profit loss asset period asset likely used derecognised vehicle acquired finance lease research development depreciated period lease agreement revenue expenditure research expensed useful life whichever shorter respective head account period incurred transition ind group elected continue carrying value development expenditure incurred property plant equipment recognised individual project carried forward st april measured per previous gaap future recoverability reasonably regarded use carrying value deemed cost assured expenditure carried forward property plant equipment amortised period expected future sale related project carrying intangible asset value development cost reviewed intangible asset recognised impairment annually asset yet probable future economic benefit use otherwise event change attributable asset flow group circumstance indicate carrying value cost asset measured reliably may recoverable intangible asset stated cost acquisition transition ind group elected less accumulated amortisation impairment continue carrying value intangible loss asset recognised st april measured per previous gaap use carrying value internally generated intangible excluding deemed cost intangible asset capitalised development cost capitalised related expenditure reflected profit financial instrument loss period expenditure financial instrument contract give incurred rise financial asset one entity financial liability equity instrument another entity software amortised estimated useful life straight line basis date financial asset available intended use subject impairment classification test group classifies financial asset subsequently measured amortised cost fair value amortisation period amortisation comprehensive income fair value method intangible asset finite profit loss basis business model useful life reviewed least end managing financial asset contractual reporting period change expected useful cash flow characteristic financial asset annual report note consolidated financial statement year ended st march initial recognition measurement investment equity instrument financial asset recognised initially equity instrument held trading fair value plus case financial asset classified fvtpl equity instrument recorded fair value profit loss classified fvtoci fair value change transaction cost attributable instrument excluding dividend acquisition financial asset recognised comprehensive income recycling amount subsequent measurement comprehensive income profit loss purpose subsequent measurement financial asset classified two broad investment debt instrument category debt instrument measured amortised cost fvtoci debt instrument financial asset fair value fvtpl fvtoci meet criterion categorization amortized financial asset amortised cost cost fvoci classified fvtpl debt instrument included within fvtpl category asset measured fair value gain measured fair value change recognised loss either recognised statement statement profit loss profit loss ie fair value profit loss fvtpl recognised comprehensive derecognition financial asset income ie fair value comprehensive financial asset primarily derecognised income fvtoci right receive cash flow asset expired group transferred financial asset measured amortised cost net right receive cash flow asset write impairment financial asset measured amortised cost impairment financial asset asset held within business model accordance ind group whose objective hold asset collecting applies expected credit loss ecl model contractual cash flow contractual term measurement recognition impairment loss asset give rise specified date cash flow financial asset debt instrument solely payment principal interest trade receivables financial asset subsequently measured amortised cost using effective interest rate financial liability eir method less impairment loss classification arising impairment recognised group classifies financial liability statement profit loss subsequently measured amortised cost fvtpl financial asset measured fair value initial recognition measurement comprehensive income fvtoci financial liability recognised initially financial asset category measured fair value case loan borrowing initially well reporting date fair payable net directly attributable value asset held within business model transaction cost whose objective hold asset collecting contractual cash flow selling financial asset financial liability include trade fair value movement recognized payable loan borrowing including bank comprehensive income overdraft derivative financial instrument financial asset measured fair value subsequent measurement profit loss fvtpl financial liability fair value profit financial asset category measured loss include financial liability held trading initially well reporting date fair financial liability designated upon initial value change recognised profit loss recognition fair value profit plan prepare perform financial statement consolidated note consolidated financial statement year ended st march loss interestbearing loan borrowing slow nonmoving material obsolesces subsequently measured amortised cost using defective inventory fully provided effective interest rate eir method gain valued net realisable value loss recognised profit loss liability derecognised well eir good material transit valued amortisation process amortised cost calculated actual cost incurred date balance taking account discount premium sheet material item held use acquisition fee cost integral production inventory written part eir eir amortisation included finished product used finance cost statement profit loss expected sold cost derecognition financial liability cash cash equivalent financial liability derecognised cash cash equivalent comprise cash obligation liability discharged hand cash bank including fixed deposithighly cancelled expires existing financial liquid investment original maturity period liability replaced another three month less readily convertible lender substantially different term term known amount cash subject existing liability substantially modified insignificant risk change value exchange modification treated derecognition original liability cash flow statement recognition new liability difference cash flow reported using indirect method respective carrying amount recognised whereby net profit tax adjusted statement profit loss effect transaction noncash nature deferral accrual past future operating derivative financial instrument cash receipt payment item income group u derivative financial instrument expense associated investing financing forward currency contract mitigate cash flow cash flow operating foreign currency risk derivative financial investing financing activity group instrument initially recognised fair value segregated date derivative contract entered subsequently remeasured fair foreign currency transaction value derivative carried financial asset revenue transaction denominated foreign fair value positive financial currency normally recorded exchange liability fair value negative rate prevailing date transaction inventory monetary item denominated foreign currency raw material packing material valued yearend remeasured exchange lower cost net realisable value cost rate prevailing balance sheet date non includes duty tax net cenvat monetary foreign currency item carried cost vat wherever applicable cost imported raw material packing material lying bonded income expense account exchange warehouse includes custom duty finished difference either settlement restatement product including traded good workin recognised statement profit loss progress valued lower cost net realisable value cost arrived fifo basis revenue recognition revenue recognised extent cost inventory computed probable economic benefit flow include cost purchase cost conversion group revenue reliably standard overhead related cost measured regardless payment incurred bringing inventory made present condition annual report note consolidated financial statement year ended st march revenue measured fair value liability regard gratuity plan consideration received receivable amount determined actuarial valuation performed disclosed revenue inclusive excise independent actuary balance duty excluding sale tax value added tax sheet date using projected unit credit service tax duty collected behalf method government net return trade discount allowance rebate amount collected company fully contributes ascertained behalf third party liability ajanta pharma limited group gratuity trust trust trustee revenue sale good recognised administer contribution made trust significant risk reward transferred contribution invested scheme buyer per term contract life insurance corporation india significant uncertainty exists regarding amount permitted law india consideration derived sale good retirement benefit obligation recognised balance sheet represents present revenue sale technology know value defined benefit obligation right licence intangible reduced fair value scheme asset recognised performance obligation asset resulting calculation completed per term agreement limited present value available income service recognised refund reduction future contribution service rendered scheme company recognizes net obligation defined benefit plan dividend income recognised right balance sheet asset liability receive dividend established interest income actuarial gain loss recognised recognised time proportion basis insurance full comprehensive income claim recognised revenue period occur effect certainty receipt prudent basis export plan amendment recognized benefit available prevalent scheme statement profit loss accounted extent considered receivable ii defined contribution plan employee benefit contribution defined contribution plan case holding company recognised expense employee employee benefit payable wholly within rendered service entitling twelve month rendering service classified benefit short term employee benefit benefit salary wage shortterm compensated absence company pay provident fund performance incentive etc expected cost contribution publicly administered bonus exgratia recognised period provident fund per local regulation employee render related service company payment obligation contribution paid defined benefit plan contribution accounted defined company provides gratuity defined contribution plan contribution benefit retirement plan gratuity plan recognized employee benefit expense covering eligible employee gratuity due prepaid contribution plan provides lumpsum payment recognized asset extent vested employee retirement death cash refund reduction future incapacitation termination employment payment available amount based respective employee salary tenure employment company plan prepare perform financial statement consolidated note consolidated financial statement year ended st march iii compensated absence subject provision republic act company policy compensated retirement law absence accumulating nonaccumulating nature expected compensated absence cost accumulating compensated absence compensated absence recognized determined actuarial valuation performed number paid leave day remaining independent actuary balance end reporting period sheet date using projected unit credit method included salary wage account additional amount expected paid recognized availed availed result unused entitlement employee accumulated balance sheet date borrowing cost borrowing cost directly attributable compensated absence acquisition construction production asset expected occur within twelve month necessarily take substantial period time end period employee get ready intended use sale capitalised render related service recognised part cost asset borrowing liability present value defined cost expensed period benefit obligation balance sheet date occur borrowing cost consist interest cost entity incurs connection expense nonaccumulating compensated borrowing fund borrowing cost also includes absence recognized period exchange difference extent regarded absence occur adjustment borrowing cost iv sharebased compensation lease company recognizes compensation determination whether arrangement expense relating sharebased payment contains lease based substance net profit using fairvalue accordance arrangement inception date whether ind sharebased payment fulfilment arrangement dependent use specific asset asset arrangement case subsidiary mauritius conveys right use asset even right employee covered explicitly specified arrangement pension plan net present value severance allowance payable employment asset acquired lease significant right act provided obligation portion risk reward ownership arising item funded retained lessor classified operating lease lease rental charged case subsidiary philippine statement profit loss straight line basis shortterm benefit company recognizes liability net finance lease transfer substantially amount already paid expense risk benefit incidental ownership service rendered employee leased item capitalised accounting period short term benefit given commencement lease fair value company employee include salary leased property lower present wage social security contribution short value minimum lease payment lease term compensated absence bonus payment apportioned finance nonmonetary benefit charge reduction lease liability achieve constant rate interest postemployment benefit remaining balance liability finance company formal charge recognised finance cost retirement benefit plan however company statement profit loss annual report note consolidated financial statement year ended st march leased asset depreciated useful life deferred income tax asset liability asset however reasonable measured using respective country tax certainty group obtain ownership rate tax law enacted end leased term asset depreciated substantively enacted balance sheet date shorter estimated useful life expected apply taxable income asset leased term year temporary difference expected recovered settled effect earnings per share change tax rate deferred income tax basic earnings per equity share computed asset liability recognized income dividing net profit attributable equity expense period includes enactment holder company weighted average substantive enactment date deferred number equity share outstanding income tax asset recognized extent period diluted earnings per equity share probable future taxable profit computed dividing net profit attributable available deductible temporary equity holder company weighted difference tax loss utilized average number equity share considered group offset current tax asset current tax deriving basic earnings per equity share also liability legally enforceable right weighted average number equity share set recognized amount could issued upon conversion intends either settle net basis realize dilutive potential equity share dilutive asset settle liability simultaneously potential equity share adjusted proceeds receivable equity share deferred income tax provided actually issued fair value dilutive potential equity undistributed earnings subsidiary share deemed converted beginning expected earnings subsidiary period unless issued later date distributed foreseeable future dilutive potential equity share determined independently period presented dividend shareholder annual dividend distribution shareholder income tax recognised liability period income tax expense comprises current dividend approved shareholder deferred income tax interim dividend paid recognised approval board director dividend payable income tax expense recognized net profit corresponding tax dividend distribution statement profit loss except recognised directly equity extent relates item recognized directly equity case recognized provision contingent liability contingent comprehensive income current income tax asset commitment current prior period recognized general amount expected paid recovered provision recognised group tax authority using respective country present obligation legal constructive result tax rate tax law enacted past event probable outflow substantively enacted balance sheet date resource required settle obligation deferred income tax asset liability respect reliable estimate made recognized temporary difference arising tax base asset liability provision excluding retirement benefit carrying amount financial statement compensated absence discounted deferred tax asset reviewed reporting present value determined based best date reduced extent estimate required settle obligation longer probable related tax benefit balance sheet date reviewed realised balance sheet date adjusted reflect current best estimate plan prepare perform financial statement consolidated note consolidated financial statement year ended st march expectation discounted current pretax rate reflects provision reimbursed reimbursement risk specific decommissioning liability recognised separate asset unwinding discount recognised reimbursement virtually certain income statement finance cost expense relating provision presented estimated future cost decommissioning statement profit loss net virtually reviewed annually adjusted appropriate certain reimbursement change estimated future cost discount rate applied added deducted effect time value money material cost asset provision discounted using current pre tax rate reflects appropriate risk fair value measurement specific liability discounting used group measure financial instrument increase provision due passage derivative fair value balance sheet time recognised finance cost date accordance ind contingent liability disclosed case financials statement prepared historical cost basis except following present obligation arising past event material item statement financial probable outflow position resource required settle obligation derivative financial instrument measured present obligation arising past event fair value received bank reliable estimate possible mutual fund measured fair value possible obligation arising past event per net asset value nav unless probability outflow resource employee stock option plan esop fair remote value per actuarial valuation report contingent liability recognised fair value price would received financial statement contingent asset sell asset settle liability ordinary neither recognised disclosed financial transaction market participant statement measurement date commitment include amount purchase fair value asset liability measured order net advance issued party using assumption market participant completion asset noncancellable would use pricing asset liability operating lease assuming market participant act economic best interest provision contingent liability contingent asset commitment reviewed balance fair value measurement nonfinancial asset sheet date take account market participant ability generate economic benefit using asset asset retirement obligation highest best use selling another asset retirement obligation aro provided market participant would use asset operating lease arrangement highest best use company binding obligation end lease period restore leased premise group u valuation technique condition similar inception lease aro appropriate circumstance provided present value expected sufficient data available measure fair value cost settle obligation using discounted maximising use relevant observable input cash flow recognised part minimising use unobservable input cost particular asset cash flow annual report note consolidated financial statement year ended st march asset liability fair value contains lease group separate measured disclosed financial statement payment consideration required categorised within fair value hierarchy arrangement lease described follows based lowest element basis level input significant fair value relative fair value measurement whole group determined based level quoted unadjusted market price evaluation term condition active market identical asset arrangement contract liability nature operating lease level valuation technique lowest level input significant fair b multiple element contract vendor value measurement directly indirectly group entered multiple element observable contract vendor supply good level valuation technique rendering service consideration lowest level input significant fair paid ismay determined independent value measurement unobservable value supply received service availed accordingly supply service asset liability recognised accounted based relative financial statement recurring basis fair value overall consideration group determines whether transfer supply finite life contract occurred level hierarchy defined significant accounting policy assessing categorisation based lowest accounted property plant level input significant fair value equipment andor intangible asset measurement whole end since group economic ownership reporting period asset group belief current treatment represents substance purpose fair value disclosure arrangement company determined class asset liability basis nature characteristic c determination functional currency risk asset liability level entity group determines fair value hierarchy explained functional currency currency primary economic environment critical accounting judgement estimate entity operates item included assumption financial statement entity preparation group financial statement measured using functional currency ind requires management make judgement effect change foreign estimate assumption affect exchange rate prescribes factor reported amount revenue expense asset considered purpose determination liability disclosure contingent functional currency management u liability end reporting period judgement determine functional however uncertainty assumption currency faithfully represents estimate could result outcome economic effect underlying require material adjustment carrying transaction event condition amount asset liability future period property plant equipment arrangement containing lease determination estimated useful life inception arrangement tangible asset assessment group determines whether arrangement component cost may contains lease inception capitalized useful life tangible asset reassessment arrangement based life useful livesrates plan prepare perform financial statement consolidated note consolidated financial statement year ended st march prescribed gaap respective amount timing future taxable income country assumption also need given wide range international business made company assesses whether relationship longterm nature asset may capitalised complexity existing contractual agreement component cost asset may difference arising actual result capitalised assumption made future change assumption could necessitate future e intangible asset adjustment tax income expense internal technical user team assess already recorded group establishes remaining useful life intangible asset provision based reasonable estimate management belief assigned useful possible consequence audit tax life reasonable authority respective country operates amount provision f recognition measurement defined based various factor experience benefit obligation previous tax audit differing interpretation obligation arising defined tax regulation taxable entity benefit plan determined basis responsible tax authority difference actuarial assumption key actuarial interpretation may arise wide variety assumption include discount rate trend issue depending condition prevailing salary escalation vested future benefit respective country life expectancy discount rate determined reference market yield deferred tax asset recognised end reporting period unused tax loss extent government bond period maturity probable taxable profit underlying bond correspond available loss probable maturity postemployment utilised significant management judgement benefit obligation required determine amount deferred tax asset recognised g recognition deferred tax asset based upon likely timing level income tax future taxable profit future tax planning deferred tax asset recognised strategy recent business performance deductible temporary difference development extent probable taxable profit available deductible h recognition measurement temporary difference utilised provision management assumes taxable profit recognition measurement available recognising deferred provision based assessment tax asset probability outflow resource past experience circumstance management judgment required known balance sheet date actual calculation provision income tax outflow resource future date may deferred tax asset liability therefore vary figure included company review balance sheet provision date carrying amount deferred tax asset factor used estimate may contingency differ actual outcome could lead management judgement required significant adjustment amount estimating possible outflow resource reported financial statement respect contingenciesclaim litigation group uncertainty exist respect possible predict outcome pending interpretation complex tax regulation matter accuracy annual report note consolidated financial statement year ended st march j allowance uncollected account recent accounting pronouncement receivable advance standard issued yet effective trade receivables carry interest march ministry corporate affair stated normal value issued company indian accounting reduced appropriate allowance standard amendment rule notifying estimated irrecoverable amount individual amendment ind statement cash flow trade receivables written ind sharebased payment management seems collectible amendment accordance recent impairment made expected credit amendment made international accounting loss present value standard board iasb ia statement cash shortfall expected life cash flow ifrs sharebased payment financial asset respectively amendment applicable group st april impairment provision financial asset based assumption risk amendment ind statement cash flow default expected loss rate judgement amendment ind requires entity making assumption selecting provide disclosure enable user financial input impairment calculation statement evaluate change liability based past history existing market arising financing activity including condition well forward looking estimate change arising cash flow noncash end reporting period change amendment effective annual period beginning st april k insurance claim application amendment result insurance claim recognised additional disclosure provided group company reasonable certainty recovery amendment ind sharebased payment amendment ind address three l impairment review main area effect vesting condition impairment exists carrying measurement cashsettled sharebased value asset cash generating unit payment transaction classification share cgu exceeds recoverable amount based payment transaction net settlement recoverable amount higher fair feature withholding tax obligation value less cost sell value use accounting modification term value use calculation based condition sharebased payment transaction discounted cash flow model calculating change classification cash settled value use certain assumption equity settled required made respect highly uncertain matter including management amendment effective annual expectation growth ebitda long term period beginning st april growth rate selection discount amendment expected impact rate reflect risk involved group plan prepare perform financial statement consolidated note consolidated financial statement year ended st march property plant equipment capital workinprogress current year cr gross block depreciation amortisation net block particular consolidation deduction consolidation deduction st april addition st march st april addition st march st march adjustment adjustment adjustment adjustment property plant equipment freehold land leasehold land leasehold improvement building plant equipment furniture fixture vehicle office equipment computer total b intangible asset computer software anda development cost total total b c capital work progress including pre operative expense cr refer note intangible asset development total b c addition includes cr used research development depreciation cr considered preoperative expenditure refer note property plant equipment capital workinprogress previous year cr gross block depreciation amortisation net net block block particular consolidation addition deduction consolidation deduction st april st march st april addition st march st march st april adjustment adjustment adjustment adjustment property plant equipment freehold land leasehold land leasehold improvement building plant equipment furniture fixture vehicle office equipment computer total b intangible asset computer software anda development cost total total b c capital work progress including pre operative expense cr refer note intangible asset development total b c addition includes cr used research development depreciation cr considered preoperative expenditure refer note annual report note consolidated financial statement year ended st march non current financial investment cr march march april long term trade investment unquoted investment investment share turkmenderman ajanta pharma ltd share u fully paidup others opgs power gujarat private limited st march nil st april nil share cr yr st march nil st april nil sub total b investment mutual fund quoted face value unit icici prudential fmp series day plan n regular plan cumulative icici prudential fmp series day plan e regular plan cumulative kotak fmp series growth hdfc fmp october series regular growth birla sun life fixed term plan series ja day idfc fixed term plan series regular plangrowth sub total b total b aggregate value quoted investment market value aggregate value unquoted investment figure bracket previous year plan prepare perform financial statement consolidated note consolidated financial statement year ended st march non current financial asset others cr march march april unsecured considered good security deposit deposit account bank original maturity month lien others cy nil py interest accrued fixed deposit bank defered tax asset net march march april others non current asset others march march april capital advance inventory march march april raw material packing material workinprocess finished good stockintrade includes transit stock finished good includes transit stock stockintrade annual report note consolidated financial statement year ended st march current financial investment cr march march april investment fair value profit loss fvtpl mutual fund quoted face value unit bsl short term fund growth franklin india low duration fund growth birla sun life cash plus daily dividend franklin india short term income plan reliance regular saving fund debt plan g sbi magnum insta cash fund daily dividend utitreasury advantage fundinstitutional plan icici prudential fmp series day plan n regular plan cumulative icici prudential interval annual plan iii regular growth icici prudential fmp series day plan regular plan cumulative kotak fmp series growth hdfc fmp october series regular growth birla sun life fixed term plan series ja day plan prepare perform financial statement consolidated note consolidated financial statement year ended st march current financial investment contd cr march march april idfc fixed term plan series regular plangrowth birla sun life dynamic bond fund retail growth sbi dynamic bond fund regular plan growth aggregate value quoted investment market value figure bracket previous year trade receivables cr march march april trade receivables considered good doubtful debt allowance doubtful debt cash cash equivalent march march april balance bank current account cash hand deposit account original maturity month less bank overdraft used cash management purpose annual report note consolidated financial statement year ended st march bank balance cash cash equivalent cr march march april earmarked balance bank unpaid dividend unpaid sale proceeds fractional share cy st march deposit account original maturity month upto month deposit account original maturity month lien others current financial asset others march march april interest receivable forward contract current tax asset net march march april income tax paid net provision current asset march march april balance statutorygovt authority excise authority vat receivable octroi refund receivable prepaid expense advance supplier advance employee advance recoverable cash kind plan prepare perform financial statement consolidated note consolidated financial statement year ended st march share capital march march april cr cr cr share fv share fv share fv authorised equity share issued equity share subscribed paidup equity share fully paid add share forfeited amount originally paid reconciliation number equity share outstanding beginning end year march march april cr cr cr share fv share fv share fv equity share outstanding beginning year add equity share allotted year option excercised esop cr yr add equity share allotted year bonus esop cr yr st march st april less equity share bought back year equity share outstanding end year termsrights attached equity share company one class equity share voting right par value per share company declares pay dividend indian rupee interim dividend paid recognised approval board director year ended st march amount dividend per equity share recognised distribution equity shareholder pr yr includes interim dividend pr yr per equity share event liquidation company holder equity share entitled receive remaining asset company distribution preferential amount distribution proportion number equity share held shareholder annual report note consolidated financial statement year ended st march detail equity share held shareholder holding march march april name shareholder share holding share holding share holding fv fv fv mr yogesh agrawal trustee yogesh agrawal trust mr rajesh agrawal trustee rajesh agrawal trust mr ravi p agrawal trustee ravi agrawal trust mr aayush agrawal trustee aayush agrawal trust gab investment private limited ganga export represented mr yogesh agrawal mr rajesh agrawal mr ravi p agrawal mr aayush agrawal mr yogesh agrawal na na mr rajesh agrawal na na mr mannalal b agrawal mr purushottam b agrawal mr madhusudan b agrawal mr manisha agrawal mr richa r agrawal mr aayush agrawal mr vimal agrawal mr mamta agrawal march march april share share share fv fv fv equity share reserved issuance employee stock option scheme company equity share aggregate number equity share issued last five year pursuant employee stock option scheme equity share equity share allotted fully paid bonus share period five year immediately preceding balance sheet date bonus share issued fy bonus share allotment esop fy bonus share allotment esop fy bonus share allotment esop fy company subsidiary company plan prepare perform financial statement consolidated note consolidated financial statement year ended st march non current financial liability borrowing cr march march april term loan secured bank foreign currency vehicle loan secured bank foreign currency loan unsecured deferred sale tax loan government maharashtra term loan secured first charge property plant equipment company second charge entire current asset company present future pari passu basis addition personal guarantee director vehicle loan secured vehicle acquired scheme repayble equal monthly instalment upto st december rate interest pa pryr pa non current financial liability march march april trade security deposit payable non current provision march march april provision employee benefit net gratuity leave benefit deferred tax liability net march march april difference tax base property plant equipment unrealised gainloss security carried fvocifvtpl b deferred tax asset mat credit entitlement c unabsorbed loss disallowance income tax e deferred tax liability net ab cd e annual report note consolidated financial statement year ended st march current financial liability borrowing cr march march april working capital loan repayable demand bank secured rupee loan foreign currency loan working capital loan repayable demand bank unsecured foreign currency loan working capital loan secured first charge current asset second charge property plant equipment company pari passu basis addition personal guarantee director current financial liability trade payable march march april trade payable current financial liability march march april current maturity longterm borrowing secured refer note foreign currency term loan bank rupee term loan bank vehicle loan unsecured deferred sale tax loan unpaid dividend unpaid sale proceeds fractional share interest accrued capital creditor others amount due outstanding credited investor education protection fund st march current liability march march april payable advance received customer statutory due payable others plan prepare perform financial statement consolidated note consolidated financial statement year ended st march current provision cr march march april provision employee benefit net gratuity leave benefit provision sale return expired good refer note current tax liability net march march april provision tax net payment revenue operation march march sale product finished good stockintrade operating revenue export incentive royalty fee others income march march exchange difference net dividend investment fvtpl gain financial instrument fvtpl interest deposit bank interest others miscellaneous income cost material consumed march march raw material consumed packing material consumed annual report note consolidated financial statement year ended st march purchase stockintrade cr march march purchase stockintrade change inventory finished good workinprogress stockintrade march march inventory beginning year workinprocess finished good stockintrade inventory end year workinprocess finished good stockintrade b total change inventory finished good workinprogress b stockintrade empolyee benefit expense march march salary wage bonus allowance expense employee stock option scheme contribution provident fund staff welfare expense finance cost march march interest expense borrowing cost including bank charge depreciation march march depreciation tangible asset refer note depreciation intangible asset refer note plan prepare perform financial statement consolidated note consolidated financial statement year ended st march expense cr march march selling expense clearing forwarding travelling expense processing charge power fuel advertisement publicity consumption store spare part rent rate tax legal professional fee postage telephone expense repair maintenance building plant machinery computer others insurance donation exchange difference net impairment loss financial asset excise duty collected sale loss salediscard property plant equipment net corporate social responsibility expense refer note miscellaneous expense capital management group policy maintain strong capital base maintain investor creditor market confidence sustain future development business management monitor return capital well level dividend equity shareholder board director seek maintain balance higher return might possible higher level borrowing advantage security afforded sound capital position group target achieve return capital return return group monitor capital using ratio adjusted net debt adjusted equity purpose adjusted net debt defined total liability comprising interestbearing loan borrowing obligation finance lease less cash cash equivalent short term investment adjusted equity comprises component equity group policy keep ratio adjusted net debt equity ratio st march follows cr particular march march april debt debt current liability less cash cash equivalent current investment net debt equity b net debt equity ratio ab annual report note consolidated financial statement year ended st march earnings per share eps numerator denominator used calculate basic diluted earnings per share particular march march basic diluted earnings per share profit attributable equity shareholder basic eps cr add dilutive effect profit cr b nil nil profit attributable equity shareholder computing diluted eps cr cab weighted average number equity share outstanding basic eps add dilutive effect option outstanding number equity share e weighted average number equity share diluted eps fde face value per equity share basic earnings per share ad diluted earnings per share cf account employee stock option scheme esos refer note consolidated financial statement present consolidated account holding company following subsidiary company detail subsidiary group country voting power name company incorporation held march ajanta pharma mauritius ltd apml mauritius ajanta pharma mauritius intl ltdapmil wholly owned subsidiary apml mauritius ajanta pharma usa inc apui usa ajanta pharma philippine inc appi philippine ajanta pharma uk ltd ap uk england wale ajanta pharma nigeria ltd apnl nigeria financial statement subsidiary used consolidation period st april st march financial statement information subsidiary audited auditor ajanta pharma uk ltd wholly owned subsidiary incorporated th november however transaction st march employee benefit respect holding company required ind employee benefit disclosure defined contribution plan company offer employee defined contribution plan form provident fund pf employee pension scheme eps government certain state plan employee state insurance esi pf eps cover substantially regular employee esi cover certain employee contribution made government fund employee company pay predetermined contribution provident fund esi scheme contribution pension fund made company plan prepare perform financial statement consolidated note consolidated financial statement year ended st march contribution normally based certain proportion employee salary year company recognised following amount account cr particular march march provident fund employee pension scheme employee state insurance total defined benefit plan gratuity company make annual contribution employee group gratuitycum life assurance cash accumulation scheme lic funded defined benefit plan qualifying employee scheme provides payment vested employee normal retirement early retirement withdrawal resignation per provision payment gratuity act vesting period year service death service per provision payment gratuity act without vesting period death benefit company provides death benefit defined benefit plan death benefit plan certain category employee death benefit plan provides lump sum payment vested employee death compensation received insurance company restricted limit set forth said plan death benefit plan nonfunded isclosures defined benefit plan ie gratuity funded plan based actuarial report st march cr particular march march change defined benefit obligation opening defined benefit obligation current service cost interest cost actuarial loss gain change financial assumption experience adjustment benefit paid closing defined benefit obligation ii change value plan asset opening value plan asset expense deducted fund adjustment opening fund interest income return plan asset excluding amount included interest income contribution employer benefit paid closing value plan asset iii amount recognized balance sheet present value funded obligation year end fair value plan asset year end net asset liability recognised year end annual report note consolidated financial statement year ended st march cr particular march march iv expense recognised statement profit loss current service cost net interest cost expense deducted fund adjustment opening fund expense recognised statement comprehensive income net actuarial lossgain recognized current year change financial assumption experience adjustment return plan asset excluding amount included interest income v asset information others policy insurance vi principal actuarial assumption used discount rate pa salary growth rate pa sensitivity analysis reasonably possible change reporting date one relevant actuarial assumption holding assumption constant would affected defined benefit obligation amount shown cr march march increase decrease increase decrease discount rate movement salary growth rate movement although analysis take account full distribution cash flow expected plan provide approximation sensitivity assumption estimate future increase compensation level considered actuarial valuation taken account inflation seniority promotion relevant factor supply demand employment market expected contribution defined benefit plan next financial year line fy leave encashment holding company employee entitled compensated absence allowed accumulated encashed per company rule liability compensated absence nonfunded provided based report independent actuary using projected unit credit method accordingly cr pr yr cr liability yearend compensated absence per actuarial valuation provided account employee retirement benefit obligation respect subsidiary mauritius employee covered pension plan net present value severance allowance payable provided cr pr yr cr employee retirement benefit obligation respect subsidiary philippine short term benefit includes salary wage government contribution due within month end period employee render related service company short term employee benefit amounted cr pr yr cr company yet set retirement plan since ten employee served least five year plan prepare perform financial statement consolidated note consolidated financial statement year ended st march share based payment holding company implemented employee stock option scheme esos approved shareholder compensation committee board director year option granted company aforesaid esos employee company grant date option exercise price vesting period july option granted exercise price accordance relevant sebi guideline force time grant option entitles holder exercise right apply seek allotment one equity share particular option esos march march particular option outstanding beginning year add option granted year less option exercised year less option lapsed year nil option outstanding year end financial instrument fair value risk management fair value measurement cr financial instrument category march march april amortised amortised amortised fvtpl fvtpl fvtpl cost cost cost financial asset forward exchange contract investment mutual fund trade receivables non current financial asset others cash cash equivalent bank balance cash cash equivalent interest receivable total financial asset financial liability borrowing non current financial liability capital creditor current financial liability trade payable total financial liability annual report note consolidated financial statement year ended st march fair value hierarchy cr financial asset liability march march april measured fair value level level level ii iii ii iii ii iii financial asset recurring fair value measurement forward exchange contract investment mutual fund non recurring fair value measurement trade receivables non current financial asset others cash cash equivalent bank balance cash cash equivalent interest receivable total financial asset financial liability borrowing non current financial liability capital creditor current financial liability trade payable total financial liability level hierarchy level includes financial instrument measured using quoted price includes mutual fund quoted price mutual fund valued using closing nav level fair value financial instrument traded active market like forward contract determined using valuation technique maximise use observable market data rely little possible entityspecific estimate significant input required fair value instrument observable instrument included level level one significant input based observable market data instrument included level case unlisted equity security etc included level financial risk management framework management responsible group exposure following risk arising developing monitoring company financial instrument risk management policy credit risk guidance audit committee liquidity risk market risk group risk management policy established identify analyse risk risk management framework faced set appropriate risk limit group board director overall control monitor risk adherence responsibility establishment limit risk management policy system oversight company risk management reviewed regularly reflect change plan prepare perform financial statement consolidated note consolidated financial statement year ended st march market condition group activity based internal rating criterion group training procedure deviation credit limit require aim maintain disciplined constructive approval director control environment employee customer transacting understand role obligation group year monitored individual group audit committee oversees business manager located management monitor compliance countriesplaces outstanding customer group risk management policy receivables regularly monitored procedure review adequacy company concentration risk management framework relation credit risk customer base risk faced group audit widely distributed economically committee assisted oversight role geographically internal audit internal audit undertakes regular ad hoc review risk st march group management control procedure customer st march result reported audit customer st april customer committee owed company cr accounted ii credit risk approximately year credit risk risk counter party ie st march st march meet obligation financial st april receivables instrument customer contract leading outstanding financial loss group exposed credit risk operating activity primarily impairment analysis performed trade receivables financing reporting date individual activity including deposit bank basis major client addition mutual fund foreign exchange transaction large number minor receivables financial instrument grouped homogenous group assessed impairment collectively trade receivables calculation based historical customer credit risk managed data maximum exposure credit business unit subject risk reporting date carrying group established policy procedure value class financial asset control relating customer credit group hold collateral risk management trade receivables security group evaluates noninterest bearing concentration risk respect mainly stockist distributor trade receivables low customer customer generally located several jurisdiction day day credit term credit operate largely independent market limit established customer expected credit loss trade receivables simplified approach cr march march april gross carrying amount average expected loss rate carrying amount trade receivables net impairment annual report note consolidated financial statement year ended st march b financial instrument optimising return financial instrument holding company limit exposure affected market risk include loan credit risk investing liquid debt borrowing deposit investment security issued mutual fund derivative financial instrument credit ranking atleast crisil equivalent rating agency group activity expose variety holding company monitor change financial risk including effect credit risk tracking published external change foreign currency exchange credit ranking based ongoing rate interest rate group u assessment counterparty risk derivative financial instrument holding company adjusts exposure foreign exchange contract manage various counterparties exposure foreign exchange fluctuation investment subsidiary transaction carried within company guideline set risk management committee iii liquidity risk liquidity risk risk group may sensitivity analysis prepared able meet present future cash basis amount net debt collateral obligation without incurring ratio fixed floating interest rate unacceptable loss group objective debt derivative proportion time maintain optimum level financial instrument foreign currency liquidity meet cash collateral constant requirement group closely monitor liquidity position deploys robust cash analysis excludes impact management system maintains adequate movement market variable source financing including bilateral loan carrying value postemployment benefit debt overdraft bank optimised obligation provision non cost working capital requirement financial asset liability adequately addressed internally generated fund trade receivables kept within sensitivity relevant income manageable level statement item effect assumed change respective market risk group aim maintain level cash based financial asset financial cash equivalent highly liability held st march st marketable debt investment amount march excess expected cash outflow financial liability next six month currency risk ratio cash cash equivalent group exposed currency risk highly marketable debt investment extent mismatch current liability st march st currency march st april sale purchase borrowing denominated respective iv market risk functional currency group market risk risk change currency market price foreign exchange transaction primarily denominated rate interest rate equity price u dollar euro mauritian rupee affect group income value philippine peso nigerian naira holding financial instrument objective market risk management point time group manage control market risk exposure cover foreign currency risk taking within acceptable parameter appropriate percentage foreign plan prepare perform financial statement consolidated note consolidated financial statement year ended st march currency exposure approved risk management committee line laid policy approved board group u forward exchange contract mitigate currency risk maturity less one year reporting date respect monetary asset liability denominated foreign currency group policy ensure net exposure kept acceptable level buying selling foreign currency spot rate necessary address shortterm imbalance following table analysis foreign currency risk st march cr particular u euro mauritian philippine nigerian total dollar rupee peso niara bank balance trade receivables asset trade payable nil borrowing financial liability nil net asset liability following table analysis foreign currency risk st march cr particular u euro mauritian philippine nigerian total dollar rupee peso niara bank balance trade receivables asset trade payable nil borrowing financial liability net asset liability following table analysis foreign currency risk st april cr particular u euro mauritian philippine nigerian total dollar rupee peso niara bank balance trade receivables asset trade payable nil borrowing financial liability nil net asset liability annual report note consolidated financial statement year ended st march year ended st march every percentage point depreciation appreciation exchange rate indian rupee respective currency affected company incremental profit tax per cr particular change effect profit currency tax exchange rate u dollar usd euro mauritian rupee mur philippine peso php nigerian niara nn year ended st march every percentage point depreciation appreciation exchange rate indian rupee respective currency affected company incremental profit tax per cr particular change effect profit currency tax exchange rate u dollar usd euro mauritian rupee mur philippine peso php nigerian niara nn year ended st april every percentage point depreciation appreciation exchange rate indian rupee respective currency affected company incremental profit tax per cr particular change effect profit currency tax exchange rate u dollar usd euro mauritian rupee mur philippine peso php nigerian niara nn b interest rate risk interest rate risk risk fair value future cash flow financial instrument fluctuate change market interest rate group exposure risk change market interest rate relates primarily group debt interest obligation group engages financing activity market linked rate change interest rate environment may impact future rate borrowing plan prepare perform financial statement consolidated note consolidated financial statement year ended st march interest rate profile group interest bearing financial instrument reported management follows cr particular march march april foreign currency term loan foreign currency packing credit nil nil total reasonably possible change basis point interest rate reporting date would impacted profit tax per analysis assumes variable particular foreign currency exchange rate remain constant cr particular march march april increase interest rate decrease interest rate c price risk group exposure price risk equity investment group disclosure operating lease ind lease holding company subsidiary company taken various premise operating lease generally cancellable range month year renewable mutual consent mutually agreeable term lease agreement price escalation clause restriction imposed lease arrangement sub lease contingent rent lease payment cr pr yr cr recognised statement profit loss rent note future minimum lease payment payment profile noncancellable operating lease cr particular march march later one year later one year later five year less five year nil nil finance lease cr total minimum future present value particular lease payment interest minimum lease outstanding outstanding payment within one year nil nil later one year later five year nil nil figure bracket indicate previous year figure future obligation towards lease rental lease agreement st march amount cr pr yr cr annual report note consolidated financial statement year ended st march contingent liability commitment contingent liability cr particular march march claim company acknowledged debt ii sale tax demand disputed company pending appeal nil iii custom duty import advance license scheme pending fulfilment export obligation iv disputed octroi amount paid protest cr pr yr cr v excise duty service tax disputed company amount paid protest cr pr yr cr vi income tax demand disputed company pending appeal amount paid protest cr pr yr cr respect clause vi management advised demand likely either deleted substantially reduced accordingly provision considered necessary future cash outflow respect liability clause dependent term agreed upon party respect clause ii vi dependent decision relevant authority respective dispute commitment estimated amount contract remaining executed capital account provided net advance cr pr yr cr b commitment noncancellable operating lease refer note related party disclosure required ind given relationship category director key management personnel relative mr mannalal b agrawal chairman mr purushottam b agrawal executive vice chairman mr madhusudan b agrawal executive vice chairman mr yogesh agrawal managing director mr rajesh agrawal joint managing director mr chandrakant khetan nonexecutive director dr anil kumar nonexecutive director mr k h viswanathan nonexecutive director mr prabhakar dalal nonexecutive director dr anjana grewal nonexecutive director mr arvind agrawal chief financial officer mr gaurang shah company secretary dr ramesh jhawar director apui mr vinayak muzumdar director apml mr suttian deerpaul director apml mr sam gioskos director appi relative key management personnel category ii enterprise person covered category ii able exercise significant control gab investment private limited seth bhagwandas agrawal charitable trust ganga export represented mr yogesh agrawal mr rajesh agrawal mr ravi agrawal mr aayush agrawal yogesh agrawal trust trustee mr yogesh agrawal wef march rajesh agrawal trust trustee mr rajesh agrawal wef march ravi agrawal trust trustee mr ravi p agrawal wef march ajanta pharma limited group gratuity trust plan prepare perform financial statement consolidated note consolidated financial statement year ended st march b following transaction carried related party cr sr particular category march march key management compensation short term employee benefit mr purushottam b agrawal mr madhusudan b agrawal mr yogesh agrawal mr rajesh agrawal mr arvind agrawal mr gaurang shah mr ramesh jhawar mr vinayak muzumdar mr suttian deerpaul mr sam gioskos postemployment benefit commission sitting fee nonexecutive director mr mannalal b agrawal mr chandrakant khetan dr anil kumar mr k h viswanathan mr prabhakar dalal dr anjana grewal rent mr manisha agrawal nil mr smriti agrawal nil mr aayush agrawal nil dividend paid ii purchase property mr yogesh agrawal nil mr rajesh agrawal nil mr ravi p agrawal nil mr aayush agrawal nil sale vehicle mr mannalal b agrawal nil mr ravi p agrawal nil corporate social responsibility expense seth bhagwandas agrawal charitable trust ii contribution made group gratuity trust premium paid lic premium paid ii c amount outstanding st march cr sr particular category march march april commission payable nonexecutive director mr mannalal b agrawal mr chandrakant khetan nil dr anil kumar nil mr k h viswanathan nil mr prabhakar dalal nil dr anjana grewal nil group completed independent evaluation international domestic transaction year ended st march reviewed year ended st march determine whether transaction associated enterprise undertaken arm length price based internal external transfer pricing review validation group belief transaction associated enterprise undertaken basis arm length principle annual report note consolidated financial statement year ended st march contribution towards corporate social responsibility particular csr expenditure follows gross amount required spent group year cr previous year cr b amount spend year sr particular cash yet paid cash total construction acquisition asset nil nil nil b purpose nil including paid related party cr refer note c amount spend previous year sr particular cash yet paid cash total construction acquisition asset nil nil nil b purpose nil including paid related party cr refer note provision anticipated sale return expired good ind cr particular march march balance beginning year add provision made year less amount written backutilized year balance end year disclosure specified bank note sbns year holding company specified note denomination note defined mca notification gsre dated march detail specified bank note sbn held transacted period november december denomination wise sbns note per notification given particular sbns denomination total note closing cash hand november permitted receipt nil permitted payment nil amount deposited bank closing cash hand december nil group one segment activity namely pharmaceutical remuneration auditor excluding service tax cr particular march march audit fee tax audit fee certification matter plan prepare perform financial statement consolidated note consolidated financial statement year ended st march research development expenditure revenue expense research development incurred year except depreciation particular march march cost materialconsumablesspare employee benefit expense utility expense total note foreign currency exposure asset liability year group entered forward exchange contract derivative instrument mitigate foreign currency risk establish amount currency indian rupee required available settlement date certain payable receivables following outstanding foreign currency forward contract entered group march march particular foreign currency foreign currency buy sell cross currency amt cr amt cr euro sell inr usd sell inr yearend foreign currency exposure mitigated derivative instrument otherwise foreign currency foreign currency cr cr foreign currency particular amt cr amt cr march march march march amount receivable usd euro nil nil gbp chf nil nil aed nil nil jpy amount payable usd euro nil nil gbp nil nil jpy gbp gbp case holding company excise duty includes cr pr yr cr net impact excise duty provision opening closing stock company invested jv turkmenderman ajanta pharma ltd tdapl two decade back management control however later company surrendered management control favour local partner since control tdapl operates severe restriction significantly impairs ability transfer fund hence company impaired entire investment tdapl considered unrelated party company making effort divest investment since last year without success annual report note consolidated financial statement year ended st march case holding company preoperative expense pending capitalisation included capital workinprogress refer note represent direct attributable expenditure setting plant prior date commencement commercial production capitalised completion project commencement commercial operation detail preoperative expense cr particular march march opening balance add incurred year employee benefit expense professional fee travelling expense depreciation others total less income less capitalised tangible asset nil closing balance additional information required schedule iii company act enterprise consolidated subsidiary st march net asset ie total asset share share total share profit loss minus total liability comprehensive income comprehensive income name enterprise amount amount amount amount consolidated consolidated consolidated consolidated cr cr cr cr net asset net asset net asset net asset holding company ajanta pharma ltd foreign subsidiary apml appi apui apnl total st march net asset ie total asset share share total share profit loss minus total liability comprehensive income comprehensive income name enterprise amount amount amount amount consolidated consolidated consolidated consolidated cr cr cr cr net asset net asset net asset net asset holding company ajanta pharma ltd foreign subsidiary apml appi apui apnl total plan prepare perform financial statement consolidated note consolidated financial statement year ended st march also refer note refer annexure b director report salient feature financial statement subsidiary income tax income tax expense benefit recognized income statement consists following cr march march current tax current tax profit year adjustment current tax prior period total current tax expense deferred tax expensebenefit origination reversal timing difference total income tax recognised income statement b reconciliation effective tax rate following reconciliation group effective tax rate year ended st march accounting profit income tax enacted tax rate india computed expected tax benefit expense tax effect due nontaxable income india tax purpose overseas tax overseas tax provision reversal effect nondeductible expense effect exempt nonoperating income tax effect chargeable different rate additional deduction rd expense investment allowance plant machinery deductible expense adjustment current tax prior period income tax benefit expense effective tax rate annual report note consolidated financial statement year ended st march c deferred tax asset liability tax effect significant temporary difference resulted deferred tax asset liability description created difference given cr march march april deferred tax liability property plant equipment gain financial instrument fair value profit loss others total deferred tax liability deferred tax asset leave encashment bonus provision expired good remeasurement gain loss defined benefit plan mat credit entitlement provision loss allowance temporary difference related subsidiary others total deferred tax asset deferred tax liability set deferred tax asset set movement deferred tax liability net opening balance remeasurement gain loss defined benefit plan tax benefitexpense period recognised profit loss others closing balance movement deferred tax asset net opening balance temporary difference related subsidiary others closing balance charge relating temporary difference year ended st march primarily account property plant equipment gain investment fvtpl partially offset provision expired good provision loss allowance compensated absence mat credit entitlement credit temporary difference year ended st march primarily account property plant equipment gain investment fvtpl partially offset provision expired good compensated absence provision loss allowance forward contract receivable plan prepare perform financial statement consolidated note consolidated financial statement year ended st march firsttime adoption ind payment transaction vested date pursuant company india accounting transition ind standard rule group adopted st march reporting date first time adoption appendix c ind requires entity india accounting standard ind consequently assess whether contract arrangement st april transition date preparation contains lease assessment financial statement financial statement carried inception contract year ended st march first financials arrangement however group used ind prepared accordance ind upto financial exemption assessed arrangement year ended st march group prepared based embedded lease based condition financial statement accordance accounting place date transition standard notified section company act read together company exception account rule previous gaap preparing following mandatory exception financial statement opening balance sheet applied accordance ind preparing prepared st april ie date transition financial statement ind figure previous period year ended st march restated derecognition financial asset financial regrouped reclassified wherever required liability comply ind schedule iii company group elected apply derecognition act make comparable requirement financial asset financial liability ind prospectively note explains principal adjustment made transaction occurring date group restating financial statement prepared transition ind accordance previous gaap including balance sheet st april financial statement classification measurement financial year ended st march asset group classified financial asset exemption accordance ind basis ind allows first time adopter certain exemption fact circumstance exist date retrospective application certain transition ind requirement ind deferred sale tax loan transition ind group applied per ind group applied requirement following exemption ind financial instrument ind accounting government grant group elected continue carrying disclosure government assistance value property plant equipment prospectively sale tax deferred loan existing recognised st april measured per date transition ind previous gaap use carrying value recognised corresponding benefit loan deemed cost property plant market rate interest government equipment grant group used previous gaap carrying amount loan date transition group elected continue carrying ind carrying amount loan value intangible asset recognised opening ind balance sheet per ind st april measured per previous loan classified amortised gaap use carrying value deemed cost since difference cost intangible asset carrying amount amount paid impact effective interest rate ie ind share based payment discountingunwinding required applied equity instrument share based annual report note consolidated financial statement year ended st march reconciliation equity previously reported igaap ind cr particular march date transition april adjustment adjustment previous previous transition ind transition ind gaap gaap ind ind asset noncurrent asset property plant equipment b capital workinprogress c intangible asset intangible asset development e financial asset investment ii others f deferred tax asset net g noncurrent asset current asset inventory b financial asset investment ii trade receivables iii cash cash equivalent iv bank balance iii v financial asset c current tax asset net current asset total asset equity liability equity equity share capital b equity liability noncurrent liability financial liability borrowing ii financial liability b provision c deferred tax liability net current liability financial liability borrowing ii trade payable iii financial liability b current liability c provision current tax liability net total equity liability plan prepare perform financial statement consolidated note consolidated financial statement year ended st march reconciliation statement profit loss previously reported igaap ind year ended st march cr adjustment particular previous gaap ind transition ind income revenue operation income total income expense cost material consumed purchase stockintrade change inventory finished good workinprogress stockintrade employee benefit expense finance cost depreciation amortisation expense expense total expense profit tax tax expense current tax deferred tax profit year comprehensive income comprehensive income reclassified profit loss subsequent year exchange difference translation foreign operation income tax effect net comprehensive income reclassified profit loss subsequent year comprehensive income reclassified profit loss subsequent year remeasurement gain loss defined benefit plan income tax effect net comprehensive income reclassified profit loss subsequent year comprehensive income year net tax total comprehensive income year net tax measurement recognition difference ind previous gaap year ended st march fair valuation investment previous gaap investment equity instrument mutual fund classified long term investment current investment based intended holding period realisability long term investment carried cost less provision temporary decline value investment current investment carried lower cost fair value ind investment required measured fair value resulting fair value change investment recognised retained earnings date transition subsequently profit loss year ended st march increased retained earnings cr st march st april cr foreign currency translation previous gaap group recognised translation difference foreign operation separate annual report note consolidated financial statement year ended st march component equity ind cumulative gain loss charged profit loss currency translation difference foreign ind remeasurements comprising actuarial operation deemed zero gain loss effect asset ceiling st april resulting adjustment recognised excluding amount included net interest net retained earnings defined benefit liability return plan asset excluding amount included net interest net proposed dividend defined benefit liability recognised immediately previous gaap proposed dividend including balance sheet corresponding debit credit dividend distribution tax ddt recognised retained earnings comprehensive liability period relate irrespective income thus employee benefit expense reduced declared ind proposed cr recognised comprehensive dividend recognised liability period income cr net deferred tax year declared company usually approved ended st march shareholder general meeting paid deferred tax therefore dividend liability proposed dividend previous gaap requires deferred tax accounting using including dividend distribution tax liability amounting income statement approach focus cr derecognised retained difference taxable profit accounting earnings date transition profit period ind requires entity account deferred tax using balance sheet proposed dividend including dividend distribution tax approach focus temporary difference liability amounting cr derecognised carrying amount asset liability transition date recognised balance sheet tax base application retained earnings year ended st march ind approach resulted recognition declared paid deferred tax new temporary difference required indian gaap defined benefit obligation previous gaap ind group addition various transitional adjustment recognised cost related post employment lead different temporary difference deferred defined benefit plan actuarial basis tax adjustment recognised correlation previous gaap entire cost related post underlying transaction either retained earnings employment defined benefit plan including actuarial separate component equity change increased decreased deferred tax follows cr particular march april financial instrument employee benefit nil provision nil stock reserve others increase deferred tax comprehensive income ind item income expense recognised period included profit loss period unless standard requires permit otherwise item income expense recognised profit loss shown statement profit loss comprehensive income includes remeasurements defined benefit plan concept comprehensive income exist previous gaap plan prepare perform financial statement consolidated note consolidated financial statement year ended st march statement cash flow presented inclusive excise duty excise duty transition previous gaap ind paid presented face statement material impact statement cash flow profit loss part expense change resulted increase total revenue ind bank overdraft repayable demand total expense year ended st march form integral part cash management inr cr impact total process included cash cash equivalent equity profit purpose presentation statement cash flow previous gaap bank overdraft cash discount considered part borrowing movement previous gaap cash discount cr bank overdraft shown part financing recognised part expense activity consequently cash cash equivalent adjusted revenue ind reduced cr st march year ended st march st april cr impact total equity profit excise duty retained earnings previous gaap revenue sale change decreased increased retained product presented exclusive excise duty earnings follows ind revenue sale good cr particular march april financial instrument net proposed dividend nil provision net deferred tax asset stock reserve others increase retained earnings preparation indas financial statement group made several presentation difference previous gaap indas difference impact reported profit total equity accordingly asset liability reclassified another line item indas date transition financial statement line item described differently indas compared previous gaap although asset liability included line item unaffected per report even date attached kapoor parekh associate behalf board director chartered accountant nilesh parekh mannalal b agrawal partner chairman purushottam b agrawal yogesh agrawal arvind agrawal vice chairman managing director chief financial officer madhusudan b agrawal rajesh agrawal gaurang shah mumbai rd may vice chairman joint managing director company secretary annual report independent auditor report conducted audit standalone ind financial member statement accordance standard auditing ajanta pharma limited specified section act standard require comply ethical requirement plan report standalone ind financial perform audit obtain reasonable assurance statement whether standalone ind financial statement free audited accompanying standalone ind financial material misstatement statement ajanta pharma limited company comprise balance sheet st march audit involves performing procedure obtain audit statement profit loss including comprehensive evidence amount disclosure income cash flow statement statement standalone ind financial statement procedure change equity year ended summary selected depend auditor judgment including significant accounting policy explanatory assessment risk material misstatement information herein referred standalone ind standalone ind financial statement whether due financial statement fraud error making risk assessment auditor considers internal financial control relevant company management responsibility standalone preparation standalone ind financial statement ind financial statement give true fair view order design audit procedure company board director responsible appropriate circumstance audit also includes matter stated section company act evaluating appropriateness accounting policy used act respect preparation presentation reasonableness accounting estimate made standalone ind financial statement give company director well evaluating overall true fair view state affair financial position presentation standalone ind financial statement profit financial performance including comprehensive income cash flow change equity company believe audit evidence obtained accordance accounting principle generally accepted sufficient appropriate provide basis audit india including indian accounting standard ind opinion standalone ind financial statement prescribed section act read relevant rule issued thereunder opinion opinion best information according responsibility also includes maintenance adequate explanation given u aforesaid standalone ind accounting record accordance provision act financial statement give information required safeguarding asset company preventing act manner required give true fair view detecting fraud irregularity selection conformity accounting principle generally accepted application appropriate accounting policy making india including ind state affair financial judgment estimate reasonable prudent position company st march profit design implementation maintenance adequate internal financial performance including comprehensive income financial control operating effectively ensuring cash flow change equity year ended accuracy completeness accounting record date relevant preparation presentation standalone ind financial statement give true fair view report legal regulatory free material misstatement whether due fraud error requirement required company auditor report order auditor responsibility order issued central government responsibility express opinion standalone india term section act give ind financial statement based audit annexure statement matter specified paragraph order taken account provision act accounting auditing standard matter required included audit report provision act rule made thereunder plan prepare perform financial statement standalone independent auditor report required section act report company disclosed impact pending litigation st march sought obtained information financial position standalone ind explanation best knowledge financial statement refer note belief necessary purpose audit standalone ind financial statement b opinion proper book account required ii company entered long law kept company far term contract including derivative contract appears examination book requiring provision applicable law accounting standard material foreseeable balance sheet statement profit c loss loss cash flow statement statement change equity dealt report delay transferring iii agreement book account amount required transferred investor education protection fund opinion aforesaid standalone ind company financial statement comply indian accounting standard prescribed section company provided requisite iv act read relevant rule issued thereunder disclosure standalone ind financial statement holding well dealing e basis written representation received specified bank note period director st march taken th november th december record board director none accordance book director disqualified st march account maintained company refer appointed director term section note standalone ind financial act statement f respect adequacy internal financial kapoor parekh associate control financial reporting company chartered accountant operating effectiveness control refer icai frn w separate report annexure b nilesh parekh g respect matter included auditor report accordance rule partner company audit auditor rule mno opinion best information mumbai rd may according explanation given u annual report annexure independent auditor report annexure referred para heading report unsecured company firm limited liability legal regulatory requirement report partnership party covered register even date member ajanta pharma limited maintained section company act standalone ind financial statement year ended accordingly paragraph iii order st march applicable company respect fixed asset opinion according information explanation given u company complied company maintained proper record provision section company showing full particular including quantitative detail act situation fixed asset company accepted deposit public b informed u management company policy physically verifying fixed asset broadly reviewed book account phased manner period maintained company pursuant rule opinion reasonable regard size prescribed central government maintenance company nature asset cost record section company informed material discrepancy act relation product manufactured noticed verification opinion prima facie prescribed account properly dealt book account record made maintained made detailed examination record view c according information explanation given determine whether accurate complete u title deed immovable property company held name company according information explanation given u according information explanation given u inventory physically verified company generally regular management reasonable interval year depositing undisputed statutory due including except stock third party provident fund employee state insurance income confirmation certificate obtained tax sale tax service tax custom duty excise company discrepancy noticed physical duty value added tax cess material verification physical stock book record statutory due appropriate authority material adequately dealt year undisputed amount book account payable respect aforesaid material statutory due st march arrears according information explanation given period six month date u company granted loan secured became payable b basis examination document record company due income tax sale tax service tax custom duty excise duty value added tax cess st march deposited account dispute except enumerated herein pending respective authority mentioned name statute nature amount period forum dispute pending due cr amount relate central excise act excise fy commissioner central excise fy thaneii central excise act excise fy assistant commissioner central fy excise thaneii central excise act excise fy superintendent central excise fy custom service tax aurangabad plan prepare perform financial statement standalone annexure independent auditor report name statute nature amount period forum dispute pending due cr amount relate central excise act excise fy additional comissioner central fy excise custom service tax aurangabad central excise act excise fy joint comissioner central excise fy custom service tax aurangabad finance act service tax fy additional comissioner central fy excise custom service tax aurangabad income tax act penalty fy commissioner income tax appeal mumbai net amount paid protest otherwise amount per demand order including interest penalty wherever quantified based audit procedure information company act detail explanation given u opinion company related party transaction disclosed defaulted repayment loan borrowing standalone ind financial statement required financial institution bank government company applicable ind outstanding debenture year according information explanation given u company made preferential allotment according information explanation given private placement share fully partly convertible u company raised money way debenture year review accordingly initial public offer public offer including debt paragraph xiv order applicable instrument taken term loan company year according information explanation given course examination book u company entered noncash record company carried accordance transaction director person connected generally accepted auditing practice india director accordingly paragraph xv order according information explanation given applicable company u neither come across instance material fraud company company officer according information explanation given employee noticed reported year u company required registered informed case management section ia reserve bank india act accordingly paragraph xvi order opinion according information applicable company explanation given u managerial remuneration paid provided accordance requisite kapoor parekh associate approval mandated provision section read chartered accountant schedule v company act icai frn w opinion according information nilesh parekh explanation given u company nidhi company accordingly paragraph xii order partner applicable company mno mumbai rd may company entered transaction related party compliance provision section annual report annexure b independent auditor report annexure referred para f heading ethical requirement plan perform audit report legal regulatory requirement obtain reasonable assurance whether adequate internal report even date member ajanta pharma financial control financial reporting established limited standalone ind financial statement maintained control operated effectively year ended st march material respect report internal financial control audit involves performing procedure obtain audit financial reporting clause sub evidence adequacy internal financial section section company act control system financial reporting operating act effectiveness audit internal financial control audited internal financial control financial financial reporting included obtaining understanding reporting ajanta pharma limitedthe company internal financial control financial reporting assessing st march conjunction audit standalone risk material weakness exists testing ind financial statement company year ended evaluating design operating effectiveness internal date control based assessed risk procedure selected depend auditor judgement including assessment management responsibility internal risk material misstatement financial statement financial control whether due fraud error company management responsible establishing maintaining internal financial control based believe audit evidence obtained internal control financial reporting criterion established sufficient appropriate provide basis audit company considering essential component opinion company internal financial control system internal control stated guidance note audit financial reporting internal financial control financial reporting issued institute chartered accountant india icai meaning internal financial control responsibility include design implementation financial reporting maintenance adequate internal financial control company internal financial control financial reporting operating effectively ensuring orderly efficient process designed provide reasonable assurance conduct business including adherence company regarding reliability financial reporting policy safeguarding asset prevention preparation financial statement external purpose detection fraud error accuracy completeness accordance generally accepted accounting principle accounting record timely preparation company internal financial control financial reporting presentation reliable financial information required includes policy procedure pertain company act maintenance record reasonable detail accurately fairly reflect transaction disposition auditor responsibility asset company provide reasonable assurance responsibility express opinion company transaction recorded necessary permit preparation internal financial control financial reporting based financial statement accordance generally accepted audit conducted audit accordance guidance accounting principle receipt expenditure note audit internal financial control financial company made accordance reporting issued icai standard auditing authorisation management director company issued icai deemed prescribed section provide reasonable assurance regarding prevention company act extent applicable timely detection unauthorised acquisition use disposition audit internal financial control applicable company asset could material effect audit internal financial control standard financial statement mentioned guidance note require comply plan prepare perform financial statement standalone annexure b independent auditor report inherent limitation internal financial reporting operating effectively st march control financial reporting based internal control financial reporting criterion inherent limitation internal financial control established company considering essential financial reporting including possibility collusion component internal control stated guidance note improper management override control material audit internal financial control financial reporting misstatement due error fraud may occur issued icai detected also projection evaluation internal financial control financial reporting future period kapoor parekh associate subject risk internal financial control chartered accountant financial reporting may become inadequate icai frn w change condition degree compliance policy procedure may deteriorate nilesh parekh opinion partner opinion company material respect mno adequate internal financial control system financial mumbai rd may reporting internal financial control financial annual report balance sheet st march cr particular note march march april asset noncurrent asset property plant equipment b capital workinprogress c intangible asset intangible asset development e financial asset investment ii financial asset f noncurrent asset current asset inventory b financial asset investment ii trade receivables iii cash cash equivalent iv bank balance iii v financial asset c current tax asset net current asset total asset equity liability equity equity share capital b equity liability noncurrent liability financial liability borrowing ii financial liability b provision c deferred tax liability net current liability financial liability borrowing ii trade payable iii financial liability b current liability c provision current tax liability net total equity liability see accompanying note forming part financial statement per report even date attached kapoor parekh associate behalf board director chartered accountant nilesh parekh mannalal b agrawal partner chairman purushottam b agrawal yogesh agrawal arvind agrawal vice chairman managing director chief financial officer madhusudan b agrawal rajesh agrawal gaurang shah mumbai rd may vice chairman joint managing director company secretary plan prepare perform financial statement standalone statement profit loss year ended st march cr note march march income revenue operation income total income expense cost material consumed purchase stockintrade change inventory finished good workinprogress stockintrade employee benefit expense finance cost depreciation amortisation expense expense total expense profit tax tax expense current tax deferred tax profit year comprehensive income comprehensive income reclassified profit loss subsequent year remeasurement gain loss defined benefit plan income tax effect net comprehensive income reclassified profit loss subsequent year comprehensive income year net tax total comprehensive income year net tax exceptional item discontinuing operation earning per equity share face value basic diluted see accompanying note forming part financial statement per report even date attached kapoor parekh associate behalf board director chartered accountant nilesh parekh mannalal b agrawal partner chairman purushottam b agrawal yogesh agrawal arvind agrawal vice chairman managing director chief financial officer madhusudan b agrawal rajesh agrawal gaurang shah mumbai rd may vice chairman joint managing director company secretary annual report statement cash flow year ended st march cr march march cash flow operating activity profit tax adjustment reconcile profit tax net cash flow depreciation amortisation expense provision expired good loss sale discard property plant equipment net interest expense dividend subsidiary gain financial instrument fvtpl income investment deposit employee stock option expense receivable written operating profit working capital change change working capital decrease increase trade receivables decrease increase current financial asset decrease increase current asset decrease increase inventory increase decrease non current financial liability increase decrease current liability increase decrease non current provision increase decrease current provision increase decrease trade payable cash generated operation direct tax paid net refund net cash generated operating activity b cash flow investing activity capital expenditure property plant equipment including capital advance proceeds sale property plant equipment bank balance considered cash cash equivalent net dividend subsidiary purchase investment proceeds investment income investment deposit investment subsidiary net cash generated used investing activity plan prepare perform financial statement standalone statement cash flow year ended st march cr march march c cash flow financing activity proceeds long term borrowing repayment long term borrowing proceeds repayment short term borrowing proceeds issue equity share esop cy interest paid dividend paid dividend distribution tax paid net cash generated used financing activity net increase decrease cash cash equivalent cash cash equivalent beginning year cash cash equivalent end year refer note figure bracket indicates outflow see accompanying note forming part financial statement per report even date attached kapoor parekh associate behalf board director chartered accountant nilesh parekh mannalal b agrawal partner chairman purushottam b agrawal yogesh agrawal arvind agrawal vice chairman managing director chief financial officer madhusudan b agrawal rajesh agrawal gaurang shah mumbai rd may vice chairman joint managing director company secretary annual report statement change equity year ended st march equity share capital cr balance change equity balance change equity balance april share capital march share capital march year year authorised issued subscribed paid b equity cr particular capital security general share retained item total redemption premium reserve based earnings comprehensive equity reserve account payment income reserve measurement gain loss defined benefit plan st april profit period comprehensive income total comprehensive income utilised bonus share transfer general reserve exercise stock option share based payment employee dividend paid dividend distribution tax reversal dividend paid reversal dividend distribution tax st march profit period comprehensive income total comprehensive income exercise stock option share based payment employee dividend paid dividend distribution tax st march see accompanying note forming part financial statement per report even date attached kapoor parekh associate behalf board director chartered accountant nilesh parekh mannalal b agrawal partner chairman purushottam b agrawal yogesh agrawal arvind agrawal vice chairman managing director chief financial officer madhusudan b agrawal rajesh agrawal gaurang shah mumbai rd may vice chairman joint managing director company secretary plan prepare perform financial statement standalone note standalone financial statement year ended st march corporate information rounding amount janta pharma limited company public limited amount disclosed financial statement company incorporated domiciled india share note rounded nearest cr amount listed bombay stock exchange national stock less shown actual exchange registered office company located ajanta house charkop kandivali west mumbai current versus noncurrent classification asset liability balance sheet company engaged development manufacturing presented based currentnoncurrent classification marketing speciality pharmaceutical finished dosage asset current expected realised intended sold financial statement company year consumed normal operating cycle ended st march authorised issue held primarily purpose trading company board director rd may expected realised within twelve month reporting period basis preparation cash cash equivalent unless restricted exchanged used settle liability financial statement company least twelve month reporting period prepared accordance indian accounting asset classified noncurrent standard indas notified company indian accounting standard rule amended liability current company indian accounting standard expected settled normal operating cycle amendment rule held primarily purpose trading financial statement company first ind due settled within twelve month financial statement covered ind reporting period firsttime adoption indian accounting standard unconditional right defer settlement liability least twelve month period including year ended reporting period st march company prepared financial liability treated noncurrent statement accordance accounting standard notified section deferred tax asset liability classified non company act read together company current asset liability respectively account rule previous gaap significant accounting policy explanation transition indas property plant equipment affected company equity net profit provided freehold land carried historical cost note item property plant equipment stated cost less accumulated depreciation financial statement prepared impairment loss accrual basis historical cost basis except following asset liability cost includes cost acquisition installation measured fair value revalued amount wherever construction direct expense incurred applicable bring asset working condition derivative financial instrument finance cost incurred date asset certain financial asset measured fair value ready intended use excludes cenvat value added tax eligible credit setoff functional presentation currency financial statement presented indian cost includes cost replacing part rupee inr rupee r plant equipment borrowing cost functional currency company longterm construction project recognition annual report note standalone financial statement year ended st march criterion met significant part plant case building constructed leasehold land equipment required replaced interval amortised primary lease period company depreciates separately based land specific useful life likewise major inspection performed cost recognised asset residual value useful life method carrying amount plant equipment depreciation reviewed financial year replacement recognition criterion end adjusted prospectively appropriate satisfied repair maintenance cost recognised statement profit loss asset carrying amount written incurred immediately recoverable amount asset carrying amount greater capital workinprogress respect asset estimated recoverable amount ready intended use carried cost comprising direct cost related transition ind company elected incidental expense attributable interest continue carrying value property plant equipment recognised identifiable revenue expense including st april measured per previous gaap interest incurred respect various project use carrying value deemed cost expansion net income earned property plant equipment project development stage prior intended use considered pre operative expense intangible asset disclosed capital work progress intangible asset recognised probable future economic benefit capital expenditure tangible asset research attributable asset flow company development classified property plant cost asset measured equipment depreciated reliably basis property plant equipment intangible asset stated cost acquisition property plant equipment eliminated less accumulated amortisation impairment financial statement either disposal loss retired active use loss arising case retirement property plant equipment internally generated intangible excluding gain loss arising disposal property capitalised development cost capitalised plant equipment recognised statement related expenditure reflected profit profit loss year occurrence loss period expenditure incurred depreciable amount asset cost asset amount substituted cost less software amortised estimated useful estimated residual value depreciation life straight line basis date property plant equipment provided available intended use subject impairment written value method useful test life asset specified schedule ii company act property plant amortisation period amortisation equipment added disposed method intangible asset finite year depreciation provided prorata useful life reviewed least end basis premium leasehold land amortised reporting period change expected useful period lease building constructed life expected pattern consumption leasehold land depreciated based future economic benefit embodied asset useful life specified schedule ii considered modify amortisation period company act lease period method appropriate treated land beyond life building change accounting estimate plan prepare perform financial statement standalone note standalone financial statement year ended st march gain loss arising derecognition subsequent measurement intangible asset measured difference purpose subsequent measurement net disposal proceeds financial asset classified two broad carrying amount asset recognised category statement profit loss asset financial asset fair value fvtpl fvtoci derecognised financial asset amortised cost research development asset measured fair value gain revenue expenditure research expensed loss either recognised statement respective head account profit loss ie fair value profit loss period incurred fvtpl recognised comprehensive income ie fair value comprehensive development expenditure incurred income fvtoci individual project carried forward future recoverability reasonably regarded financial asset measured amortised cost net assured expenditure carried forward write impairment amortised period expected future financial asset measured amortised cost sale related project carrying asset held within business model value development cost reviewed whose objective hold asset collecting impairment annually asset yet contractual cash flow contractual term use otherwise event change asset give rise specified date cash flow circumstance indicate carrying value solely payment principal interest may recoverable financial asset subsequently measured amortised cost using effective interest rate transition ind company elected eir method less impairment loss continue carrying value intangible arising impairment recognised asset recognised st april measured statement profit loss per previous gaap use carrying value deemed cost intangible asset financial asset measured fair value comprehensive income fvtoci financial instrument financial asset category measured financial instrument contract give initially well reporting date fair rise financial asset one entity financial value asset held within business model liability equity instrument another entity whose objective hold asset collecting contractual cash flow selling financial asset financial asset fair value movement recognized classification comprehensive income company classifies financial asset subsequently measured amortised cost fair financial asset measured fair value value comprehensive income profit loss fvtpl fair value profit loss basis financial asset category measured business model managing financial asset initially well reporting date fair contractual cash flow characteristic value change recognised profit loss financial asset investment subsidiary initial recognition measurement investment equity instrument subsidiary financial asset recognised initially measured cost per ind fair value plus case financial asset financial statement investment subsidiary recorded fair value profit loss company carried cost carrying amount transaction cost attributable reduced recognise impairment acquisition financial asset value investment annual report note standalone financial statement year ended st march investment equity instrument recognition fair value profit equity instrument held trading loss interestbearing loan borrowing classified fvtpl equity instrument subsequently measured amortised cost using classified fvtoci fair value change effective interest rate eir method gain instrument excluding dividend loss recognised profit loss recognised comprehensive income liability derecognised well eir recycling amount amortisation process amortised cost calculated comprehensive income profit loss taking account discount premium acquisition fee cost integral investment debt instrument part eir eir amortisation included debt instrument measured amortised finance cost statement profit loss cost fvtoci debt instrument meet criterion categorization derecognition financial liability amortized cost fvoci classified financial liability derecognised fvtpl debt instrument included within obligation liability discharged fvtpl category measured fair value cancelled expires existing financial change recognised statement profit liability replaced another loss lender substantially different term term existing liability substantially modified derecognition financial asset exchange modification treated financial asset primarily derecognised derecognition original liability right receive cash flow asset recognition new liability difference expired company transferred respective carrying amount recognised right receive cash flow asset statement profit loss impairment financial asset derivative financial instrument accordance ind company company u derivative financial instrument applies expected credit loss ecl model forward currency contract mitigate measurement recognition impairment loss foreign currency risk derivative financial financial asset debt instrument instrument initially recognised fair value trade receivables date derivative contract entered subsequently remeasured fair financial liability value derivative carried financial asset classification fair value positive financial company classifies financial liability liability fair value negative subsequently measured amortised cost fvtpl inventory initial recognition measurement raw material packing material valued financial liability recognised initially fair lower cost net realisable value cost value case loan borrowing includes duty tax net cenvat payable net directly attributable transaction vat wherever applicable cost imported raw cost material packing material lying bonded warehouse includes custom duty finished financial liability include trade product including traded good workin payable loan borrowing including bank progress valued lower cost net overdraft derivative financial instrument realisable value cost arrived fifo basis cost inventory computed subsequent measurement include cost purchase cost conversion financial liability fair value profit standard overhead related cost loss include financial liability held trading incurred bringing inventory financial liability designated upon initial present condition plan prepare perform financial statement standalone note standalone financial statement year ended st march slow nonmoving material obsolesces revenue measured fair value defective inventory fully provided consideration received receivable amount valued net realisable value disclosed revenue inclusive excise duty excluding sale tax value added tax good material transit valued service tax duty collected behalf actual cost incurred date balance government net return trade discount sheet material item held use allowance rebate amount collected production inventory written behalf third party finished product used expected sold cost revenue sale good recognised significant risk reward transferred cash cash equivalent buyer per term contract cash cash equivalent comprise cash significant uncertainty exists regarding amount hand cash bank including fixed deposithighly consideration derived liquid investment original maturity period sale good three month less readily convertible known amount cash subject revenue sale technology know insignificant risk change value right licence intangible recognised performance obligation cash flow statement completed per term agreement cash flow reported using indirect method income service recognised whereby net profit tax adjusted service rendered effect transaction noncash nature deferral accrual past future operating dividend income recognised right cash receipt payment item income receive dividend established interest income expense associated investing financing recognised time proportion basis insurance cash flow cash flow operating claim recognised revenue investing financing activity company certainty receipt prudent basis export benefit segregated available prevalent scheme accounted extent considered receivable foreign currency transaction revenue transaction denominated foreign employee benefit currency normally recorded exchange employee benefit payable wholly within rate prevailing date transaction twelve month rendering service classified short term employee benefit benefit monetary item denominated foreign currency salary wage shortterm compensated yearend remeasured exchange absence performance incentive etc rate prevailing balance sheet date expected cost bonus exgratia recognised nonmonetary foreign currency item carried period employee render cost related service income expense account exchange defined benefit plan difference either settlement restatement company provides gratuity defined recognised statement profit loss benefit retirement plan gratuity plan covering eligible employee gratuity revenue recognition plan provides lumpsum payment revenue recognised extent vested employee retirement death probable economic benefit flow incapacitation termination employment company revenue reliably amount based respective measured regardless payment employee salary tenure made employment company annual report note standalone financial statement year ended st march liability regard gratuity plan performed independent actuary determined actuarial valuation performed balance sheet date using projected independent actuary balance sheet unit credit method additional amount date using projected unit credit method expected paidavailed result unused entitlement accumulated company fully contributes ascertained balance sheet date liability ajanta pharma limited group gratuity trust trust trustee compensated absence administer contribution made trust expected occur within twelve month contribution invested scheme end period employee life insurance corporation india render related service recognised permitted law india liability present value defined benefit obligation balance sheet date retirement benefit obligation recognised balance sheet represents present expense nonaccumulating compensated value defined benefit obligation absence recognized period reduced fair value scheme asset absence occur asset resulting calculation limited present value available iv sharebased compensation refund reduction future contribution company recognizes compensation scheme company recognizes expense relating sharebased payment net obligation defined benefit plan net profit using fairvalue accordance balance sheet asset liability actuarial ind sharebased payment gain loss recognised full comprehensive income period borrowing cost occur effect plan borrowing cost directly attributable amendment recognized statement acquisition construction production asset profit loss necessarily take substantial period time get ready intended use sale capitalised ii defined contribution plan part cost asset borrowing contribution defined contribution plan cost expensed period recognised expense employee occur borrowing cost consist interest rendered service entitling cost entity incurs connection benefit company pay provident fund borrowing fund borrowing cost also includes contribution publicly administered provident exchange difference extent regarded fund per local regulation company adjustment borrowing cost payment obligation contribution paid contribution lease accounted defined contribution determination whether arrangement plan contribution recognized contains lease based substance employee benefit expense arrangement inception date whether due prepaid contribution recognized fulfilment arrangement dependent asset extent cash refund use specific asset asset arrangement reduction future payment available conveys right use asset even right explicitly specified arrangement iii compensated absence company policy compensated asset acquired lease significant absence accumulating portion risk reward ownership nonaccumulating nature expected retained lessor classified operating cost accumulating compensated absence lease lease rental charged determined actuarial valuation statement profit loss straight line basis plan prepare perform financial statement standalone note standalone financial statement year ended st march earnings per share recognized income expense period basic earnings per equity share computed includes enactment substantive dividing net profit attributable equity enactment date deferred income tax asset holder company weighted average recognized extent probable number equity share outstanding future taxable profit available period diluted earnings per equity share deductible temporary difference computed dividing net profit attributable tax loss utilized company offset equity holder company weighted current tax asset current tax liability average number equity share considered legally enforceable right set deriving basic earnings per equity share also recognized amount intends either weighted average number equity share settle net basis realize asset could issued upon conversion settle liability simultaneously dilutive potential equity share dilutive potential equity share adjusted dividend shareholder proceeds receivable equity share annual dividend distribution shareholder actually issued fair value dilutive potential equity recognised liability period share deemed converted beginning dividend approved shareholder period unless issued later date interim dividend paid recognised dilutive potential equity share determined approval board director dividend payable independently period presented corresponding tax dividend distribution recognised directly equity income tax income tax expense comprises current provision contingent liability contingent deferred income tax asset commitment general income tax expense recognized net profit provision recognised company statement profit loss except present obligation legal constructive extent relates item recognized directly result past event probable equity case recognized outflow resource required settle comprehensive income current income tax obligation respect reliable estimate current prior period recognized made amount expected paid recovered tax authority using tax rate tax law provision excluding retirement benefit enacted substantively enacted compensated absence discounted balance sheet date deferred income present value determined based best tax asset liability recognized estimate required settle obligation temporary difference arising tax balance sheet date reviewed base asset liability carrying balance sheet date adjusted reflect amount financial statement deferred tax current best estimate asset reviewed reporting date reduced extent longer probable expectation related tax benefit realised provision reimbursed reimbursement recognised separate asset deferred income tax asset liability reimbursement virtually certain measured using tax rate tax law expense relating provision presented enacted substantively enacted statement profit loss net virtually balance sheet date expected certain reimbursement apply taxable income year temporary difference expected effect time value money material recovered settled effect change tax provision discounted using current pre rate deferred income tax asset liability tax rate reflects appropriate risk annual report note standalone financial statement year ended st march specific liability discounting used financials statement prepared increase provision due passage historical cost basis except following time recognised finance cost material item statement financial position contingent liability disclosed case derivative financial instrument measured present obligation arising past event fair value received bank probable outflow mutual fund measured fair value resource required settle obligation per net asset value nav present obligation arising past event employee stock option plan esop fair reliable estimate possible value per actuarial valuation report possible obligation arising past event unless probability outflow resource fair value price would received remote sell asset settle liability ordinary transaction market participant contingent liability recognised measurement date financial statement contingent asset neither recognised disclosed financial fair value asset liability measured statement using assumption market participant would use pricing asset liability commitment include amount purchase order assuming market participant act net advance issued party completion economic best interest asset noncancellable operating lease fair value measurement nonfinancial asset provision contingent liability contingent asset take account market participant ability commitment reviewed balance generate economic benefit using asset sheet date highest best use selling another market participant would use asset asset retirement obligation highest best use asset retirement obligation aro provided operating lease arrangement company u valuation technique company binding obligation end appropriate circumstance lease period restore leased premise sufficient data available measure fair value condition similar inception lease aro maximising use relevant observable input provided present value expected minimising use unobservable input cost settle obligation using discounted cash flow recognised part asset liability fair value cost particular asset cash flow measured disclosed financial statement discounted current pretax rate reflects categorised within fair value hierarchy risk specific decommissioning liability described follows based lowest unwinding discount recognised level input significant fair value income statement finance cost measurement whole estimated future cost decommissioning level quoted unadjusted market price reviewed annually adjusted appropriate active market identical asset change estimated future cost liability discount rate applied added deducted level valuation technique cost asset lowest level input significant fair value measurement directly indirectly fair value measurement observable company measure financial instrument level valuation technique derivative fair value balance sheet lowest level input significant fair date accordance ind value measurement unobservable plan prepare perform financial statement standalone note standalone financial statement year ended st march asset liability recognised amendment effective annual financial statement recurring basis period beginning st april company determines whether transfer amendment expected impact occurred level hierarchy company assessing categorisation based lowest level input significant fair value critical accounting judgement estimate measurement whole end assumption reporting period preparation company financial statement requires management make judgement estimate purpose fair value disclosure assumption affect reported amount company determined class asset revenue expense asset liability liability basis nature characteristic disclosure contingent liability end risk asset liability level reporting period however uncertainty fair value hierarchy explained assumption estimate could result outcome require material adjustment carrying recent accounting pronouncement amount asset liability future period standard issued yet effective march ministry corporate affair arrangement containing lease issued company indian accounting inception arrangement company standard amendment rule notifying determines whether arrangement contains amendment ind statement cash flow lease inception reassessment ind sharebased payment arrangement contains lease company amendment accordance recent separate payment consideration amendment made international accounting required arrangement standard board iasb ia statement lease element cash flow ifrs sharebased payment basis relative fair value respectively amendment applicable company st april company determined based evaluation term condition arrangement amendment ind statement cash flow contract nature operating amendment ind requires entity lease provide disclosure enable user financial statement evaluate change liability b multiple element contract vendor arising financing activity including company entered multiple element change arising cash flow noncash contract vendor supply good change amendment effective rendering service consideration paid ismay annual period beginning st april determined independent value supply application amendment result received service availed accordingly additional disclosure provided company supply service accounted based relative fair value overall consideration amendment ind sharebased payment supply finite life contract amendment ind address three defined significant accounting policy main area effect vesting condition accounted property plant measurement cashsettled sharebased equipment andor intangible asset since payment transaction classification share company economic ownership asset based payment transaction net settlement company belief current treatment feature withholding tax obligation represents substance arrangement accounting modification term condition sharebased payment transaction c property plant equipment change classification cash settled determination estimated useful life equity settled tangible asset assessment annual report note standalone financial statement year ended st march component cost may capitalized probability outflow resource useful life tangible asset based life past experience circumstance known prescribed schedule ii company act balance sheet date actual outflow assumption also need made resource future date may therefore vary company assesses whether asset may figure included provision capitalised component cost asset may capitalised h contingency management judgement required estimating intangible asset possible outflow resource internal technical user team assess respect contingenciesclaimlitigations remaining useful life intangible asset company possible predict management belief assigned useful life outcome pending matter accuracy reasonable allowance uncollected account receivable e recognition measurement defined advance benefit obligation trade receivables carry interest obligation arising defined benefit plan stated normal value reduced determined basis actuarial assumption appropriate allowance estimated irrecoverable key actuarial assumption include discount rate amount individual trade receivables written trend salary escalation vested future management deems collectible benefit life expectancy discount rate impairment made expected credit loss determined reference market yield present value cash shortfall end reporting period government expected life financial asset bond period maturity underlying bond correspond probable maturity impairment provision financial asset postemployment benefit obligation based assumption risk default expected loss rate judgement making recognition deferred tax asset income tax f assumption selecting input deferred tax asset recognised impairment calculation based past history deductible temporary difference extent existing market condition well forward looking probable taxable profit estimate end reporting period available deductible temporary difference utilised management j insurance claim assumes taxable profit available insurance claim recognised company recognising deferred tax asset reasonable certainty recovery management judgment required k impairment review calculation provision income tax impairment exists carrying value deferred tax asset liability company asset cash generating unit cgu exceeds review balance sheet date carrying recoverable amount recoverable amount amount deferred tax asset factor used higher fair value less cost sell estimate may differ actual outcome value use value use calculation based could lead significant adjustment discounted cash flow model calculating amount reported standalone financial value use certain assumption required statement made respect highly uncertain matter including management expectation growth recognition measurement provision g ebitda long term growth rate selection recognition measurement discount rate reflect risk involved provision based assessment plan prepare perform financial statement standalone note standalone financial statement year ended st march property plant equipment capital workinprogress current year cr gross block depreciation amortisation net block particular addition deduction addition deduction st april adjustment st march st april adjustment st march st march property plant equipment freehold land lease hold land building plant equipment laboratory equipment furniture fixture vehicle office equipment computer total b intangible asset anda development cost computer software total total b c capital work progress including pre operative expense cr refer note intangible asset development total fixed asset b c addition includes cr used research development depreciation cr considered preoperative expenditure refer note property plant equipment capital workinprogress previous year cr gross block depreciation amortisation net block net block particular addition deduction addition deduction st april adjustment st march st april adjustment st march st march st april tangible asset freehold land lease hold land building plant equipment laboratory equipment furniture fixture vehicle office equipment computer total b intangible asset anda development cost computer software total total b c capital work progress including pre operative expense cr refer note intangible asset development total fixed asset b c addition includes cr used research development depreciation cr considered preoperative expenditure refer note annual report note standalone financial statement year ended st march non current financial investment cr march march april long term trade investment unquoted investment investment equity instrument subsidiary company ajanta pharma mauritius ltd ordinary share mauritian rupee fully paid ajanta pharma usa inc common stock u fully paid ajanta pharma philippine inc share philippine peso fully paid ajanta pharma nigeria ltd st march st april ordinary share nigerian naira fully paid investment share turkmenderman ajanta pharma ltd share u fully paidup others opgs power gujarat private limited st march nil st april nil share cr yr st march nil st april nil sub total b investment mutual fund quoted face value unit icici prudential fmp series day plan n regular plan cumulative icici prudential fmp series day plan e regular plan cumulative kotak fmp series growth hdfc fmp october series regular growth birla sun life fixed term plan series ja day idfc fixed term plan series regular plangrowth sub total b total aggregate value quoted investment market value aggregate value unquoted investment figure bracket previous year plan prepare perform financial statement standalone note standalone financial statement year ended st march non current financial asset others cr march march april security deposit deposit account bank original maturity month lien others cy nil py interest accrued fixed deposit bank non current asset others march march april capital advance inventory march march april raw material packing material workinprogress finished good finished good transit stockintrade stockintrade transit current financial investment march march april investment fair value profit loss fvtpl mutual fund quoted face value unit utitreasury advantage fundinstitutional plan birla sun life cash plus daily dividend ular plan birla sun life dynamic bond fund growth regular plan annual report note standalone financial statement year ended st march current financial investment contd cr march march april franklin india low duration fund growth franklin india short term income plan retail plan birla sun life short term fund growth regular plan reliance regular saving funddebt plan growth plan growth option sbi magnum insta cash fund direct plan daily dividend sbi dynamic bond fund regular plan growth icici prudential fmp series day plan n regular plan cumulative icici prudential interval annual plan iii regular growth icici prudential fmp series day plan e regular plan cumulative kotak fmp series growth regular plan hdfc fmp october series regular growth birla sun life fixed term plan series ja day idfc fixed term plan series regular plangrowth aggregate value quoted investment market value figure bracket previous year plan prepare perform financial statement standalone note standalone financial statement year ended st march trade receivables cr march march april trade receivables considered good doubtful debt allowance doubtful debt includes receivable subsidiary refer note c cash cash equivalent march march april balance bank current account deposit account original maturity month less cash hand bank overdraft used cash management purpose bank balance cash cash equivalent march march april earmarked balance bank unpaid dividend unpaid sale proceeds fractional share cy st march deposit account original maturity month upto month deposit account original maturity month lien others current financial asset others march march april interest receivable forward contract current tax asset net march march april income tax paid net provision annual report note standalone financial statement year ended st march current asset cr march march april balance statutorygovt authority excise authority vat receivable octroi refund receivable prepaid expense advance supplier advance employee advance recoverable cash kind share capital march march april cr cr cr share fv share fv share fv authorised equity share issued equity share subscribed paid equity share fully paid add share forfeited amount originally paid reconciliation number equity share outstanding beginning end year march march april cr cr cr share fv share fv share fv equity share outstanding beginning year add equity share allotted year option exercised esop cy add equity share allotted year bonus esop cryr st march st april less equity share bought back year equity share outstanding end year termsrights attached equity share company one class equity share voting right par value per share company declares pay dividend indian rupee interim dividend paid recognised approval board director plan prepare perform financial statement standalone note standalone financial statement year ended st march year ended st march amount dividend per equity share recognised distribution equity shareholder pr yr includes interim dividend pr yr per equity share event liquidation company holder equity share entitled receive remaining asset company distribution preferential amount distribution proportion number equity share held shareholder detail equity share held shareholder holding cr march march april holding holding holding name shareholder share share share fv fv fv mr yogesh agrawal trustee yogesh agrawal trust mr rajesh agrawal trustee rajesh agrawal trust mr ravi purushottam agrawal trustee ravi agrawal trust mr aayush madhusudan agrawal trustee aayush agrawal trust gab investment private limited ganga export represented mr yogesh agrawal mr rajesh agrawal mr ravi p agrawal mr aayush agrawal mr yogesh agrawal na na mr rajesh agrawal na na mr mannalal b agrawal mr purushottam b agrawal mr madhusudan b agrawal mr manisha agrawal mr richa r agrawal mr aayush agrawal mr vimal agrawal mr mamta agrawal march march april share share share fv fv fv equity share reserved issuance employee stock option scheme company equity share aggregate number equity share issued last five year pursuant employee stock option scheme equity share equity share allotted fully paid bonus share period five year immediately preceding balance sheet date bonus share issued fy bonus share allotment esop fy bonus share allotment esop fy bonus share allotment esop fy company subsidiary company annual report note standalone financial statement year ended st march non current financial liability borrowing cr march march april term loan secured bank foreign currency loan unsecured deferred sale tax loan government maharashtra term loan secured first charge fixed asset company second charge entire current asset company present future pari passu basis addition personal guarantee director non current financial liability march march april trade security deposit payable non current provision march march april provision employee benefit net gratuity leave benefit deferred tax liability net march march april difference tax base property plant equipment unrealised gainloss security carried fvocifvtpl deferred tax asset mat credit entitlement b disallowance income tax c deferred tax liability net b c current financial liability borrowing march march april working capital loan repayable demand bank secured rupee loan foreign currency loan plan prepare perform financial statement standalone note standalone financial statement year ended st march working capital loan secured first charge current asset second charge fixed asset company pari passu basis addition personal guarantee director current financial liability trade payable cr march march april trade payable refer note micro small medium enterprise disclosure current financial liability march march april current maturity longterm borrowing secured refer note foreign currency term loan bank rupee term loan bank unsecured deferred sale tax loan unpaid dividend unpaid sale proceeds fractional share interest accrued capital creditor others amount due outstanding credited investor education protection fund st march current liability march march april payable advance received customer statutory due payable current provision march march april provision employee benefit net gratuity leave benefit provision sale return expired good refer note annual report note standalone financial statement year ended st march current tax liability net cr march march april provision tax net payment revenue operation march march sale product finished good stockintrade operating revenue export incentive royalty fee others income march march dividend subsidiary company dividend investment fvtpl gain financial instrument fvtpl interest deposit bank interest others exchange difference net miscellaneous income cost material consumed march march raw material consumed packing material consumed purchase stockintrade march march purchase stockintrade plan prepare perform financial statement standalone note standalone financial statement year ended st march change inventory finished good workinprogress stockintrade cr march march inventory beginning year workinprocess finished good stockintrade inventory end year workinprocess finished good stockintrade b total change inventory finished good workinprogress stockintrade b employee benefit expense march march salary wage bonus allowance contribution provident fund expense employee stock option scheme staff welfare expense finance cost march march interest expense borrowing cost including bank charge depreciation march march depreciation tangible asset refer note depreciation intangible asset refer note annual report note standalone financial statement year ended st march expense cr march march selling expense clearing forwarding travelling expense processing charge power fuel advertisement publicity consumption store spare part rent rate tax legal professional fee postage telephone expense repair maintenance building plant machinery computer others insurance donation exchange rate difference net impairment loss financial asset excise duty collected sale loss salediscard property plant equipment net corporate social responsibility expense refer note miscellaneous expense capital management company policy maintain strong capital base maintain investor creditor market confidence sustain future development business management monitor return capital well level dividend equity shareholder board director seek maintain balance higher return might possible higher level borrowing advantage security afforded sound capital position company target achieve return capital return return company monitor capital using ratio adjusted net debt adjusted equity purpose adjusted net debt defined total liability comprising interestbearing loan borrowing obligation finance lease less cash cash equivalent current investment adjusted equity comprises component equity company policy keep ratio adjusted net debt equity ratio st march follows cr organisation march march april debt debt current liability less cash cash equivalent current investment net debt equity b net debt equity ratio ab plan prepare perform financial statement standalone note standalone financial statement year ended st march earnings per share eps numerator denominator used calculate basic diluted earnings per share march march basic diluted earnings per share profit attributable equity shareholder basic eps cr add dilutive effect profit cr b nil nil profit attributable equity shareholder diluted eps cr cab weighted average number equity share outstandingfor basic eps add dilutive effect option outstandingnumber equity share e weighted average number equity share diluted eps fde face value per equity share basic earnings per share ad diluted earnings per share cf account employee stock option scheme esosrefer note employee benefit required ind employee benefit disclosure defined contribution plan company offer employee defined contribution plan form provident fund pf employee pension scheme eps government certain state plan employee state insurance esi pf eps cover substantially regular employee esi cover certain employee contribution made government fund employee company pay predetermined contribution provident fund esi scheme contribution pension fund made company contribution normally based certain proportion employee salary year company recognised following amount account cr particular march march provident fund employee pension scheme employee state insurance defined benefit plan gratuity company make annual contribution employee group gratuitycum life assurance cash accumulation scheme lic funded defined benefit plan qualifying employee scheme provides payment vested employee normal retirement early retirement withdrawal resignation per provision payment gratuity act vesting period year service death service per provision payment gratuity act without vesting period death benefit company provides death benefit defined benefit plan death benefit plan certain category employee death benefit plan provides lump sum payment vested employee death compensation received insurance company restricted limit set forth said plan death benefit plan nonfunded annual report note standalone financial statement year ended st march disclosure defined benefit plan ie gratuity funded plan based actuarial report st march cr particular march march change defined benefit obligation opening defined benefit obligation current service cost interest cost actuarial loss gain change fi nancial assumption experience adjustment benefit paid closing defined benefit obligation ii change value plan asset opening value plan asset expense deducted fund nil adjustment opening fund nil interest income return plan asset excluding amount included interest income contribution employer benefit paid closing value plan asset iii amount recognised balance sheet present value funded obligation year end fair value plan asset year end net asset liability recognised year end iv expense recognised statement profit loss current service cost net interest cost expense deducted fund nil adjustment opening fund nil expense recognised statement comprehensive income net actuarial lossgain recognized current year change financial assumption experience adjustment return plan asset excluding amount included interest income v asset information others policy insurance vi principal actuarial assumption used discount rate pa salary growth rate pa plan prepare perform financial statement standalone note standalone financial statement year ended st march sensitivity analysis reasonably possible change reporting date one relevant actuarial assumption holding assumption constant would affected defined benefit obligation amount shown cr particular march march increase decrease increase decrease discount rate movement salary growth rate movement although analysis take account full distribution cash flow expected plan provide approximation sensitivity assumption estimate future increase compensation level considered actuarial valuation taken account inflation seniority promotion relevant factor supply demand employment market expected contribution defined benefit plan next financial year line fy leave encashment company employee entitled compensated absence allowed accumulated encashed per company rule liability compensated absence nonfunded provided based report independent actuary using projected unit credit method accordingly cr pr yr cr liability yearend compensated absence per actuarial valuation provided account share based payment company implemented employee stock option scheme esos approved earlier year shareholder company compensation committee board director year option granted company aforesaid esos employee company grant date option exercise price vesting period july option granted exercise price accordance relevant sebi guideline force time grant option entitles holder exercise right apply seek allotment one equity share particular option esos cr march march particular option outstanding beginning year add option granted year less option exercised year less option lapsed year nil option outstanding year end annual report note standalone financial statement year ended st march financial instrument fair value risk management fair value measurement cr financial instrument march march april category fvpl amortised fvpl amortised fvpl amortised cost cost cost financial asset forward exchange contract investment mutual fund investment unquoted equity share cy trade receivables non current financial asset others cash cash equivalent bank balance cash cash equivalent interest receivable total financial asset financial liability bank borrowing non current financial liability capital creditor current financial liability trade payable total financial liability plan prepare perform financial statement standalone note standalone financial statement year ended st march fair value hierarchy section explains judgement estimate made determining fair value financial instrument recognised measured fair value b measured amortised cost fair value disclosed financial statement provide indication reliability input used determining fair value company classified financial instrument three level prescribed accounting standard explanation level follows underneath table cr financial asset liability march march april measured fair value level level level ii iii ii iii ii iii financial asset recurring fair value measurement forward exchange contract investment mutual fund non recurring fair value measurement investment unquoted equity share cy trade receivables non current financial asset others cash cash equivalent bank balance cash cash equivalent interest receivable total financial asset financial liability non recurring fair value measurement bank overdraft non current financial liability capital creditor current financial liability trade payable total financial liability level level hierarchy includes financial instrument measured using quoted price includes mutual fund quoted price mutual fund valued using closing nav level fair value financial instrument traded active market like forward contract determined using valuation technique maximise use observable market data rely little possible entityspecific estimate significant input required fair value instrument observable instrument included level level one significant input based observable market data instrument included level case unlisted equity security etc included level annual report note standalone financial statement year ended st march b financial risk management trade receivables company exposure following risk arising customer credit risk managed financial instrument business unit subject company credit risk established policy procedure liquidity risk control relating customer credit risk market risk management trade receivables mainly wholesaler noninterest bearing risk management framework generally day day credit company board director overall term credit limit established responsibility establishment oversight customer based internal rating criterion company risk management framework deviation credit limit require management responsible developing approval director monitoring company risk management policy customer transacting guidance audit committee company year monitored individual business company risk management policy manager located country established identify analyse risk place outstanding customer receivables faced set appropriate risk limit regularly monitored company control monitor risk adherence concentration credit risk customer limit risk management policy system base widely distributed economically reviewed regularly reflect change market geographically condition company activity company training management standard st march company procedure aim maintain disciplined customer excluding subsidiary constructive control environment st march customer st april employee understand role obligation customer owed company cr accounted company audit committee oversees approximately year ie management monitor compliance company st march st march st april risk management policy procedure receivables outstanding review adequacy risk management framework relation risk faced company impairment analysis performed audit committee assisted oversight role reporting date individual internal audit internal audit undertakes basis major client addition large regular ad hoc review risk management number minor receivables grouped control procedure result homogenous group assessed reported audit committee impairment collectively calculation based exchange loss historical data ii credit risk maximum exposure credit risk credit risk risk counter party reporting date carrying value meet obligation financial instrument class financial asset company customer contract leading financial hold collateral security company loss company exposed credit risk evaluates concentration risk operating activity primarily trade receivables respect trade receivables low financing activity including deposit customer located several jurisdiction bank mutual fund financial institution operate largely independent market foreign exchange transaction financial instrument plan prepare perform financial statement standalone note standalone financial statement year ended st march expected credit loss trade receivables simplified approach cr march march april gross carrying amount average expected loss rate export sale carrying amount trade receivables net impairment b financial instrument highly marketable debt investment company limit exposure credit risk outflow st march st march investing liquid debt security issued st april mutual fund credit ranking least crisil iv market risk equivalent rating agency company monitor market risk risk change change credit risk tracking published market price foreign exchange external credit ranking based ongoing rate interest rate equity price assessment counterparty risk company affect company income value adjusts exposure various counterparties holding financial instrument objective market risk management iii liquidity risk manage control market risk exposure liquidity risk risk company may within acceptable parameter able meet present future cash optimising return financial instrument collateral obligation without incurring affected market risk include loan unacceptable loss company objective borrowing deposit investment time maintain optimum level derivative financial instrument liquidity meet cash collateral requirement company closely monitor company activity expose variety liquidity position deploys robust cash financial risk including effect management system maintains adequate change foreign currency exchange rate source financing including bilateral interest rate company u derivative loan debt overdraft bank financial instrument foreign exchange optimised cost working capital requirement contract manage exposure foreign adequately addressed internally exchange fluctuation transaction generated fund trade receivables kept carried within guideline set within manageable level risk management committee company aim maintain level sensitivity analysis prepared cash cash equivalent highly basis amount net debt marketable debt investment amount ratio fixed floating interest rate excess expected cash outflow debt derivative proportion financial liability next six month financial instrument foreign currency ratio cash cash equivalent constant annual report note standalone financial statement year ended st march analysis excludes impact currency transaction movement market variable primarily denominated u dollar euro carrying value postemployment benefit obligation provision non point time company cover financial asset liability foreign currency risk taking appropriate percentage foreign currency exposure sensitivity relevant income statement approved risk management committee item effect assumed change line laid policy approved respective market risk based board company u forward exchange financial asset financial liability held contract mitigate currency risk st march st march maturity less one year reporting date respect monetary currency risk asset liability denominated foreign group exposed currency risk currency company policy ensure extent mismatch net exposure kept acceptable currency sale purchase level buying selling foreign currency borrowing denominated spot rate necessary address respective functional currency company shortterm imbalance following table analysis foreign currency risk financial instrument st march cr particular u dollar euro total bank balance trade receivables financial asset trade payable financial liability net asset liability following table analysis foreign currency risk financial instrument st march cr particular u dollar euro total bank balance trade receivables financial asset trade payable financial liability net asset liability following table analysis foreign currency risk financial instrument st april cr particular u dollar euro total bank balance trade receivables financial asset trade payable financial liability net asset liability plan prepare perform financial statement standalone note standalone financial statement year ended st march year ended st march every percentage point depreciation appreciation exchange rate indian rupee respective currency affected company incremental profit tax per cr particular change effect profit currency tax exchange rate u dollar usd euro year ended march every percentage point depreciationappreciation exchange rate indian rupee respective currency affected company incremental profit tax per cr particular change effect profit currency tax exchange rate u dollar usd euro year ended st april every percentage point depreciationappreciation exchange rate indian rupee respective currency affected company incremental profit tax per cr particular change effect profit currency tax exchange rate u dollar usd euro b interest rate risk interest rate risk risk fair value future cash flow financial instrument fluctuate change market interest rate company exposure risk change market interest rate relates primarily company debt interest obligation company engages financing activity market linked rate change interest rate environment may impact future rate borrowing interest rate profile company interestbearing financial instrument reported management follows cr particular march march april foreign currency term loan nil foreign currency packing credit nil nil nil annual report note standalone financial statement year ended st march reasonably possible change basis point interest rate reporting date would impacted profit tax per analysis assumes variable particular foreign currency exchange rate remain constant cr particular march march april increase interest rate nil decrease interest rate nil c price risk company exposure price risk equity investment company except subsidiary disclosure operating lease ind lease company taken various premise operating lease generally cancellable range month year renewable mutual consent mutually agreeable term lease agreement price escalation clause restriction imposed lease arrangement sub lease contingent rent lease payment cr pr yr cr recognised statement profit loss rent note future minimum lease payment payment profile noncancellable operating lease cr particular march march later one year later one year later five year later five year nil nil contingent liability commitment contingent liability cr particular march march claim company acknowledged debt ii sale tax demand disputed company pending appeal nil iii custom duty import advance license scheme pending fulfilment export obligation iv disputed octroi amount paid protest cr pr yr cr v excise duty service tax disputed company amount paid protest cr pr yr cr vi income tax demand disputed company pending appeal amount paid protest cr pr yr cr vii unpaid allotment money respect share ajanta pharma uk ltd wholly owned subsidiary equivalent uk pound pr yr uk pound respect clause vi management advised demand likely either deleted substantially reduced accordingly provision considered necessary plan prepare perform financial statement standalone note standalone financial statement year ended st march future cash outflow respect liability clause dependent term agreed upon party respect clause ii vi dependent decision relevant authority respective dispute respect clause vii dependent call made investee company commitment estimated amount contract remaining executed capital account provided net advance cr pr yr cr b commitment noncancellable operating lease refer note related party disclosure required ind given relationship category subsidiary ajanta pharma mauritius ltd apml ajanta pharma mauritius international ltd apmil ajanta pharma nigeria limited apnl ajanta pharma usa inc apui ajanta pharma philippine inc appi ajanta pharma uk ltd apuk category ii director key management personnel relative mr mannalal b agrawal chairman mr purushottam b agrawal executive vice chairman mr madhusudan b agrawal executive vicechairman mr yogesh agrawal managing director mr rajesh agrawal joint managing director mr chandrakant khetan nonexecutive director dr anil kumar nonexecutive director mr k h viswanathan nonexecutive director mr prabhakar dalal nonexecutive director dr anjana grewal nonexecutive director mr arvind agrawal chief financial officer mr gaurang shah company secretary relative key management personnel category iiienterprise person covered category ii able exercise significant control gab investment private limited seth bhagwandas agrawal charitable trust ganga export represented mr yogesh agrawal mr rajesh agrawal mr ravi agrawal mr aayush agrawal yogesh agrawal trust trustee yogesh agrawal wef th march rajesh agrawal trust trustee rajesh agrawal wef th march ravi agrawal trust trustee ravi p agrawal wef th march ajanta pharma limited group gratuity trust annual report note standalone financial statement year ended st march b following transaction carried related party cr sr particular category march march sale good apml appi apmil apui apnl dividend subsidiary company apml appi expense reimbursement apui key management compensation short term employee benefit mr purushottam b agrawal ii mr madhusudan b agrawal ii mr yogesh agrawal ii mr rajesh agrawal ii mr arvind agrawal ii mr gaurang shah ii postemployment benefit ii commission sitting fee nonexecutive director mr mannalal b agrawal ii mr chandrakant khetan ii dr anil kumar ii mr k h viswanathan ii mr prabhakar dalal ii dr anjana grewal ii rent mr manisha agrawal ii nil mr smriti rajesh agrawal ii nil mr aayush agrawal ii nil dividend paid ii iii investment subsidiary apnl nil purchase property mr yogesh agrawal ii nil mr rajesh agrawal ii nil mr ravi p agrawal ii nil mr aayush agrawal ii nil sale vehicle mr mannalal b agrawal ii nil mr ravi p agrawal ii nil corporate social responsibility expense seth bhagwandas agarwal charitable trust iii contribution made group gratuity trust premium paid lic premium paid iii bad debt apnl nil plan prepare perform financial statement standalone note standalone financial statement year ended st march c amount outstanding st march cr sr particular category march march april trade receivables appi apui apnl apmil nil receivable appi nil nil investment apml appi apui apnl trade payable apui nil advance received apml commission payable nonexecutive director mr mannalal b agrawal ii mr chandrakant khetan ii nil dr anil kumar ii nil mr k h viswanathan ii nil mr prabhakar dalal ii nil dr anjana grewal ii nil company completed independent evaluation international domestic transaction year ended st march reviewed year ended st march determine whether transaction associated enterprise undertaken arm length price based internal external transfer pricing review validation company belief transaction associated enterprise undertaken basis arm length principle contribution towards corporate social responsibility particular csr expenditure follows gross amount required spent company year cr previous year b amount spend year sr particular cash yet paid cash total construction acquisition asset nil nil nil b purpose nil includes paid related party cr refer note c amount spend previous year sr particular cash yet paid cash total construction acquisition asset nil nil nil b purpose nil includes paid related party cr refer note annual report note standalone financial statement year ended st march provision anticipated sale return expired good ind cr particular march march balance beginning year add provision made year less amount written backutilized year balance end year disclosure specified bank note sbns year company specified note denomination note defined mca notification gsre dated st march detail specified bank note sbn held transacted period th november th december denomination wise sbns note per notification given sbns total particular denomination note closing cash hand th november permitted receipt nil permitted payment nil amount deposited bank closing cash hand th december nil company one segment activity namely pharmaceutical remuneration auditor excluding service tax cr particular march march audit fee tax audit fee certification matter detail due micro small enterprise defined micro small medium enterprise development act information determined extent party identified basis information available company cr march march principle amount interest due thereon remaining unpaid supplier end accounting year principle amount due micro small enterprise nil interest due nil b amount interest paid buyer term section micro small nil nil medium enterprise development act along amount payment made supplier beyond appointed day accounting year c amount interest due payable period delay making payment nil paid beyond appointed day year without adding interest specified micro small medium enterprise development act amount interest accrued remaining unpaid end accounting year nil e amount interest remaining due payable even succeeding nil nil year date interest due actually paid small enterprise purpose disallowance deductible expenditure section micro small medium enterprise development act plan prepare perform financial statement standalone note standalone financial statement year ended st march research development expenditure revenue expense research development incurred year except depreciation cr particular march march cost materialconsumablesspares employee benefit expense utility expense total note foreign currency exposure asset liability year company entered forward exchange contract derivative instrument mitigate foreign currency risk establish amount currency indian rupee required available settlement date certain payable receivables following outstanding foreign currency forward contract entered company march march particular foreign currency foreign currency buy sell cross currency amt cr amt cr euro sell inr usd sell inr yearend foreign currency exposure mitigated derivative instrument otherwise cr cr foreign currency foreign currency foreign currency particular amt cr amt cr march march march march amount receivable usd euro chf nil nil gbp nil nil aed nil nil jpy amount payable usd euro nil nil gbp nil nil jpy gbp py gbp excise duty includes cr pr yr cr net impact excise duty provision opening closing stock company granted loan advance nature loan stipulated regulation f read schedule v security exchange board india listing obligation disclosure requirement regulation purpose loan employee per company policy security deposit paid towards premise taken leave license basis considered hence investment loan share parent company andor subsidiary company annual report note standalone financial statement year ended st march company invested jv turkmenderman ajanta pharma ltd tdapl two decade back management control however later company surrendered management control favour local partner since control tdapl operates severe restriction significantly impairs ability transfer fund hence company impaired entire investment tdapl considered unrelated party company making effort divest investment since last year without success preoperative expense pending capitalisation included capital workinprogress refer note represent direct attributable expenditure setting plant prior date commencement commercial production capitalised completion project commencement commercial operation detail pre operative expense cr particular march march opening balance add incurred year employee benefit expense professional fee travelling expense depreciation others total less income less capitalised tangible asset nil closing balance income tax income tax expensebenefit recognized income statement consists following cr march march current tax current tax profit year adjustment current tax prior period total current tax expense deferred tax expensebenefit origination reversal timing difference total income tax expense recognized income statement b reconciliation effective tax rate following reconciliation company effective tax rate year ended st march accounting profit income tax enacted tax rate india computed expected tax benefitexpenses effect nondeductible expense effect exempt nonoperating income tax effect chargeable different rate additional deduction r expense investment allowance plant machinery others deductible expense adjustment current tax prior period income tax benefitexpenses effective tax rate plan prepare perform financial statement standalone note standalone financial statement year ended st march c deferred tax asset liability tax effect significant temporary difference resulted deferred tax asset liability description created difference given cr particular march march april deferred tax liability property plant equipment gain financial instrument fair value profit loss total deferred tax liability deferred tax asset leave encashment bonus provision expired good remeasurement gain loss defined benefit plan mat credit entitlement provision loss allowance total deferred tax asset deferred tax liability set movement deferred tax liability net opening balance remeasurement gain loss defined benefit plan tax benefitexpense period recognised profit loss closing balance charge relating temporary difference year ended st march primarily account property plant equipment gain investment fvtpl partially offset provision expired good provision loss allowance compensated absence mat credit entitlement credit temporary difference year ended st march primarily account property plant equipment gain investment fvtpl partially offset provision expired good compensated absence provision loss allowance forward contract receivable firsttime adoption ind pursuant company indian accounting standard rule company adopted st march reporting date first time adoption indian accounting standard indas consequently st april transition date preparation financial statement financial statement year ended st march first financials prepared accordance indas upto financial year ended st march company prepared financial statement accordance accounting standard notified section company act read together company account rule previous gaap preparing financial statement opening balance sheet prepared st april ie date transition indas figure previous period year ended st march restated regrouped reclassified wherever required comply indas schedule iii company act make comparable note explains principal adjustment made company restating financial statement prepared accordance previous gaap including balance sheet st april financial statement year ended st march annual report note standalone financial statement year ended st march exemption exception ind allows firsttime adopter certain exemption following exception applied retrospective application certain accordance ind preparing financial requirement ind statement transition ind company applied derecognition financial asset financial following exemption liability company elected continue carrying company elected apply derecognition value property plant equipment requirement financial asset financial recognised st april measured per liability ind prospectively previous gaap use carrying value transaction occurring date deemed cost property plant transition ind equipment classification measurement financial asset company elected continue carrying company classified financial asset value intangible asset recognised accordance ind basis st april measured per previous gaap fact circumstance exist date use carrying value deemed cost transition ind intangible asset government loan ind sharebased payment per ind company applied applied equity instrument sharebased requirement ind financial instrument payment transaction vested date ind accounting government transition ind grant disclosure government assistance prospectively sale tax deferral loan existing appendix c ind requires entity date transition ind assess whether contract arrangement recognised corresponding benefit loan contains lease assessment belowmarket rate interest government carried inception contract grant company used previous gaap arrangement however company used ind carrying amount loan date transition exemption assessed arrangement ind carrying amount loan based embedded lease based condition opening ind balance sheet per ind place date transition loan classified amortised cost since difference company elected apply previous gaap carrying amount amount paid carrying amount investment subsidiary impact effective interest rate ie deemed cost date transition ind discounting unwinding required plan prepare perform financial statement standalone note standalone financial statement year ended st march reconciliation equity previouly reported igaap ind cr particular march date transition april previous gaap adjustment ind previous gaap adjustment ind transition transition ind ind asset noncurrent asset property plant equipment b capital workinprogress c investment property goodwill e intangible asset f intangible asset development g biological asset bearer plant h financial asset investment ii trade receivables iii loan iv others deferred tax asset net j noncurrent asset current asset inventory b financial asset investment iitrade receivables iiicash cash equivalent ivbank balance iii vloans viothers c current tax asset net current asset total asset equity liability equity equity share capital b equity liability noncurrent liability financial liability borrowing ii trade payable iii financial liability b provision c deferred tax liability net noncurrent liability current liability financial liability borrowing ii trade payable iii financial liability b current liability c provision current tax liability net total equity liability annual report note standalone financial statement year ended st march reconciliation statement profit loss previously reported igaap ind year ended st march cr previous gaap adjustment ind transition ind continuing operation income revenue operation gross income total income expense cost material consumed purchase stockintrade change inventory finished good workinprogress stockintrade employee benefit expense finance cost depreciation amortisation expense expense total expense profit tax tax expense current tax deferred tax charge credit profit year comprehensive income comprehensive income reclassified profit loss subsequent year remeasurement gain loss defined benefit plan income tax effect net comprehensive income reclassified profit loss subsequent year comprehensive income year net tax total comprehensive income year net tax easurement recognition difference ind previous gaap year ended st march fair valuation investment previous gaap investment equity instrument mutual fund classified long term investment current investment based intended holding period realisability long term investment carried cost less provision temporary decline value investment current investment carried lower cost fair value ind investment required measured fair value resulting fair value change investment recognised retained earnings date transition subsequently profit loss year ended st march increased retained earnings cr net deffered tax st march st april cr proposed dividend previous gaap proposed dividend including dividend distribution tax ddt recognised liability period relate irrespective declared ind proposed dividend recognised liability period declared company usually approved shareholder general meeting paid plan prepare perform financial statement standalone note standalone financial statement year ended st march therefore dividend liability proposed dividend retained earnings comprehensive including dividend distribution tax liability amounting income thus employee benefit expense reduced cr derecognised retained cr recognised comprehensive earnings date transition income cr net deffered tax year ended st march proposed dividend including dividend distribution tax liability amounting cr deferred tax derecognised transition date previous gaap requires deferred tax accounting using recognised retained earnings year ended income statement approach focus st march declared paid difference taxable profit accounting profit period ind requires entity defined benefit obligation account deferred tax using balance sheet oth previous gaap ind company b approach focus temporary difference recognised cost related postemployment carrying amount asset liability defined benefit plan actuarial basis balance sheet tax base application previous gaap entire cost related post ind approach resulted recognition employment defined benefit plan including actuarial deferred tax new temporary difference gain loss charged profit loss required previous gaap ind remeasurements comprising actuarial gain loss effect asset ceiling excluding addition various transitional adjustment amount included net interest net defined lead different temporary difference deferred benefit liability return plan asset excluding tax adjustment recognised correlation amount included net interest net defined underlying transaction either retained earnings benefit liability recognised immediately separate component equity balance sheet corresponding debit credit change increased decreased deferred tax liability follows cr particular march april financial instrument employee benefit nil provision nil increase deferred tax liability comprehensive income ind item income expense recognised period included profit loss period unless standard requires permit otherwise item income expense recognised profit loss shown statement profit loss comprehensive income includes remeasurements defined benefit plan concept comprehensive income exist previous gaap statement cash flow transition previous gaap ind material impact statement cash flow ind bank overdraft repayable demand form integral part cash management process included cash cash equivalent purpose presentation statement cash flow previous gaap bank overdraft considered part borrowing movement bank overdraft shown part financing activity consequently cash cash equivalent reduced cr st march st april cr annual report note standalone financial statement year ended st march excise duty u nder previous gaap revenue sale product presented exclusive excise duty ind revenue sale good presented inclusive excise duty excise duty paid presented face statement profit loss part expense change resulted increase total revenue total expense year ended st march inr cr impact total equity profit cash discount nder previous gaap cash discount cr recognised part expense adjusted u revenue ind year ended st march impact total equity profit retained earnings change decreased increased retained earnings follows cr particular march april financial instrument net proposed dividend nil provision net increase retained earnings preparation indas financial statement company made several presentation difference previous gaap indas difference impact reported profit total equity accordingly asset liability reclassified another line item indas date transition financial statement line item described differently indas compared previous gaap although asset liability included line item unaffected see accompanying note forming part financial statement per report even date attached kapoor parekh associate behalf board director chartered accountant nilesh parekh mannalal b agrawal partner chairman purushottam b agrawal yogesh agrawal arvind agrawal vice chairman managing director chief financial officer madhusudan b agrawal rajesh agrawal gaurang shah mumbai rd may vice chairman joint managing director company secretary cin lmhplc redg office ajanta house charkop kandivali west mumbai tel fax website wwwajantapharmacom email investorgrievanceajantapharmacom notice notice hereby given thirtyeighth annual general office conclusion annual general meeting till meeting member ajanta pharma limited held conclusion rd annual general meeting subject wednesday th day july aspee ratification appointment shareholder every auditorium laxminarayan mandir complex marve road next annual general meeting held annual general nutan school malad west mumbai transact meeting remuneration mutually agreed following business board director bsr co llp ordinary business resolved board director company secretary hereby authorized receive consider adopt settle question difficulty doubt may arise audited standalone financial statement giving effect resolution act company financial year ended st march deed thing may necessary expedient together report board desirable purpose giving effect resolution director auditor thereon special business b audited consolidated financial statement company financial year ended st march consider thought fit pa without together report auditor modification following resolution ordinary resolution confirm interim dividend paid equity share year ended st march final resolved pursuant section company act company audit auditor appoint director place mr madhusudan b rule remuneration lac plus service tax agrawal din retires rotation reimbursement actual travel outofpocket eligible offer reappointment expense fixed board sevekari khare associate cost accountant audit cost record appoint director place mr rajesh agrawal maintained company financial year ending din retires rotation st march hereby ratified eligible offer reappointment consider thought fit pa without order board director modification following resolution ordinary resolution gaurang shah resolved pursuant provision section rd may avp legal applicable provision company company secretary act company audit auditor rule registered office bsr co llp chartered accountant firm ajanta house charkop registration ww hereby kandivali west appointed statutory auditor company hold mumbai note term section company act explanatory statement pursuant section dividend remaining unpaid period seven company act set detail relating year due date payment required special business meeting annexed hereto transferred investor education protection fund accordingly unpaid dividend lying dividend member entitled attend vote account year transferred meeting entitled appoint proxy investor education protection fund appropriate attend vote instead time current financial year member proxy need member company encashed dividend warrant requested write person cannot act proxy member exceeding registrar share transfer agent shareholder fifty holding aggregate ten visit company website wwwajantapharmacom percent total share capital company check detail unclaimed dividend investor section proxy form sent herewith proxy form order effective must duly completed signed deposited shareholder seeking information regard registered office company less hour annual report requested write company commencement meeting proxy submitted early date information kept ready behalf company society etc must supported appropriate resolutionauthority applicable support green initiative government electronic copy annual report year ended corporate member intending send authorised st march notice th agm representative attend meeting requested sent member whose mail id available send company certified copy board companydepository participant communication resolution authorising representative attend purpose unless member requested physical vote behalf meeting copy member registered email address physical copy annual report pursuant regulation listing regulation notice sent permitted secretarial standard general meeting issued mode please note annual report notice institute company secretary india detail th agm also posted website www director seeking reappointment annual general ajantapharmacom download copy annual meeting agm form part notice report shall provided shareholder agm required register member transfer book respect equity share remain closed voting electronic mean wednesday th june wednesday th july compliance provision section day inclusive purpose agm company act rule company management administration rule order prevent fraudulent encashment dividend amended company management warrant company encourages remittance administration amendment rule dividend ecsneft dividend future would regulation sebi listing obligation remitted ecsneft shareholder disclosure requirement regulation registered mandate company company pleased provide member facility bank particular registered respective depository exercise right vote resolution account respect share held demat mode proposed considered th agm shareholder therefore requested update electronic mean business may bank account detail transacted evoting service facility casting vote member using electronic respect share held demat mode informing voting system place venue change depository participant agm remote evoting provided national member security depository limited nsdl ii respect share held physical mode furnish ii remote evoting period commences sunday mandate company company rt nd july end tuesday th agent link intime india private limited bank account july pm period member detail dividend shall remitted company holding share either physical ecsneftnecs form dematerialized form cutoff date wednesday th june may cast vote xii institutional shareholder ie remote evoting remote evoting module shall individual huf nri etc required disabled nsdl voting thereafter vote send scanned copy pdfjpg format resolution cast member member relevant board resolution shall allowed change subsequently authority letter etc together attested specimen signature duly authorized iii instruction evoting signatoryies authorized case member receives email nsdl vote scrutinizer email member whose email id registered scrutinizerajantapharmacom companydepository participantss copy marked evotingnsdlcoin open email open pdf file viz apl b case member receives physical copy remote evotingpdf client id notice agm member whose email id folio password said pdf file registered companydepository contains user id passwordpin participantss requesting physical copy remote evoting please note password initial password initial password provided attendance slip agm note shareholder already registered even e voting event number nsdl evoting receive user id ___________ pdf file aplremote evotingpdf passwordpin _________ ii launch internet browser typing following ii please follow step sr ii sr url httpswwwevotingnsdlcom xii cast vote iii click shareholder login iv case query may refer frequently asked question faq shareholder remote iv put user id password click login evoting user manual shareholder available downloads section wwwevotingnsdlcom call v password change menu appears change toll free passwordpin new password choice minimum digit v already registered nsdl remote evoting character combination thereof note use existing user id passwordpin new password strongly recommended casting vote share password person take utmost care keep note shareholder forgot user detail password confidential password use forgot user detailspassword physical user reset password option available vi home page evoting open click wwwevotingnsdlcom evoting active voting cycle case shareholder holding share demat select electronic voting event number vii mode user id combination dp id client id even ajanta pharma limited case shareholder holding share physical viii ready evoting cast mode userid combination even vote page open folio ix cast vote selecting appropriate vi also update mobile number email id option click submit also user profile detail folio may used confirm prompted sending future communication upon confirmation message vote x vii voting right member shall proportion cast successfully displayed share paid equity share capital company cutoff date wednesday voted resolution xi th june person whose name recorded allowed modify vote register member register beneficial owner maintained depository chairman person authorized cutoff date shall entitled avail writing shall countersign facility remote evoting well voting declare result voting forthwith agm person ceased member company cutoff date result declared alongwith report xii entitled remote evoting voting meeting scrutinizer shall placed website person becomes member company company wwwajantapharmacom dispatch notice holding share website nsdl immediately declaration cutoff date may obtain login id password result chairman person authorized sending request evotingnsdlcoin writing result shall also immediately company however already registered forwarded bse limited nse mumbai nsdl evoting use existing user id passwordpin casting vote pursuant section act member holding share physical form advised file nomination viii member may participate agm even prescribed form sh company share exercising right vote remote evoting transfer agent respect share held electronic shall allowed vote agm demat form member may please contact respective depository participant ix mr alwyn dsouza practicing company secretary mumbai membership certificate register director key managerial personnel practice appointed shareholding maintained section scrutinizer providing facility member act register contract arrangement company scrutinize voting remote director interested section evoting process fair transparent manner act available inspection agm x chairman shall agm end discussion route map showing direction reach venue resolution voting held allow th agm given end notice per voting assistance scrutinizer use requirement secretarial standards general ballot paper member present meeting agm cast vote availing remote evoting facility order board director xi scrutinizer shall conclusion voting general meeting first count vote cast gaurang shah meeting thereafter unblock vote cast avp legal remote evoting presence least rd may company secretary two witness employment company shall make later three day regd office conclusion agm consolidated scrutinizer ajanta house charkop report total vote cast favour kandivali west mumbai explanatory statement respect special business accompanying notice pursuant section company act item board recommends resolution item accompanying notice approval member pursuance section company act company rule company audit auditor rule board shall appoint cost accountant practice none director andor key managerial personnel auditing cost record company appointment shall company relative concerned interested recommendation audit committee financial otherwise resolution set item shall also recommend remuneration cost auditor remuneration recommended audit committee shall order board director considered approved board director ratified shareholder gaurang shah recommendation audit committee board avp legal meeting held rd may considered approved rd may company secretary appointment sevekari khare associate cost accountant cost audit cost record maintained regd office company remuneration lac plus service tax ajanta house charkop applicable reimbursement actual travel kandivali west mumbai pocket expense year ending st march subject ratification member route map venue agm address aspee auditorium laxminarayan mandir complex marve road next nutan school malad west mumbai maharashtra map legend aspee auditorium malad station new link road way highway way distance malad station km mith chowky km pushpa park km scan code map detail director seeking appointmentreappointment thirtyeighth agm pursuant regulation listing regulation clause secretarial standard general meeting name director mr madhusudan b agrawal mr rajesh agrawal date birth din date appointment expertise specific functional rich experience decade strong business acumen proven record area excellent relationship management skill coupled accomplishment building growing extensive contact industry regulatory business every segment market business circle sustained improved ranking upto date knowledge latest happening effective leadership motivation skill indian pharma industry well global setting higher goal standard driving trend team achieve exceptional ability identifying business strongly pursues adhering instilling opportunity form gap patient company value workforce need availability getting developed promoting good governance culture across r getting timely regulatory organisation approval strategically launching product ahead competition core contributes innovative idea risk mitigation competence putting effective process excellent rapport industry leader control mechanism qualification ieducational bsc mba iiexperience year share held company nil relationship director brother mr purushottam b agrawal mr brother mr yogesh agrawal son key managerial personnel mannalal b agrawal uncle mr yogesh mr mannalal b agrawal agrawal mr rajesh agrawal board meeting attended five five fy directorship company inspira project limited ajanta pharma philippine inc inspira infra aurangabad limited gab investment private limited louroux bio energy limited ajanta pharma usa inc membership committee ajanta pharma limited ajanta pharma limited member c chairman executive committee executive committee b stakeholder relationship committee louroux bio energy limited executive committee bnomination remuneration committee inspira infra aurangabad limited executive committee c term condition wholetime director liable retire rotation wholetime director liable retire appointment rotation disclaimer annual report disclosed forward looking information enable investor comprehend prospect take investment decision report statement written oral periodically make contain forward looking statement set anticipated result based management plan assumption tried wherever possible identify statement using word anticipate estimate expects project intends plan belief word similar substance connection discussion future performance cannot guarantee forward looking statement realised although believe prudent assumption achievement result subject risk uncertainty even inaccurate assumption known unknown risk uncertainty materialise underlying assumption prove inaccurate actual result could vary materially anticipated estimated projected reader keep mind undertake obligation publicly update forward looking statement whether result new information future event otherwise cin lmhplc redg office ajanta house charkop kandivli west mumbai tel fax website wwwajantapharmacom email investorgrievanceajantapharmacom